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1 Introduction 
 
1 Introduction 
label: "An item used to identify something or someone, as a small piece of paper or cloth 
attached to an article to designate its origin, owner, contents, use, or destination."[1] 
tracer: "An identifiable substance, such as a dye or a radioactive isotope, that is introduced 
into a biological or mechanical system and can be followed through the course of a process, 
providing information on the pattern of events in the process or on the redistribution of the 
parts or elements involved. Also called label."[1] 
Fluorescence labeling of molecules is a powerful method to elucidate processes hidden in 
the dark. It is very sensitive and allows investigating biological pathways in their natural 
environment. Either a fluorescent molecule can be tracked on the whole, or particular 
positions within a macromolecule by following the fluorescence emission. This gives 
information about positions, distances and dynamics. However, many challenges arise in the 
labeling of complex macromolecules. Several requirements have to be fulfilled by the label, 
such as specificity of the position, good yields, a fast and simple attachment procedure, no 
disturbance of the target and its function, stability, and visibility (brightness, signal-to-
background). These aspects typically need to be optimized for each individual system. 
This work addresses the topic of fluorescence labeling and deals with the development of 
new strategies to elucidate particular mechanisms of complex RNAs. 
In the following chapter the basic characteristics of RNA are briefly introduced as well as 
FRET, a fluorescence technique used in these studies. 
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1.1 RNA 
1.1.1 The Central Dogma of Molecular Biology 
Deoxyribonucleic acids (DNA), ribonucleic acids (RNA) and proteins play a major role in 
every living organism. In the last 100 years the research in this field made outstanding efforts 
to clarify the structure, mechanism and interplay of these essential biological 
macromolecules. More than 30 Nobel prizes were awarded in this field up to now. But many 
questions are still unanswered and many details are not yet discovered. The interaction of 
DNA, RNA and proteins was summarized in 1958 to the “central dogma of molecular biology” 
(Figure 1).[2] 
 
Figure 1: Central dogma of molecular biology. Transfer of genetic information from DNA to RNA to proteins. 
DNA is the storage unit for genetic information in every living cell. It can be replicated and 
serves as a template for the synthesis of RNA. This process is called transcription. RNA can 
then further be translated into proteins, which are the essential machinery in living organism. 
However, it has been discovered that these general processes are much more complex and 
this scheme represents merely the most basic interactions of DNA, RNA and proteins. 
1.1.2 Structure of RNA 
The nucleic acids DNA and RNA contain the nucleobases guanine (G), adenine (A), 
cytosine (C) and in DNA thymine (T), or in RNA uracil (U). The bases have either purine 
based structures in case of A and G or pyrimidine based structures (Figure 2 a). The next 
bigger units (nucleotides) are formed together with a monosaccharide sugar, deoxyribose for 
DNA and ribose for RNA, and a phosphate group. These nucleotides are covalently linked 
between the sugar of one nucleotide and the phosphate group of the next nucleotide forming 
a highly negatively charged sugar-phosphate backbone. The asymmetric ends of these 
strands are denominated 3’ and 5’ according to the free linking position of the last nucleotide. 
The 3’ end has a terminal hydroxyl group on the sugar moiety and the 5’ end has a terminal 
11 
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phosphate group (Figure 2 b). Most importantly, the nucleobases can additionally form 
intermolecular hydrogen-bond interactions following Watson-Crick base pairing  
rules (Figure 2 c). 
 
Figure 2: Characteristic structural elements of nucleic acids. Differences of RNA to DNA are marked in red. 
a) Basic structural elements with atom numbering. b) Covalently linked nucleotides (boxed) form an RNA single 
strand. c) Watson-Crick base pairing formed by the nucleobases. 
Apart from the Watson-Crick base pairing scheme nucleic acids can pair in a Hoogsteen 
fashion (Figure 3) with the N7 of the purine base and the C6 group binding to N3 and N4 
face of the pyrimidine base.[3,4] The base pairing interactions lead to a double helical 
structure of DNA formed by two complementary single strands. 
 
Figure 3: Hoogsteen base pairing. Purine N7 and C6 positions interact with pyrimidine N3 and N4 positions. 
RNA typically appears single-stranded and can thus adopt various intrastrand structures. 
Besides Watson-Crick base pairs it can form further base pairs such as a GU wobble pair.[5] 
This variety of interactions allows RNA to fold flexibly into a vast range of specific three-
dimensional structures. RNA differs from DNA in the presence of a 2’-hydroxyl group at the 
ribose sugar (Figure 2 a and b). This not only makes the RNA less stable than DNA due to 
12 
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hydrolysis, but also leads to important structural differences. RNA adopts a so-called A-form 
helix for double-stranded regions, whereas in DNA the B-form predominates.[6–8] Both helix 
types are right-handed but differ in the conformation of the sugar. This leads to a narrower 
major groove and shallower minor groove of A-from RNA compared to B-form DNA. This is 
important in terms of interaction with binding partners because the bases are differently 
accessible. 
Besides the helical tertiary structures, single-stranded RNA can form a variety of 
characteristic secondary structure motifs such as hairpin loops, tetraloops, bulges, internal 
loops, multihelix and junction loops. These sub-structures can interact and play an important 
role for the tertiary structure of RNAs and hence their functions. An overview of several RNA 
motifs occurring in a functional RNA riboswitch aptamer (Chapter 2) is shown in Figure 4. 
 
Figure 4: RNA secondary structure motifs exemplified by a riboswitch aptamer. Examples for different 
structure motifs are highlighted in red. 
One example for such interplay is the ‘kissing interaction’ between two hairpin loops. The 
unpaired nucleotides of each loop base pair to form a so called loop-loop pseudoknot. Those 
structure motifs often play a crucial role in the functions of RNA as they can dynamically 
change in response to stimuli such as the binding of a metabolite.[9] 
1.1.3 Folding and Functions of RNA 
RNA is an essential biomolecule and extremely manifold in its occurrence and functions. In 
fact, the discovery that RNA fulfills such a variety of functions led to the 'RNA world 
hypothesis', proposing that RNA molecules were the precursors of all current life.[10,11] The 
RNA functions strongly depend on its structure, the so-called 'structure-function relationship'. 
The elucidation of RNA folding processes and mechanisms is therefore of interest for a 
better understanding of the associated functions. 
To stabilize secondary and tertiary structures, RNA, and for that matter also DNA, requires 
cations such as mono- or divalent metal ions due to their negatively charged backbone. A 
pre-organization is reached in the presence of K+ or Na+ whereas Mg2+ is crucial for folding 
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into complex and functional tertiary structures. The metal ions induce a contraction or 
‘collapse’ of the secondary structure into compact conformations.[12,13] The majority of metal 
ions interact non-specifically with the RNA, but some metal ions bind specifically to certain 
sites within an RNA structure and can also play crucial roles in RNA catalysis.[14] 
The first function known for RNA was its role as messenger of information stored in DNA for 
the transfer into protein synthesis (Chapter 1.1.1), but since then a vast variety of other 
functions was discovered. RNA is involved in catalysis and regulation of gene expression, 
and can be a part of large protein-RNA complexes, for example ribosomes and 
spliceosomes. Different subtypes of RNA are categorized according to their function such as 
messenger (mRNA), transfer (tRNA), ribosomal (rRNA), small nuclear (snRNA), or small 
interfering (siRNA). Apart from mRNA all other kinds are classified as non-coding RNAs, i.e. 
functional but not translated into a protein.  
The complexity of RNA functions makes it a fascinating molecule to study. To this end, non 
clarified folding mechanisms have to be understood. Not least, the elucidation of RNA folding 
processes and their three-dimensional architecture could lead to very practical applications in 
modern biotechnology and medicine, e.g. as novel targets in antibiotic drug development.[15] 
1.2 FRET (Förster Resonance Energy Transfer) 
The classical methods to elucidate the structure and function of RNA molecules, X-ray 
crystallography and nuclear magnetic resonance (NMR) spectroscopy, have certain 
limitations. The crystallization of large and complex biomolecules is tedious and often 
unsuccessful. X-ray crystallography can provide detailed structural information, but cannot 
reveal dynamics of a process. Structures obtained from NMR measurements exhibit, besides 
the structure in solution, also information about structural dynamics. However, solving large 
RNA structures consisting of several hundreds of nucleotides is to date not possible. Single-
molecule FRET for example can be used to determine distances within a molecule in motion 
to obtain conformational and kinetic details of folding processes. The fluorescence based 
techniques thus cannot be used for a complete structure determination but give the 
opportunity to investigate fundamental processes of large molecules and their dynamics in 
their natural environment. Fluorescence is manifold in its application and is extensively used 
in biotechnology, medical diagnostics, DNA sequencing, forensics and many more fields. 
1.2.1 Principle 
Luminescence is the emission of light from an electronically excited state of a molecule. The 
excitation is usually accomplished by irradiation with light. Depending on the nature of the 
excited state the emission process is called fluorescence or phosphorescence. Absorption 
and emission processes can be summarized in a Jablonski energy scheme (Figure 5). 
14 
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Different electronic states such as singlet (S) and triplet (T) of a molecule are depicted with 
their vibrational energy levels (0, 1, 2). Upon light absorption the molecule is excited from the 
singlet ground state S0 to an excited state S1 or S2 followed by a non-radiative rapid (10-12 s) 
relaxation to the lowest vibrational level of the first excited state with the same multiplicity, 
so-called internal conversion (ITC). Only from this state the molecule can return effectively to 
the ground state under emission of fluorescence, as stated by Kasha’s rule. Alternatively, it 
can undergo a spin conversion to the first triplet state T1 via intersystem crossing (ISC). 
Emission from T1 is named phosphorescence and is shifted to longer wavelength compared 
to fluorescence. Transitions from T1 to the singlet ground state S0 are quantum mechanically 
forbidden and the emission rates appear rather slow (103 to 100 s-1). In comparison, the 
emission rates of fluorescence are typically 108 s-1 corresponding to a fluorescence lifetime in 
the nanosecond range. 
 
Figure 5: Jablonski energy scheme. Excitation from singlet ground state (S0) to excited states (S1, S2), and 
emission of fluorescence or phosphorescence. 
The number of emitted photons relative to the number of absorbed photons is expressed in 
the quantum yield, which is an important characteristic of a fluorophore. The higher the 
quantum yield is, the brighter is the emission. Various processes compete with the emissive 
decay and can therefore decrease the fluorescence quantum yield, i.e. quench the 
fluorescence. The excited fluorophore can for example be deactivated by interaction with 
another molecule in solution. Förster Resonance Energy Transfer (FRET) is a non-radiative 
energy transfer between two fluorescent dye molecules.[16] The energy is transferred from a 
donor, which is in its excited state, to an acceptor, which is in its ground state (Figure 6). For 
this process to occur, the emission spectrum of the donor has to overlap with the absorption 
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spectrum of the acceptor (compare Figure 9). The thus excited acceptor then relaxes via 
radiative emission. 
 
Figure 6: Energy transfer from an excited donor fluorophore to an acceptor. a) Excitation of a donor 
fluorophore (green) and florescence emission of the donor while bound to a macromolecule. b) Energy transfer 
from an excited donor fluorophore (green) to an acceptor (red) in close proximity. The emission intensity of the 
donor is decreased and the one of the acceptor is increased. 
FRET is a highly distance dependent process. The efficiency of the energy transfer (E) can 
be expressed as a function of the distance between the dyes in accordance to equation (1): 
ܧ ൌ 1
1 ൅ ቀ ܴܴ଴ቁ
଺ (1)
with R = inter-dye distance and R0 = Förster radius. The Förster radius R0 is the distance at 
which the efficiency is 50 % (see Figure 7). 
0 20 40 60 80 100
0.0
0.5
1.0
E F
R
ET
R [Å]
R0 = 50 Å
 
Figure 7: Distance dependency of the energy transfer efficiency E. R0 is the Förster distance at which the 
efficiency is 50 %. 
Typically Förster radii are in the range from 15 to 60 Å. Exploiting this distance dependency, 
a common application of FRET is the measurement of distances within macromolecules 
(spectroscopic ruler), between donor and acceptor dyes. If the dyes are attached to remote 
locations within a macromolecule, the monitoring of the FRET efficiency can give real-time 
information about conformational dynamics of the molecule. 
 
a) b)
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Importantly, the efficiency of the energy transfer depends on several factors: 
 relative emission strength of the donor and acceptor fluorophores, 
 donor-acceptor separation (distance), 
 fluorescence quantum yield of the isolated donor, 
 relative orientation of donor and acceptor transition dipoles, 
 spectral overlap between donor emission and acceptor excitation. 
Only the donor-acceptor distance directly appears in equation (1). The donor quantum yield, 
relative orientation, and spectral overlap are indirectly included as they influence the Förster 
radius R0. The Förster radius (in Å) can thus be expressed as: 
ܴ଴଺ ൌ 8.79 ൈ 10ିହ൫ߢଶ݊ିସܳ஽ܬሺߣሻ൯ (2) 
with ߢଶ being a factor describing the relative orientation of the fluorophore dipoles, ܳ஽ being 
the quantum yield of the donor in absence of an acceptor, ݊ being the refractive index, and 
ܬሺߣሻ being the overlap integral over the wavelength in nm, which expresses the degree of 
spectral overlap between donor emission and acceptor absorption.[17] 
The Förster radius R0 is a specific constant for a given dye pair. However, it is based on the 
assumption of free rotation of the fluorophores. The attachment of the dye to a 
macromolecule can impede the rotational freedom, leading to a changed apparent R0 value. 
As can be seen on the basis of the discussion about the Förster radius, the choice of the 
dyes is of high importance. Many additional factors have to be considered such as 
photostability, availability, and interaction with the target molecule. 
1.2.2 Cyanine Dyes 
Cyanine dyes (Cy) are widely used in biological applications such as structural investigations 
of nucleic acids. A common FRET pair is Cy3 (donor) and Cy5 (acceptor). The popularity of 
these cyanine dyes is due to their photostability and commercial availability.[18] The class of 
(carbo)cyanine dyes are based on a polymethine structure, which is a CH chain with 
alternating single and double bonds giving an extended π-conjugates system (see Figure 8). 
Generally, an extension of the π-system leads to a decrease in the HOMO-LUMO gap and 
thus to a red-shift of the absorption band. In this way, the emission and excitation wavelength 
can be tuned. The number in the name of the cyanine dyes designates the length of this 
chain. Cyanines typically have the structure depicted in Figure 8, but variations in the 
substituents R (e.g. methyl, ethyl) and R' (e.g. sulfonate, H), and even more drastically 
substitutions such as the replacement of the phenyl by naphthyl moieties are possible.  
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For the present studies Cy3 (n = 1) and Cy5 (n = 2) with R = methyl, R’ = H or SO32- were 
used. 
 
Figure 8: Common structure of cyanine dyes. n = 1 Cy3, n = 2 Cy5. The number in the name describes the 
length of the polymethine chain. 
Cyanine dyes have absorption and emission wavelengths above 550 nm. They typically 
display a rather small Stokes shift with the emission maxima being red-shifted about 30 nm 
from the absorption maxima (Figure 9).[17] 
 
Figure 9: Absorption and emission spectra of Cy3 and Cy5. Overlay of normalized absorption and emission 
spectra of Cy3 (green) and Cy5 (red).[19] The spectral overlap of the Cy3 emission with the Cy5 absorption (solid 
lines) is depicted in grey. 
The photophysical properties of the cyanine dyes depend strongly on their surroundings. For 
example, photoisomerization, that is rotation among the polymethine chain, deactivates the 
first singlet excited state to a ground state photoisomer. The efficiency of this process is 
dependent on the environment,[20–22] leading to a strong dependence of the their quantum 
yields on the viscosity of solvent.[23] 
Cy3 donor Cy5 acceptor
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A variation on the classical fluorophore-fluorophore energy transfer scheme is the use of so-
called dark quencher dyes, which can function as acceptors. They dissipate the absorbed 
energy without exhibiting fluorescence, therefore reducing issues due to background 
fluorescence. One example for dark quenchers are the so-called ‘black hole 
quenchers’ (BHQ), which quench by FRET and static quenching mechanisms.[24] 
Cyanine Dyes as Fluorescent Probes for Nucleic Acids 
Cyanine dyes are applied in various fluorescence techniques, e.g. for the imaging of single 
molecules in living cells,[25] and fluorescence in situ hybridization (FISH).[26] Especially Cy3 
and Cy5 are often used for covalent labeling of nucleic acids, proteins and peptides.[27] 
For the labeling of nucleic acids a couple of important points have to be considered. The 
attachment of the dye to the RNA, and macromolecules in general, can impede the rotational 
freedom. Increasing the length of linkage between the dye and the RNA can support the free 
dye rotation but leads to greater uncertainties for intermolecular distances in RNA due to the 
increased conformational flexibility of the linker.[21] Moreover, it is known that the 
fluorescence of Cy3 and Cy5 is enhanced by the attachment to nucleic acids. This is due to a 
reduced trans-cis isomerization (vide supra) caused by dye-nucleobase interactions.[20–22,28,29] 
Furthermore, terminally attached Cy3 and Cy5 appear stacked at the 5'-end of a DNA duplex 
similar to an additional base pair. This behavior has been observed with both a short (3 
carbon) and a long (13 atoms) tether. The stacking thus influences the FRET efficiency.[30–34] 
1.2.3 Single-Molecule FRET Microscopy 
Förster Resonance Energy Transfer is a powerful tool to study the conformational dynamics 
of biomolecules, especially on the single molecule level (smFRET).[35–38] Following a single 
molecule at a time with FRET reveals detailed information about folding pathways that are 
lost in ensemble measurements due to the inherent signal averaging. Several fundamental 
processes have been investigated with this technique, e.g. the dynamics of ribosomal 
translation,[39] and the ligand recognition of a riboswitch aptamer.[40] 
More generally, single-molecule microscopy is used in a variety of different approaches such 
as fluorescence correlation spectroscopy, atomic force microscopy, confocal microscopy or 
total internal reflection fluorescence (TIRF) microscopy. TIRF is based on the excitation of 
molecules by an evanescent wave, which is formed at the interface between the microscope 
slide and the sample solution and only extends 100 – 200 nm in the solution. The small 
excitation volumes lead to a reduced background if surface-immobilized molecules are 
imaged. The TIRF effect can be realized by a prism-based (Figure 10) or objective-based 
method. A conventional TIRF setup consists of laser(s) for the excitation of the fluorophores, 
a measuring chamber placed on a microscope with an objective to collect the fluorescence 
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emission, and a CCD camera for the detection of the single-molecule fluorescence. Notably, 
in all setups featuring a camera the time resolution is limited by the frame rate of the CCD 
camera.[18,41] 
 
Figure 10: Single-molecule detection by prism-based TIRF microscopy. The laser beam (green line) is 
focused through a prism towards immobilized molecules labeled with dyes. The angle of incidence θ must be 
greater than θc (critical angle) to achieve TIRF. Emitted fluorescence (red and green wavy arrows) is detected by 
an objective. Figure based on Ref. [42]. 
Each well separated single molecule can be detected as individual spot in wavelength 
separated donor and acceptor channels to obtain fluorescence trajectories. In case of energy 
transfer changes, these trajectories typically exhibit an anti-correlated behavior. Due to the 
distance dependency of the energy transfer between the fluorophores, the intensity of donor 
emission is decreased while the one of the acceptor is increased when the fluorophores get 
closer to one another (Figure 11 a). Apparent FRET is thus calculated (Figure 11 b) from the 
intensities of the donor (ID) and acceptor (IA) emission: 
ܨܴܧܶ ൌ ܫ஺ܫ஽ ൅ ܫ஺ (3)
The obtained FRET is further analyzed by specialized software which allows a detailed 
thermodynamic and kinetic analysis. FRET trajectories can be binned into histograms to 
reveal the relative probability of each state (Figure 11 c) and rate constants can be 
determined from the dwell-times of different states (Figure 11 b). 
Quartz slide
Cover slip
Biotin
Streptavidin
532 nm
Prism
Objective
Buffer solution
θ
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Figure 11: Example of single-molecule trajectories and data analysis by use of an RNA model system.     
a) Fluorescence emission time trajectories from donor (green) and acceptor (red) fluorophores. b) Calculated 
FRET time trajectory with dwell-times (τ) of formation and dissociation states of an RNA complex. c) FRET 
histogram obtained from binning of single time trajectories. Reprinted from Ref. [41], Copyright (2009), with 
permission from Elsevier. 
Sample immobilization can be reached by different methods. A commonly used approach is 
the use of a biotin-streptavidin linkage (Figure 10). In case of nucleic acid studies biotinylated 
bovine serum albumin (BSA) is adsorbed at the surface of a quartz slide. For proteins 
polyethylene glycol (PEG) is often used for passivation.[18] The photostability of the 
fluorophores can be increased by addition of different reagents such as oxygen scavenging 
systems. Additionally, triplet-state quenchers can be added, e.g. Trolox, to reduce 
photoinduced blinking, i.e. random fluorescence intensity-fluctuations, of the dyes.[18,35,41,43–45] 
As smFRET is an extremely sensitive method reliable results depend on a vast variety of 
factors such as sample preparation, selection of the fluorophores and their respective 
position within the target molecule, background noise issues, photostability, and data 
analysis. However, the opportunity to answer fundamental questions about transcription, 
translation, RNA folding and catalysis, conformational changes and many more makes this 
method so important. 
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1.3 Thesis Outline 
The aim of this work is the development and improvement of new fluorescence labeling 
strategies for the investigation of folding mechanism of large functional RNA systems by 
Förster Resonance Energy Transfer. Our particular interest is the elucidation of the complex 
mechanism of B12 binding to the btuB riboswitch of E. coli and its subsequent structural 
rearrangement (Figure 12). As FRET is based on the energy transfer from a donor 
fluorophore to an acceptor, a labeling of the target molecule(s) is necessary. 
 
Figure 12: Labeling strategy for the investigation of the btuB riboswitch by FRET. Structural rearrangement 
of the RNA upon binding of B12 and resulting FRET between the fluorophores (green and red). 
Chapter 2 focuses on the labeling of the metabolite B12. The synthesis of new fluorescent B12 
derivatives and their characterization is described. Furthermore, in-line probing experiments 
are conducted to characterize the influence of the modified derivatives on the btuB riboswitch 
structure.  
Chapter 3 deals with the labeling of large RNAs with 
PNA-dye conjugates as specific indirect labels. The 
investigation and optimization of the labeling is 
described using the group II intron ribozyme as 
model. This system has been well studied and 
therefore allows a critical comparison of data 
obtained with the new PNA-based strategy and the 
previously used DNA-based one. The goal is to 
proof and improve the applicability of PNA probes 
for fluorescence techniques especially smFRET. 
Chapter 4 goes beyond the scope of the previous chapters and describes collaborations for 
further applications of the fluorescent PNA derivatives, as well as studies on the influence of 
Rhenium compounds on RNA, exemplified once more on the group II intron model.
Co
Co
Figure 13: Group II intron model system
with dye- labels. 
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2 Labeling of B12 
2.1 Introduction 
The btuB riboswitch RNA of Escherichia coli possesses a gene regulating function by 
rearranging its three dimensional structure (“switching”) upon specific binding of cobalamin 
(Chapter 2.3).[46] This B12-dependent riboswitch has one of the most complex riboswitch 
structures and its metabolite B12 is the largest metabolite binding to RNA. Yet, the binding of 
the B12 to the btuB riboswitch and the structural rearrangement of the RNA is not fully 
understood. The elucidation of this complex mechanism can give new insights into 
fundamental processes of RNA function and interaction. Manifold applications could arise 
from this. Riboswitches are already under investigation for intracellular sensors for the 
detection of small molecule concentrations to study cellular processes.[47] Synthetic 
riboswitches can be used to control gene expression in cell-like systems.[48] Furthermore, 
riboswitches have been identified as highly selective antibacterial drug targets, addressable 
by non-functional metabolite mimics.[15] 
The secondary structure and binding/switching capabilities of the RNA can be investigated 
by in-line probing (Chapter 2.3.5).[49] Moreover, several smaller riboswitches have already 
been explored by single-molecule FRET.[50] This technique could be used to gather 
information about the folding dynamics of the btuB riboswitch of E. coli upon metabolite 
binding. To date, this large and complex system has not been studied by such a real-time 
method. 
2.2 B12 
2.2.1 Structure and Reactivity 
Cobalamines, also named B12, are complex biomolecules and among the largest 
metabolites, and play important roles in living organism, including the human metabolism. 
The most prominent B12 derivatives are vitamin B12 (cyanocobalamin, CNCbl, VitB12), the 
organometallic cofactor coenzyme B12 (5’-deoxy-5’adenosylcobalamin, AdoCbl), 
methylcobalamin (MeCbl), aquocobalamin (AqCbl) and hydroxocobalamin (OHCbl). The red 
cobalt(III)-complex vitamin B12 was first isolated in the late 1940’s. For the elucidation of the 
complex structure of B12, and others, by X-ray crystallography D. Crowfoot Hodgkin was 
awarded the Nobel Prize in 1964 (Figure 15).[51] 
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The basic structure of B12 derivatives is composed of several characteristic subunits: a 
cobalt-coordinating corrin macrocycle with a dimethyl-
benzimidazole (DMB) nucleotide moiety at the α-face (lower) and 
a ligand (R) on the β-face (Figure 14). The Co3+ center is 
coordinated to six ligand atoms in a pseudo-octahedral 
conformation including four nitrogen atoms in the corrin ring as 
part of the π-conjugated chromophore system.[52] These corrin 
based cyclic systems containing four pyrrole rings (A-D in Figure 
14) similar to porphyrins belong to the group of corrinoids. So-called ‘complete’ corrinoids 
coordinate a nucleotide base at the α-face of the cobalt-center (‘base-on’). Typically this 
‘base-on’ form is favored and the one being recognized by proteins. However, a switch to a 
‘base-off’ (DMB-base de-coordinated) form can occur at higher temperatures, upon 
protonation of the nucleotide base or substitution by an external group such as histidine by 
binding to proteins or cyanide. The molecular switch between ‘base-on’ and ‘base-off’ is an 
important feature of B12 to modulate its organometallic reactivity and redox chemistry 
regarding the needs of the corresponding enzyme.[53–55] 
 
Figure 15: Structure and nomenclature of cobalamin derivatives. a) Chemical structure of cobalamin and 
characteristic elements.[56] b) Crystal structure of AdoCbl; figure kindly provided by Dr. Joachim Schnabl. 
Figure 14: Schematic 
structure of cobalamins. 
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In coenzyme B12 (adenosylcobalamin, AdoCbl) the ligand R = 5’-deoxy-5’-adenosyl is 
coordinated at the β-face of the cobalt center via a highly light sensitive organometallic Co-C 
bond (Figure 15).[57,58] The Co-C bond can be cleaved homolytically (Scheme 1) via a one-
electron ‘inner-sphere’ reduction as for AdoCbl or heterolytically as a two-electron ‘inner-
sphere’ reduction as for methylcobalamin.[53,59,60] Homolytic cleavage of AdoCbl with a bond 
dissociation energy of ~30 kcal mol-1 leads to a formation of a 5’-deoxyadenosyl radical and 
cob(II)alamin (B12r; Scheme 1).[61] The penta-coordinated radicaloid B12r can further react with 
alkyl radicals as a β-specific ‘radical trap’ or with oxygen to form hydroxocob(III)alamin.[62–64] 
 
Scheme 1: Photolytic Co-C bond cleavage. Formation of a radical (R) and cob(II)alamin upon homolytic Co-C 
bond cleavage of organometallic B12 derivatives; e.g. R = 5’-deoxyadenosyl.[56] 
MeCbl can react via a nucleophilic attack to form cob(I)alamin and a methylating agent. With 
its ability to transfer the methyl group to nucleophiles, MeCbl fulfills a cofactor function for 
enzymes.[53,56] 
2.2.2 Biological Relevance 
The physiological role of vitamin B12 derivatives is mainly fulfilled by the organometallic 
cofactors, which are involved in human, animal and microbial metabolism. In fact, B12 
cofactors catalyze a variety of biological processes that are essential for many living 
organisms. Several enzymes, e.g. corrinoid dehalogenases and methyl transferases, use B12 
as a cofactor, often in a ‘base-off/His-on’ form with a histidine provided by the ‘B12-binding 
motif’ of the protein (His-X-Asp). B12 binds further to proteins such as B12 transport proteins 
and interacts with nucleic acids (Chapter 2.3.4).[53,65,66] 
Microorganisms in the class of bacteria and archaea are able to partially or fully synthesize 
B12. E. coli and several other bacteria require either cobinamides (‘incomplete’ corrinoids that 
lack the nucleotide) or different cobalamins for the conversion into MeCbl and coenzyme B12. 
In gram-negative bacteria the corrinoid transport depends on the ‘B-twelve-uptake’ (Btu) 
system (Figure 16). The outer membrane transporter BtuB binds the corrinoids and transfers 
the substrate into the periplasm. It is trapped there by BtuF and further transferred to the 
cytoplasm via the inner membrane transporter BtuC2D2F.[56,67–72] 
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Figure 16: Schematic overview of B12 transport in E. coli by the Btu system. Corrinoids cross the outer 
membrane trough the transport protein BtuB, are transferred through the periplasm by BtuF and further to the 
cytoplasm by BtuC2D2F. 
Mammals cannot synthesize corrinoids at all and are dependent on uptake by nutrition. The 
corrinoids such as vitamin B12 are then metabolized to the physiologically relevant cofactors, 
e.g. AdoCbl. 
2.3 Riboswitches 
2.3.1 Classification and Function 
The relationship between structure and function of biomolecules is fundamental for the 
explanation of biochemical processes. An example for this is the class of riboswitches, 
regulatory elements that serve as cis-acting genetic control modules with response to target 
ligands.[73–76] Riboswitches are involved in the synthesis or import of cognate metabolites by 
feedback repression of genes, and recognize fundamental metabolites such as coenzymes, 
amino acids, nucleobases and aminosugars. More than 20 distinct classes of riboswitches 
have been identified to date. The size of the metabolite-binding domains can vary from 
smaller structures as for preQ1 (34 nts, prequeuosine-1) to large complex structures as for 
AdoCbl (~200 nts). These metabolite-sensing RNAs are involved in regulatory mechanisms 
of transcription, translation and alternative splicing. Typically, riboswitches are located in the 
5’ untranslated region (UTR) of bacterial mRNA. They generally consist of an aptamer 
domain and an expression platform, and can up- or down-regulate gene expression. 
Depending on the metabolite concentration both domains participate in folding and in a 
structural rearrangement forming an intrinsic transcription terminator or competing RNA 
structure (Figure 17). The aptamer is crucial for the binding of the metabolite and is 
interacting with the expression platform that translates the information to control the 
expression.[73] Two main types of expression platforms are known. One is based on the 
mechanism of transcription termination. An intrinsic terminator stem is formed, typically 
followed by five to nine uridines, which causes the RNA polymerase (RNAP) to halt 
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transcription (Figure 17 a).[77,78] The other regulatory mechanism relies on the influenced 
accessibility of the Shine-Dalgarno (SD) sequence, which is a ribosomal binding site 
consisting of a short, purine-rich sequence that recruits 30S ribosomal subunits near AUG 
start codons of mRNA.[79] Riboswitches involving a SD sequence modulate translation 
initiation upon their ligand-induced structural changes (Figure 17 b).[73,74,80] 
 
Figure 17: Mechanism of riboswitch-mediated gene control. Schematic representation of a riboswitch that 
represses gene expression upon ligand binding by controlling a) transcription termination, and b) translation 
initiation. Figure adapted from Ref. [73]. 
2.3.2 B12-Sensing Riboswitches 
B12-riboswitches are among the largest and most complex of these regulatory RNAs. They 
can bind B12 derivatives such as coenzyme B12, methylcobalamin and aquocobalamin. 
Comparison among known riboswitch structures revealed common structural elements. 
Based on this, B12-dependent riboswitches are divided into two classes depending on the B12 
derivative they bind.[81–83] The AdoCbl-binding class differs from the AqCbl- and MeCbl-
binding class in an additional peripheral extension of the pairing element P6 by P7-P11 
(Figure 18 a). A common core around a four-way junction (J), and a ‘kissing-loop’ interaction 
(see Chapter 1.1) between loop L5 and L13 are similar in both classes. In transcription 
a)
b)
Ribosome
28 
2 Labeling of B12 
 
regulating riboswitches, P13 typically involves the anti-terminator, whereas P13 in translation 
regulating riboswitches contains the ribosomal binding site (RBS) or related structures (vide 
supra). The junction J6/3 between the pairing elements P3 and P6 is the key element for 
cobalamin recognition, as known from crystal structures of AdoCbl-binding riboswitches of 
Symbiobacterium thermophilum and Thermoanaerobacter tengcongensis (Tte; Figure 18 b 
and c), as well as of the smaller AqCbl-binding env8AqCbl. The conformation of the junction 
J6/3 in the AdoCbl-binding class is defined by the extensions P7-P11 providing a cavity for 
the adenosyl moiety. It serves as a cobalamin-binding pocket mainly driven by van der Waals 
interactions. The AqCbl-binding-class reaches ligand specificity for AqCbl by the 
arrangement of the purines within the junction, limiting the space available for the B12. 
Consequently, the binding of B12  derivatives containing large substituents on the β-face is 
prevented by sterical hindrance. The kissing-loop interaction L5-L13 encapsulates the bound 
cobalamin.[81–83] 
 
Figure 18: Crystal structures of B12 riboswitches. a) Secondary structure organization of AdoCbl riboswitches. 
Junction J6/3 (blue) is the key element for ligand recognition. Loops L5 (green) and L13 (red) form a kissing-loop 
interaction upon B12 binding.[81] b) Ribbon representation of the AdoCbl riboswitch structure of S. thermophilum 
bound to AdoCbl. Figure adapted by permission from Macmillan Publishers Ltd: Nature Structural & Molecular 
Biology, Ref. [82], copyright 2012. c) Representation of the AdoCbl-bound riboswitch Tte. Figure adapted from 
Ref. [81] with permission. 
2.3.3 The btuB Riboswitch of E. coli 
One of the first representatives in the class of riboswitches that was discovered is the btuB 
riboswitch of Escherichia coli. It specifically binds coenzyme B12 as its natural ligand. The 
btuB riboswitch is located in the 5’ UTR of the btuB gene, which encodes an outer membrane 
protein that is involved in the B12 transport (Chapter 2.2.2). Expression of the btuB protein is 
repressed only by AdoCbl, by inhibiting ribosome binding to the riboswitch.[74,84] This 
riboswitch is therefore actively involved in the regulation of the cobalamin concentration. 
b) c)a)
L5
L13
P6
P11P1 5’
3’
J6/3
P7 P8
P10
P13
P3
29 
2 Labeling of B12 
 
Phylogeny, structure modeling, structural mapping and transcription pausing studies 
provided a consensus structure model of the btuB riboswitch of E. coli.[46,84,85] Nevertheless, 
the complete structure remains unknown as no crystal structure is available so far for this 
riboswitch. The riboswitch is composed of two functional domains; one serves as natural 
aptamer (~200 nts) that binds B12, and the other one is an expression platform (~40 nts) that 
is responsible for the gene regulation (Figure 19 a).[46] 
 
Figure 19: Secondary structure of the btuB riboswitch of E. coli. a) Aptamer and expression platform (box) in 
the gene-off state (B12 bound and ribosomal binding site (RBS) blocked). b) Antiaptamer, gene-on (B12 not bound, 
RBS accessible).The start codon AUG of the coding region is underlined.[46,85] 
 
Figure 20: Folding of the btuB riboswitch of E. coli upon B12 binding. The ribosomal binding site (RBS) 
marked in green is blocked due to the structural rearrangement of the riboswitch upon B12 binding (red). A kissing-
loop interaction is highlighted in orange. Based on figure from Dr. Sofia Gallo.[86] 
At high cellular concentrations of coenzyme B12, the metabolite binds to the aptamer and 
induces a conformational switch (schematically shown in Figure 20). The expression 
platform, including the ribosomal binding site (RBS), is thereby structurally rearranged. 
Consequently, the RBS becomes inaccessible and the translation of the protein is 
suppressed (bound, gene-off, Figure 19 a). At low concentration of the B12 metabolite, the 
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RNA adopts an antiaptamer structure that allows for translation (apo, gene-on, Figure 19 b). 
More in detail, the large aptamer domain folds into a complex tertiary structure depending on 
B12 binding, whereas the expression platform folds into simple secondary structures dictated 
by the aptamer. When B12 is bound the anti-anti-RBS region is part of the aptamer, the 
formation of a hairpin loop of the anti-RBS with the RBS region takes place and gene 
translation is thus turned off. In the ligand-free apo form the anti-anti-RBS is paired with the 
anti-RBS including a three-way junction, and the RBS is in a single-stranded region and 
consequently available for ribosome binding.[46,74,85] Experiments carried out in transcription 
mixture and in comparison with purified and refolded RNA revealed that the transcription 
plays a crucial role for efficient folding and conformational change of the btuB riboswitch. 
Transcriptional pausing by E. coli RNA polymerase at the end of the aptamer domain 
coordinates the formation of the secondary structure of the expression platform.[85] 
2.3.4 Interactions of the btuB Riboswitch and Coenzyme B12 Derivatives 
The conformational changes of the btuB riboswitch of E. coli upon binding of the metabolite 
AdoCbl can be monitored by in-line probing titration experiments (Chapter 2.3.5). With this 
method appearance and disappearance of distinct cleavage bands as a function of 
concentration are detected. From the literature, nine cleavage sites are known for the 
aptamer sequence (202 nts), which are affected by AdoCbl binding.[46,87] Other B12 
derivatives are also recognized by the riboswitch, such as vitamin B12, adenosyl factor A 
(AdoFactA) and adenosyl-cobinamide (AdoCobi). These derivatives lack either the upper 
organometallic group or the lower base. They induce the same conformational changes of 
the RNA but exhibit an up to 1000-fold lower binding affinity than AdoCbl. Consequently, 
apical ligands that are bound to the cobalt center are generally expected to only influence the 
binding affinity, but not the folding.[87] Further studies with modified side chains of the corrin 
ring revealed that the unchanged corrin moiety of cobalamin is crucial for the correct folding 
of the RNA.[88] Regardless of these general trends, a prediction of influences on the 
riboswitch folding behavior and binding affinity from other B12 derivative is difficult and in-line 
probing experiments are needed to verify hypotheses. 
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2.3.5 Principle of In-line Probing 
The secondary structure of complex RNA molecules can be elucidated with the well-
established in-line probing technique. Furthermore, ligand binding affinities can be 
determined. In particular, this assay can be used for the investigation of a riboswitch 
aptamer.[49] 
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Figure 21: Self-cleavage of RNA promoted by the presence of metal ions. In-line nucleophilic attack of the 2’-
OH with 5’-oxygen as leaving group cleaves the phosphodiester linkage (SN2). The reaction is catalyzed by the 
magnesium-aqua-hydroxo-complex (red) via deprotonation of the nucleophile. For visualization purpose, the RNA 
is [32P]-5’-end labeled (radioactive symbol). Based on figure from Dr. Sofia Gallo.[86] 
The method is based on the structure-dependent specific degradation of RNA, either in 
presence of divalent metal ions or acid/base.[89] Single-stranded regions are flexible and 
therefore susceptible to self-cleavage, in contrast to highly structured regions of folded RNA. 
The dominant pathway of RNA degradation involves an 'in-line' conformation of the 2’-
oxygen with the phosphorous and the adjacent 5’-oxygen. This allows for a nucleophilic 
attack of the 2’-oxygen at the phosphodiester backbone (Figure 21). The cleavage products 
of the RNA can be separated via denaturing PAGE and give a characteristic pattern which 
can then be compared in presence or absence of the metabolite and its derivatives. For a 
highly sensitive detection, [32P]-5’-end labeled RNA is used. By means of in-line probing 
titration experiments the dissociation constant KD can be determined, which represents the 
concentration of ligand required to convert half of the aptamer into its ligand-bound form.[49] 
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2.4 Aim of the Chapter 
Since the discovery of the btuB riboswitch of E. coli as one of the first representatives of the 
gene-regulating RNA riboswitches, many efforts have been undertaken to elucidate their 
structure and function. Structural mapping, transcriptional pausing studies, and comparison 
to crystal structures of similar riboswitches revealed details on the btuB riboswitch 
conformation in absence and presence of the metabolite B12. Further studies on the 
interaction of the riboswitch with different natural occurring or chemically modified B12 
derivatives gave insights into the binding specificity. However, the binding of B12 to the 
riboswitch and the consequent structural switch have not been studied dynamically. 
This chapter is focused on the dye labeling of the B12 metabolite to investigate the complex 
mechanism of B12 binding to the btuB riboswitch of E. coli and its structural rearrangement by 
use of Förster Resonance Energy Transfer. Compared to other methods like X-ray 
crystallography, FRET allows investigating dynamic folding processes of complex molecules 
or binding events in real time. FRET was already applied on the single-molecule level to 
study conformational changes of RNA upon binding of metals or metabolites.[42,50] So far the 
metabolites binding to the investigated riboswitches were rather small molecules such as S-
adenosylmethionine (SAM) or thiamine pyrophosphate (TPP).[40,90] In the case of the btuB 
riboswitch the metabolite is B12, which is a fairly large biomolecule. Cob(III)alamin itself is not 
fluorescent and can therefore not be visualized by fluorescence techniques. However, the 
structure of this metabolite gives the opportunity for fluorescence labeling, allowing to 
investigate its binding to the RNA, together with the induced RNA folding.  
Herein, the synthesis and characterization of new dye-labeled B12-derivates is described 
(Figure 22). 
 
Figure 22: Schematic structure of dye-labeled B12-derivatives. Attachment of a dye (green) to the β-face of 
cobalamin (black) with an aminopropyl linker (red). 
The fluorescent dyes of choice are the common FRET pair Cy3 and Cy5, which are well 
established for nucleic acid investigations (Chapter 1.2.2). Alternatively, Cy5 is replaced by 
the ‘black hole quencher‘ BHQ-2 in order to minimize possible background issues that could 
arise due to fluorescence of the labeled metabolite in high concentrations. The donor dye 
Cy3 can be located at the B12 and the acceptor dye Cy5 or BHQ-2, respectively, at the RNA, 
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or vice versa. This reduces the possibility of misinterpreted artifacts in smFRET as both 
labeling schemes should give the same results. Furthermore, two derivatives of Cy3 and Cy5 
differing in their substituents and charge were chosen to find the optimal label at the 
metabolite, that induces a correct riboswitch folding. Cy3 and Cy5 are positively charged, 
and BHQ-2 is uncharged. Sulfo-Cy3/Cy5 are negatively charged at the sulfonate groups and 
have thus a reduced possibility of intercalation into nucleic acids due to electrostatic 
repulsion (Chapter 1.2). For the attachment of the dye the axial position on the β-face of the 
cobalamin was chosen since this position of the cobalamin is known to influence only the 
binding affinity of the B12 to the riboswitch, but not the folding. Modifications at the corrin ring 
typically lead to a different folding of the RNA (see Chapter 2.3.4).[87] As the probes are 
designed to be used in folding investigations of the RNA, attachment at the side chains of the 
corrin ring would therefore not be suitable. Thus a linker group, which carries a suitable 
functionality, is introduced at the cobalt center of B12, allowing for the coupling of the dyes. 
An important assumption using this methodology is that the modified B12 derivatives do not 
change the riboswitch folding drastically. Therefore, interactions of the novel dye-labeled B12 
derivatives with the btuB riboswitch are studied by in-line probing experiments. 
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2.5 Results 
2.5.1 Synthesis of Dye-labeled B12 Derivatives 
The synthetic route towards dye-labeled B12 derivatives starts from hydroxocobalamin. In the 
first step, a primary amine function is attached to the cobalt center of the cobalamin on the β-
face of the corrin ring. To this amine function the dyes are subsequently coupled via N-
hydroxysuccinimide (NHS) ester chemistry. All reactions and analyses of B12 derivatives and 
dyes were done in the dark to prevent from decomposition or deactivation. 
Cyanine Dyes Cy3, Cy5 and NHS Esters 
Commercially available cyanine dyes are rather expensive, especially in their active forms 
such as azides, phosphoramidites and NHS esters. Therefore Cy3 and Cy5 were 
synthesized in a one-pot reaction approach (Scheme 2). 
 
Scheme 2: Synthesis of Cy3 and Cy5 NHS esters. Synthesis of (i) Cy3 NHS ester and (ii) Cy5 NHS ester 
starting from 2-methylene-1,3,3-trimethylindoline, 1-(5-carboxypentyl)-2,3,3-trimethyl-3H-indolium chloride, (i) 
N,N'-diphenylformamidine, and (ii) N-((1E)-3-(phenylimino)prop-1-enyl)benzenamine hydrochloride via Cy3/Cy5, 
followed by addition of DSC; a) NaOAc, EtOH, 24 h, 85 °C, (i) yield: 17 %; ii) yield not determined; b) DIPEA, 
DMF, 2 h, 60 °C. 
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Indole, N,N'-diphenylformamidine or malondialdehyde dianil hydrochloride, and the 
carboxypentyl indolium salt were brought to reaction to obtain the cyanine acid Cy3 or 
Cy5.[91,92] Due to side product formation the yield was low compared to the multi-step 
approach.[93] 
NHS esters are sensitive to hydrolysis. To avoid this deactivation during long storage, Cy3 or 
Cy5 NHS esters were prepared in situ by addition of DSC to the Cy acid. These derivatives 
were used for the following coupling to the respective B12 derivative. 
B12-linker 
The addition of a linker to B12 providing a suitable functional group gives the possibility to 
attach various dyes to the B12. This function is fulfilled by a primary amine group to which 
fluorophores can be attached via activated esters, forming a stable amide bond. B12-linker 
was synthesized according to the literature procedure.[94] Starting from commercially 
available hydroxocobalamin (OHCbl), 3-aminopropylchloride was attached to the cobalt 
center of cobalamin replacing the hydroxo moiety in the upper β-face position (Scheme 3). 
Zinc dust was used as a reducing agent. The cobalt center in hydroxocob(III)alamin is 
reduced to Co+, followed by the alkylation via bimolecular nucleophilic substitution (SN2) to 
give β-(3-aminopropyl)cobalamin as a Co3+ species.[95] As mentioned before, the synthesis 
was carried out in the dark, as the newly formed organometallic cobalt-carbon bond is 
sensitive to cleavage by light. 
 
Scheme 3. Synthesis of B12-linker. Reaction of hydroxocobalamin and 3-aminopropylchloride; a) Zn-dust, 
NH4Cl, H2O, 5 h, r.t., yield: 82 %. 
B12-dye 
The fluorescent cyanine dyes Cy3, Cy5, Sulfo-Cy3 and Sulfo-Cy5, as well as the ‘black hole 
quencher’ BHQ-2 were used as NHS esters and coupled to the primary amine group of the 
linker in B12-linker. The reactions yielding the B12-Cy derivatives B12-Cy3, B12-Cy5, B12-
Sulfo-Cy3 and B12-Sulfo-Cy5 were carried out at room temperature in the presence of 
DIPEA and under nitrogen atmosphere to avoid hydrolysis of the NHS ester (Scheme 4). 
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Scheme 4. Synthesis of B12-dye derivatives. Synthesis of B12-dye derivatives starting from B12-linker and dye 
NHS ester; a) i: DIPEA, DMF, 24 h, r.t., yields: 40-70 % (Cy3, Cy5, Sulfo-Cy3, Sulfo-Cy5); ii: 0.1 M CO32-/HCO3- 
buffer (pH 8.3), r.t., yield: 48 % (BHQ-2). 
The synthesis of B12-BHQ-2 was carried out by reacting B12-linker with BHQ-2 NHS ester in 
carbonate-bicarbonate buffer at pH 8.3. The buffer and pH were chosen to be optimal for the 
NHS ester crosslinking reaction. 
B12-dye products were obtained in yields of 40-70 %. Each derivative was characterized by 
UV/Vis, HPLC, NMR and ESI-MS/HR-ESI-MS (Chapter 2.5.2). 
2.5.2 Characterization of Dye-labeled B12 Derivatives 
UV/Vis Spectroscopy 
UV/Vis spectra of the B12-dye derivatives in water show the characteristic absorption bands 
of cobalamin combined with the ones corresponding to the respective dye. B12-linker reveals 
the main peaks at 266, 281, 317, 349, 375 and 526 nm (Figure 23), which are in agreement 
with the literature values of unmodified AdoCbl (260, 288, 315, 340, 375, 522 nm, see 
Appendix).[57] In spectra of B12-Cy3 and B12-Sulfo-Cy3 (Figure 23 a and Appendix) the 
characteristic absorption peaks for the Cy3 dye are observed at λmax = 545 nm (Cy3) and 
λmax = 551 nm (Sulfo-Cy3), together with a shoulder at 514 nm (Cy3) and 518 nm (Sulfo-
Cy3), respectively. Likewise, in spectra of B12-Cy5 and B12-Sulfo-Cy5 (Appendix) the 
characteristic absorption peaks for the Cy5 dye are observed at λmax = 642 nm (Cy5) and 
λmax = 648 nm (Sulfo-Cy5), as well as a shoulder at 599 nm (Cy5) and 604 nm (Sulfo-Cy5), 
respectively. B12-BHQ-2 shows the absorption maximum of the BHQ-2 at 559 nm (Figure 
23 b). 
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Figure 23: UV/Vis spectra of B12 derivatives. Normalized absorbance spectra in water at r.t. of a) B12-linker 
(dotted line), Sulfo-Cy3 (dashed line) and B12-Sulfo-Cy3 (solid line), b) B12-linker (dotted line) and B12-BHQ-2 
(solid line). 
HPLC 
HPLC analysis of B12-linker shows an increased retention in comparison to 
hydroxocobalamin (OHCbl) due to the replacement of the hydroxyl moiety by the less polar 
aminopropyl linker (Figure 24). 
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Figure 24: HPLC chromatograms of B12-linker and OHCbl recorded at 360 nm. OHCbl (dashed line) elutes 
1 min earlier than B12-linker. 
B12-dye derivatives were identified by HPLC analysis with product peaks at a retention time 
of around 15 min for Cy3/Cy5 derivatives, 11 min for sulfonated Cy3/Cy5 derivatives, and 
18 min for the BHQ-2 derivative under the applied conditions. 
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A characteristic comparison of HPLC traces of starting material (B12-linker) and product is 
shown in an overlay chromatogram (Figure 25). The clear separation of B12-linker at tR = 
7 min from the product B12-Cy5 is observed. The signal overlay of the HPLC traces for B12-
Cy5 at 360 nm, 650 nm and fluorescence emission at 670 nm shows the absorption and 
emission of the individual components B12 and Cy5. 
0 5 10 15 20 25
0
500
1000
1500
2000
2500
  360 nm
  650 nm
  650 nm/670 nm
In
te
ns
ity
 [m
A
U
]
retention time [min] 
16 18
0
500
1000
1500
2000
In
te
ns
ity
 [m
A
U
]
retention time [min] 
 
Figure 25: HPLC chromatograms of B12-linker and B12-Cy5. B12-linker (dashed line) with a retention time of 
7 min is clearly separated from B12-Cy5 (solid line) at 16.5 min. The successful attachment of Cy5 to B12 in B12-
Cy5 can be observed in the overlay of chromatograms at the different wavelength for the components 360 nm 
(Cbl), 650 nm (Cy5) and fluorescence emission at 670 nm (Cy5, excitation at 650 nm). The inset shows a close-
up of the region 15 to 19 min. 
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Figure 26: Contour plot of B12-Cy5. 3D field of the HPLC DAD. The maximum absorption is detected at 650 nm 
(Cy5). The characteristic cobalamin absorption is detected at around 300 nm to 360 nm. 
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Additionally, the wavelengths of the different functionalities can be seen in the 3D field 
contour plot of B12-Cy5 measured with the diode array detector (DAD) in an HPLC 
experiment (Figure 26). The same is observed for the other derivatives (data not shown). 
NMR Spectroscopy 
For the characterization of the novel B12 derivatives 1H- and 13C{1H}-NMR experiments were 
performed. Most of the peaks could be assigned with these and the 2D experiments [1H,1H]-
COSY (correlation spectroscopy), [1H,13C]-HSQC (Heteronuclear Single Quantum 
Coherence) and [1H,13C]-HMBC (Heteronuclear Multiple Bond Correlation). HSQC 
experiments show the correlation between chemical shifts of directly bound nuclei, and 
HMBC of nuclei separated by two or more chemical bonds. The atom numbering of the 
different compounds is depicted in Figure 27. 
 
Figure 27: Nomenclature for the atom positions of B12, B12-linker, and cyanine dyes. Atom numbering of a) 
B12, B12-linker, and b) the cyanine dyes Cy3, Cy5, Sulfo-Cy3 and Sulfo-Cy5. 
In the 1H-NMR spectrum of B12-linker the characteristic peaks for B12 are observed (Figure 
28). In the aromatic region between 7.5 and 6 ppm the peaks of 2N, 4N and 7N of the 
benzimidazole moiety, 1R of the ribose, and 10 of the corrin ring can be seen. The 
assignment is in perfect agreement with the literature.[96] Another significant region is located 
between 5 and 3 ppm. Here, 2R, 3R, 4R and 5R of the ribose, 3, 8, and 19 of the corrin ring, 
and 175, 176 are found (see inset in Figure 28). Additionally, the peaks for the newly 
attached linker can be seen in the high field region between -0.5 and 2.7 ppm. Notably, 
protons closest to the cobalt center have a negative shift. 
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Figure 28: 1H-NMR spectrum of B12-linker in MeOD-d4. The signals of the most characteristic protons are 
indicated. Protons belonging to the attached linker group are marked with black dots (). The inset shows a 
close-up of the region 4.5 to 3.5 ppm. 
The successful coupling of Cy3 to B12-linker is observed in the NMR spectrum of B12-Cy3 
(Figure 29). In the aromatic region, the signals of B12 (2N, 4N, 7N, 1R and 10), the signals of 
the alkene chain in Cy3 (a, b and c), and of the Cy3 phenyl rings (4, 5, 6 and 7) can be 
assigned. Protons of the carboxypentyl chain are located high field between 2.3 and 
1.5 ppm. 
Analog to B12-Cy3 the corresponding signals are observed for B12-Cy5 with the additional 
CH2 signals at 8.3 ppm and 6.3 ppm, and a small shift of a, b and c of the alkene chain 
(Figure 30). 
The sulfonated derivatives B12-Sulfo-Cy3 and B12-Sulfo-Cy5 reveal a shift of the phenyl 
signals 4 and 6 to down field due to the electron-withdrawing sulfonate groups at C5 
(Appendix). 
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Figure 29: 1H-NMR spectrum of B12-Cy3 in MeOD-d4. Proton signals belonging to Cy3 are marked with black 
dots (). Other signals are assigned to B12. 
 
Figure 30: 1H-NMR spectra of B12-Cy3 and B12-Cy5 in MeOD-d4. Aromatic region of a) B12-Cy3 and b) B12-Cy5.
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The designated atom numbering of B12-BHQ-2 is shown in Figure 31. 
 
Figure 31: Nomenclature for the atom positions of BHQ-2 in B12-BHQ-2. 
In the NMR spectrum of B12-BHQ-2 (Figure 32), the signals in the aromatic region can be 
assigned to the protons Q6, Q7, Q10, Q14 and Q15 of the BHQ-2 phenyl rings. The methoxy 
groups show peaks at 4.0 ppm and NMe at 3.1 ppm. Alkyl proton signals Q2 and Q3 are 
located high field at 2.1 and 1.8 ppm, and Q4 at 3.5 ppm. 
 
Figure 32: 1H-NMR spectrum of B12-BHQ-2 in MeOD-d4. Proton signals belonging to BHQ-2 are marked with 
black dots (). Other signals are assigned to B12. 
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Mass Spectrometry 
In ESI-MS and high resolution (HR)-ESI-MS measurements of the B12 derivatives B12-linker, 
B12-Cy3, B12-Cy5, B12-Sulfo-Cy3, B12-Sulfo-Cy5 and B12-BHQ-2 the respective products 
peaks were detected. Furthermore, fragments due to Co-C bond cleavage during the 
measurement are observed. The B12-linker product peak ([M]+ calcd.: 1387.6 m/z) is 
detected in the ESI-MS positive mode at 1387.7 m/z, as well as the protonated doubly 
charged compound at 694.4 m/z. In HR-ESI-MS experiments of B12-Cy3 (Figure 33) all 
peaks are assigned to the desired product or to various product fragments present as 
sodium, methanol or protonated adducts. Main peaks are detected at m/z = 940.94318, 
being a doubly charged methanol-sodium adduct of the target compound B12-Cy3 
([M+Na+MeOH]2+ calcd. for C96H135CoN16O16PNa2+: 940.96159 m/z). The cobalamin 
fragment without the apical ligand is detected as singly charged species at 1351 m/z and 
doubly charged at 676 m/z with various adducts in the same region. The Cy3-linker fragment 
is located at m/z = 530 and adducts between m/z = 486 and 544. 
 
Figure 33: High resolution ESI-MS spectrum of B12-Cy3. The product peak is located at m/z = 940 and the 
cleavage fragments at m/z = 530 and 674. 
In positive mode ESI-MS measurements B12-Cy5 is detected at 1852.9 m/z ([M]+) and 
926.9 m/z ([M+H]2+). In HR-ESI-MS, signals are observed at 942.96065 m/z, belonging to the 
doubly charged protonated methanol adduct of B12-Cy5 ([M+H+MeOH]2+), and at 
953.95183 m/z, belonging to the doubly charged methanol-sodium adduct ([M+Na+MeOH]2+ 
calcd. for C98H137CoN16O16PNa2+: 953.96942 m/z). 
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The sulfonated B12 derivatives are detected in HR-ESI-MS measurements (negative mode) 
with the B12-Sulfo-Cy3 main peak at 991.89869 ([M-H]2- calcd. for C95H128CoN16O21PS2-: 
991.89978 m/z), and B12-Sulfo-Cy5 at 1004.90741 m/z ([M-H]2- calcd. for 
C97H130CoN16O21PS2-: 1004.90760 m/z). 
In ESI-MS measurements the product peak of B12-BHQ-2 is observed at m/z = 1875.8 
([M+H]+) and its sodium adduct at 1898.7 m/z ([M+Na]+). 
Quantum Yields and Steady-State Anisotropy 
The fluorescence quantum yield of a dye is an important property in FRET experiments 
(Chapter 1.2.1). Cobalamin has been reported to quench the fluorescence of covalently 
bound fluorescein derivatives due to the overlap of the electronic orbital of cobalamin with 
the excited state of the dye.[94] The fluorescence quantum yields (Φs) of the novel B12-cyanine 
conjugates were therefore determined and compared to the free cyanine dyes Cy3 and Cy5 
(Table 1). Indeed, the quantum yields of the B12 derivatives are reduced. B12-Cy3 revealed a 
quantum yield that is 6.5-fold lower, and B12-Sullfo-Cy3 a quantum yield that is 10-fold lower 
than their corresponding free dyes. The quantum yield of Cy5 is 2.5-fold and of Sulfo-Cy5 4-
fold higher, compared to their corresponding B12 derivatives (Figure 34). B12-Cy5 and B12-
Sulfo-Cy5 are thus from this point of view more suitable for FRET experiments than the 
other derivatives. Cy3 or Sulfo-Cy3 can then be placed at the RNA to complete the FRET 
pair. 
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Figure 34: Quantum yields of free dyes and B12-dye derivatives in PBS buffer. The quantum yields of the B12 
derivatives are reduced compared to the corresponding free dyes. 
Additionally, steady-state fluorescence anisotropy (r) was measured to determine the 
changes of rotational freedom of the dye when attached to B12 (Table 1). No differences were 
observed between unbound Cy3 and B12-Cy3 conjugates with all values being around 
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r = 0.25. B12-Cy5 derivatives exhibit a value of 0.26 (0.23 sulfonated), while free Cy5 has a 
lower anisotropy value of 0.15 (0.13 sulfonated). 
Table 1. Fluorescence quantum yields (Φs) and static fluorescence anisotropy values (r) of free Cy3 or Cy5 
derivatives and their B12 conjugates in PBS buffer (pH 7.4) at 22 °C. 
Compound          Φs r 
Cy3 0.026 ± 0.001[a] 0.263 ± 0.006 
Sulfo-Cy3 0.055 ± 0.002[a] 0.247 ± 0.005 
B12-Cy3 0.004 ± 0.0004 0.255 ± 0.008 
B12-Sulfo-Cy3 0.006 ± 0.0003 0.247 ± 0.009 
Cy5 0.110 ± 0.006[b] 0.153 ± 0.008 
Sulfo-Cy5 0.198 ± 0.009[b] 0.133 ± 0.005 
B12-Cy5 0.041 ± 0.001 0.258 ± 0.010 
B12-Sulfo-Cy5 0.054 ± 0.005 0.225 ± 0.012 
 [a] Cy3 derivative in PBS Φ = 0.04[23]; [b] Cy5 derivative in PBS Φ = 0.20[23] 
Photostability 
As mentioned earlier (Chapter 2.2.1), the Co-C bond between the cobalamin and the linker 
can be cleaved by photolysis. The formed B12 radical can further react to hydroxocobalamin. 
To verify the stability of the B12-dye compounds, absorbance and fluorescence spectra 
exemplary of B12-Cy3 were recorded before and after irradiation for 10 min at 532 nm, which 
corresponds to the standard measuring time and the wavelength of the green laser used in 
FRET experiments (Figure 35). 
300 400 500 600 700
0.00
0.05
0.10
0.15
0.20
0.25
550 600 650 700 750
0
20
40
60
80
100
b)
A
bs
or
ba
nc
e
wavelength [nm]
 before
 after
a)
In
te
ns
ity
wavelength [nm]
 before
 after
 
Figure 35: Absorbance and fluorescence spectra of B12-Cy3. a) Absorbance spectra and b) fluorescence 
spectra of B12-Cy3 before (black) and after (red) irradiation at 532 nm for 10 min. 
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After irradiation, the absorbance peak of the cleavage product hydroxocobalamin appears at 
350 nm, and at the same time the fluorescence intensity is increased. This shows once more 
the quenching effect of B12, which is reduced upon cleavage of Cy3 from B12. 
2.5.3 Interaction of the btuB Riboswitch and Dye-labeled B12 Derivatives 
Modifications of AdoCbl, the natural metabolite of the btuB riboswitch of E. coli, can lead to 
an altered structural conformation of the RNA and a changed binding behavior of the B12 
(Chapter 2.3.4). In-line probing was used to monitor the structural rearrangement of the btuB 
riboswitch upon binding of the modified B12 derivatives B12-linker, B12-Cy3, B12-Cy5, B12-
Sulfo-Cy3, B12-Sulfo-Cy5 and B12-BHQ-2 in comparison to the natural ligand AdoCbl. In-line 
probing titration experiments were performed with the [32P]-5’-end-labeled full-length aptamer 
sequence of the btuB riboswitch of E. coli designed by Gallo et al.[87] The RNA was therefore 
incubated in the presence of increasing concentrations of the modified B12 derivatives. The 
experiments were carried out in the dark to prevent photolysis of the Co-C bond. The 
cleavage products were separated by denaturing polyacrylamide gel electrophoresis (PAGE) 
and analyzed. The concentration of B12 was plotted versus the intensities of characteristic 
bands and fitted to a 1:1 binding isotherm[97] to obtain the respective binding affinity 
constants. 
In presence of the natural ligand AdoCbl nine characteristic cleavage sites (Figure 36, 
marked with grey triangles) are observed in the btuB riboswitch. The resulting cleavage 
pattern was used for comparison in presence of the modified B12 derivatives. Upon addition 
of AdoCbl (+) the intensities of bands 1, 2b, 3, 4 and 8 decrease, whereas 2, 5, 6, and 7 
increase compared to the negative control (-, incubation of RNA in absence of metabolite). 
Additionally to the previously described cleavage sites, cleavage site B (U19) increases with 
higher concentrations of AdoCbl (Figure 36, green triangle). Each experiment was carried out 
together with the described +/- controls to ensure a correct folding behavior of the riboswitch 
under the applied conditions. An additional control (c), which shows the unreacted riboswitch 
in absence of metal ions and cobalamin, was applied to ensure the purity of the labeled RNA. 
An OH ladder (alkaline hydrolysis), which is cleaving after every nucleotide, and a T1 ladder 
(RNAse T1 digestion), cleaving after each guanine residue, were used to assign the 
cleavage sites. 
The fairly large dyes Cy3 and Cy5 were attached to the B12 (Chapter 2.5.1) to fluorescently 
label the metabolite, e.g. for FRET experiments. To rule out that the dyes themselves 
influence the riboswitch, control experiments with Cy3, Cy5, Sulfo-Cy3 and Sulfo-Cy5 were 
carried out. The incubation of the RNA with high concentrations of Cy3 or Cy5 carrying a 
positive charge prevented the RNA from entering the gel, possibly due to electrostatic 
interactions. The RNA is mainly detected in the upper part of the gel and in the full length 
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band indicating a suppressed cleavage reaction. In comparison, the incubation of the RNA 
with Sulfo-Cy3 or Sulfo-Cy5 (Figure 36) carrying negative charges at the sulfonate groups 
does not change the cleavage pattern, thus proving that the dyes do not interact with the 
riboswitch. 
 
Figure 36: In-line probing experiments of the 202 nt long btuB riboswitch (pSG1) with Sulfo-Cy3 and 
Sulfo-Cy5. a) Secondary structure of pSG1 with the nine characteristic cleavage sites (marked in grey) and an 
additional cleavage site B (green). b) Structure of Sulfo-Cy3 and Sulfo-Cy5. c) Incubation of pSG1 in absence (–) 
and presence (+) of AdoCbl, and increasing concentrations of Sulfo-Cy3 and Sulfo-Cy5. Lane T1: RNAse T1 
digestion; lane OH: alkaline hydrolysis ladder; lane c: control (unreacted RNA). 
To compare the influence of the replacement of the upper ligand (adenosyl moiety) by the 
amine linker, the RNA was incubated with B12-linker. However, no significant change in the 
intensity of the cleavage bands upon increasing B12 concentrations was observed, indicating 
that no structural switch of the RNA is induced. 
Incubation of the btuB riboswitch with B12-BHQ-2, which is an uncharged derivative, shows 
the same trends in all cleavage sites (Figure 37 a) as with AdoCbl (vide supra). Further 
cleavage sites situated at U58 (F) and A64 (G), as well as a, I, J, L, and M are observed. An 
increase in the intensity of the corresponding bands with higher B12 concentration was 
detected. The sites a, I, J, L, and M cannot be assigned as the ladders are not sufficiently 
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resolved in this particular region. Intensity changes at sites 1 (Figure 37 b), 2, 2b, 3, 4 and 8 
were plotted versus the B12 concentration and were fitted to a 1:1 binding isotherm model[97]. 
The resulting KD is 150 ± 16 μM, and therefore higher than the value observed for AdoCbl 
(KD = 89 ± 6 nM)[87]. A higher KD value indicates a weaker binding of the B12 to the RNA. The 
KD of B12-BHQ-2 is however in the same order of magnitude as other cobalamin derivatives 
of VitB12 (KD = 314 ± 141 μM)[87]. 
 
Figure 37: In-line probing experiments of pSG1 with B12-BHQ-2. a) Incubation of the pSG1 riboswitch RNA 
with increasing concentrations of B12-BHQ-2. The characteristic cleavage sites similar to AdoCbl are marked in 
grey and additional cleavage sites in green. b) Intensity changes at cleavage site 1 of pSG1 in dependence of 
increasing B12-BHQ-2 concentrations. Experimental data points are fitted to a 1:1 binding isotherm (dotted 
line).[97] 
The dye-labeled B12 derivatives B12-Cy3, B12-Cy5 and B12-Sulfo-Cy3, B12-Sulfo-Cy5 were 
incubated with the btuB riboswitch (btuB construct pPC1, Figure 38). Surprisingly, each 
derivative reveals a different cleavage pattern. The derivatives are fairly similar in their 
chemical structure with the difference that B12-Cy3 and B12-Cy5 are positively charged, and 
their sulfonated variants B12-Sulfo-Cy3 and B12-Sulfo-Cy5 are negatively charged. Cy3 and 
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Cy5 only differ in two CH2 groups in the polymethine chain (Figure 36 b). Cleavage sites of 
each derivative were compared to the ones of AdoCbl. Some cleavage sites are similar to 
AdoCbl (indicated with grey triangles in Figure 38 a and b) and others are changed (indicated 
with green triangles in Figure 38 a and b). 
 
Figure 38: In-line probing experiments of the 216 nt long btuB riboswitch (pPC1) with B12-Cy3, B12-
SulfoCy3, B12-Cy5 and B12-SulfoCy5. a) Incubation of pPC1 with increasing concentrations of B12-Cy3, B12-
SulfoCy3, B12-Cy5, and B12-SulfoCy5, respectively. b) Secondary structure of pPC1 including the nine 
characteristic cleavage sites with AdoCbl (marked in grey) and additional cleavage sites with the B12-dye 
derivatives (green). The numbering corresponds to the 202 nt long pSG1 structure. c) Schematic structure of the 
B12-dye derivatives. 
Incubation of the btuB riboswitch with B12-Cy3 induces an overall similar cleavage pattern as 
with AdoCbl (Figure 39 a). However, cleavage sites 5, 6 and 7 are mainly unaffected and 
reveal no clear trend. Furthermore, three additional cleavage sites C (A47), G (A64), and H 
(U82) can be observed, which have an increase in intensity with higher B12 concentration. 
Site C is located in P5 (kissing-loop region, see Chapter 2.3.2), G in P7 and H in P9 (see 
Figure 38 b for the location of the sites). The KD calculated from the concentration dependent 
intensity changes at sites 1, 2b, 3, 4 and 8 is 202 ± 42 μM. Compared to B12-BHQ-2 the 
binding affinity is in the same order of magnitude. 
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Incubation of the btuB riboswitch with B12-Cy5 also exhibits mainly similarities to the AdoCbl 
cleavage pattern (Figure 39 b). Cleavage sites 1, 3, 4 and 8 decrease with higher 
concentrations of B12-Cy5, while 2b and B increase. In contrast, cleavage sites 2, 5, 6 and 7 
are unaffected by the B12 concentration. This indicates that region P8 is not rearranged upon 
B12-Cy5 binding. The additional cleavage site C that was observed for B12-Cy3 (Figure 39 a) 
is also detected. Cleavage sites I, J, and M are similar to B12-BHQ-2 (Figure 37). 
Additionally, site K, which is situated between sites 5 and 6, reveals an increase in intensity 
at higher concentrations. Only sites 1 and 8 were fitted to the 1:1 binding model with a 
resulting KD of 275 ± 3 μM. The binding constant is therefore similar to B12-Cy3 and B12-
BHQ-2. 
 
Figure 39: In-line probing experiments of pPC1 with B12-Cy3 and B12-Cy5. Incubation of the pPC1 riboswitch 
RNA with increasing concentrations of a) B12-Cy3 and b) B12-Cy5. The characteristic cleavage sites similar to 
AdoCbl are marked in grey and changed or additional cleavage sites in green. 
B12-Sulfo-Cy3 induces a different cleavage pattern of the btuB riboswitch compared to other 
derivatives (Figure 40 a). Interestingly, the cleavage pattern is the same as for the c-acid 
VitB12 derivative reported by Gallo et al. (Figure 40 b).[88] 
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Figure 40: In-line probing experiments of pPC1 with B12-SulfoCy3 and pSG1 with c-acid VitB12.                  
a) Incubation of pPC1 with increasing concentrations of B12-Sulfo-Cy3. b) Incubation of pSG1 with increasing 
concentrations of c-acid VitB12 (adapted from Dr. Sofia Gallo).[88] The numbering corresponds to the 202 nt long 
pSG1 structure. The characteristic cleavage sites similar to AdoCbl are marked in grey and changed or additional 
cleavage sites in green. 
Structural similarities between the two B12 derivatives exist, which could explain the similar 
trends (see Figure 41). Both derivatives have a negative charge located at the β-side of the 
corrin ring; the c-acid directly at the corrin ring and the sulfonated Cy3 at the dye in the axial 
position. An interaction of the negative charges with the riboswitch is therefore likely. 
 
Figure 41: Schematic drawing of the structures of c-acid VitB12 and B12-Sulfo-Cy3. Both derivatives carry a 
negative charge at the β-side of the corrin ring (highlighted in a red circle). 
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Moreover, a site-specific degradation of the RNA is observed with higher B12-Sulfo-Cy3 
concentrations. Therefore most of the characteristic intensity changes are superimposed by 
this specific degradation pattern. Intensities of cleavage sites 1, 2b, 3, 4, 8 and N are 
decreasing whereas A, B, D, E, F, H, I, J, 5, K, 6, L, and 7 are increasing with higher 
concentration of B12. Sites F, I and J were also detected in experiments with B12-BHQ-2; I, J, 
K with B12-Cy5 and H with B12-Cy3. The binding constant of B12-Sulfo-Cy3 could not be 
determined as its binding to the riboswitch does not follow a 1:1 binding model. The 
intensities of the bands rather show a linear decrease or increase. 
Incubation of the riboswitch with B12-Sulfo-Cy5 does not show a significant change in 
intensity of the cleavage bands, indicating that this derivative does not bind to the RNA at all 
(Figure 38). 
The results of the in-line probing experiments of the btuB riboswitch with the B12-dye 
derivatives are summarized in Table 2 in comparison to naturally occurring B12 derivatives. 
Table 2: Summarized results of in-line probing experiments of the btuB riboswitch with B12 derivatives. KD values 
of B12 derivatives and most notable observations from in-line probing experiments are shown. 
B12 derivative KD Most notable observations 
AdoCbl 89 ± 6 nM[87]  
CNCbl 314 ± 141 μM[87]  
B12-linker - No binding 
B12-Cy3 202 ± 42 μM Additional: C, G, H 
B12-Cy5 275 ± 3 μM Additional: C, I, J, K, M 
B12-Sulfo-Cy3 
- 
Completely changed pattern 
Additional: A, D, E, F, H, I, J, K, L, N 
Site-specific degradation at high [B12] 
B12-Sulfo-Cy5 - No binding 
B12-BHQ-2 150 ± 16 μM Additional: a, F, G, I, J, L, M 
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2.6 Discussion and Conclusion 
The driving force for the above described studies was the investigation of a new labeling 
strategy for the elucidation of the structural rearrangements of the btuB riboswitch upon 
binding of the B12 metabolite by FRET. To this end, dyes of the common FRET couples 
Cy3/Cy5 and Cy3/BHQ-2 were chemically attached to the fairly large metabolite itself. New 
B12-dye derivatives were successfully synthesized and characterized. 
A first step was the synthesis of the fluorescent cyanine dyes Cy3 and Cy5 followed by their 
activation to an NHS ester. The one-pot synthesis of Cy3 resulted in a low yield compared to 
the multi-step approach known from literature due to the formation of various side 
products.[93] An alternative synthetic approach is therefore recommended, e.g. a one-pot 
synthesis postulated by Korshun and coworkers in which Cy3 can be obtained in a higher 
yield.[27] 
To find the optimal labeling scheme which induces a correct folding of the riboswitch, 
derivatives of Cy3 and Cy5 differing in their substituents and charges were used. To 
determine the optimum measuring conditions for FRET additionally the FRET pair was 
varied. The donor dye Cy3 is placed at the B12 and either one of the acceptor dyes 
Cy5/BHQ-2 at the RNA, or vice versa. The attachment of the dye was chosen to be in axial 
position of the cobalamin since this position of the cobalamin should only influence the 
binding affinity of the B12 to the riboswitch, whereas modifications at the corrin ring can lead 
to a different folding of the RNA (see Chapter 2.3.4).[87] The dyes were coupled via a 
covalently bound linker to the cobalt center of the B12 yielding the new derivatives B12-Cy3, 
B12-Cy5, B12-Sulfo-Cy3, B12-Sulfo-Cy5 and B12-BHQ-2. 
Stability measurements, exemplarily undertaken with B12-Cy3, showed a partial 
decomposition to B12 and Cy3 due to the Co-C bond cleavage upon excitation at 532 nm for 
10 min. This is due to the low dissociation energy of ~37 kcal/mol of the Co-C bond that is 
within the range of visible photons.[53] The photolysis could therefore be a disadvantage in 
FRET experiments using laser excitation of Cy3 at 532 nm. However, by keeping the 
measuring time short and the excitation intensity low enough this effect is negligible. 
Another issue of B12 derivatives is the fluorescence quenching ability of cobalamin of the 
excited electronic state of the attached fluorophore. The electronic orbital of cobalamin 
overlaps with the frontier orbital of the excited state of the fluorophore.[94] Fluorescence 
quantum yields of B12-flurophore derivatives are therefore lower than of the free dyes. To 
overcome the quenching, Grissom and coworkers reduced the intramolecular dynamic 
movement by incorporation of a rigid linker, which is attached at the ribose moiety of the 
cobalamin, and thus further away from the corrin ring.[98] However, this approach is not 
suitable with the btuB riboswitch, as it is known that modifications at this position would lead 
56 
2 Labeling of B12 
 
to an unnatural folding of the RNA, which can lead to a loss of function. On the other hand, 
one could take advantage of the quenching behavior of the B12 and use it for FRET studies 
acting as acceptor. This approach is similar to the use of dark quenchers (Chapter 
1.2.2).[99,100] 
As the rotational freedom of the dyes is an important factor in terms of FRET (see 
Chapter 1.2), steady-state fluorescence anisotropy measurements were conducted. Similar 
values for free Cy3 and Cy3 attached to B12 were observed. Comparison of free Cy5/Sulfo-
Cy5 to B12-Cy5/B12-Sulfo-Cy5 shows an increase of the anisotropy value r by 0.1. A high 
value is usually associated with a rotationally restricted environment. Attachment to a 
macromolecule typically increases the r value of the dye.[101] However, the origin of the 
different behavior of Cy3 and Cy5 remains unclear. A possible reason is that steady-state 
fluorescence anisotropy in some cases can give misleading results, as it has been shown by 
Levitus and coworker.[21] In a next step time-resolved measurements could give more details 
about the rotational freedom of the dye upon attachment to B12. 
Furthermore, in-line probing experiments were performed in order to clarify the structural 
conformation of the btuB riboswitch in presence of the modified B12 derivatives B12-linker, 
B12-Cy3, B12-Cy5, B12-Sulfo-Cy3, B12-Sulfo-Cy5 and B12-BHQ-2. The observed cleavage 
sites were compared to the ones of the natural metabolite AdoCbl. Influence of the dyes by 
themselves on the RNA was ruled out by control experiments in which the RNA was 
incubated in presence of the free dyes. To compare the influence of the replacement of the 
upper ligand (adenosyl moiety) by the amine linker, the RNA was incubated with B12-linker. 
No significant changes in the intensities of the cleavage bands were observed, suggesting no 
binding of this derivative under the applied conditions. It is known from the literature that 
replacing the bulky upper ligand by a smaller residues leads to a reduced binding affinity to 
the RNA.[87] Additionally, under the applied conditions a positive charge is located at the 
primary amine of the linker which might affect the binding. Altogether, the binding affinity of 
B12-linker is too low and no specific binding to the riboswitch occurs. The binding affinities of 
B12-Cy3, B12-Cy5 and B12-BHQ-2 are in the order of magnitude of VitB12 (~ 200 μM) and 
therefore 1000 times lower than the one of AdoCbl. The consequence for FRET experiments 
is the need of higher B12 concentrations, which increases background fluorescence. To 
overcome this drawback zero-mode waveguides or vesicle encapsulation could be used to 
lower the fluorescent species concentration.[102,103] Furthermore, possible changes in the 
RNA folding behavior as a consequence of the structural changes to the natural metabolite 
have to be considered. Although the dyes have a similar chemical structure, each B12-dye 
conjugate induces a different folding behavior of the riboswitch. B12-Cy3 induces an 
additional cleavage site C which might be an indicator that the kissing loop interaction is 
affected. From the crystal structure of another B12-binding riboswitch is known that these 
57 
2 Labeling of B12 
 
motif encapsulates the cobalamin in the binding pocket.[83] Consequently, Cy3 might 
sterically prevent the complete formation of this interaction. Nevertheless, B12-Cy3 shows a 
rather similar behavior to AdoCbl. In contrast, the sulfonated variant B12-Sulfo-Cy3 exhibits a 
completely changed cleavage pattern. The changes are analogous to the ones previously 
observed for c-acid VitB12.[88] In both cases site-specific degradation of the RNA occurs at 
high B12 concentrations. The c-acid carries a negative charge at the β-side of the corrin ring. 
The negative charge of the sulfonated Cy3 in B12-Sulfo-Cy3 is also located at the dye in the 
axial position of B12. This clearly indicates an influence of charged ligands on the riboswitch 
folding due to electrostatic effects. B12-Cy5 and B12-BHQ-2 induce some additional cleavage 
sites compared to AdoCbl, but show an overall similar cleavage pattern. Unexpectedly, 
incubation of the riboswitch with B12-Sulfo-Cy5 does not induce significant changes in the 
intensities of the cleavage bands, suggesting that this derivative does not bind to the RNA. 
Absence of binding due to steric hindrance would be expected to also affect the unsulfonated 
derivative B12-Cy5. If the negative charge would lead to a charge repulsion and, therefore, 
prevent the ligand from binding to the RNA, the same would be true for the sulfonated Cy3 
derivative B12-Sulfo-Cy3. It seems that the combination of steric and electrostatic 
interactions causes that B12-Sulfo-Cy5 is not recognized by the riboswitch. Consequently, 
charge, size and position of modifications on the B12 are crucial for the folding of the 
riboswitch, showing once more the ligand specificity of the riboswitch. 
In conclusion, the B12-Cy3, B12-Cy5 and B12-BHQ-2 are the most promising candidates for 
FRET experiments. The attachment of bulky residues like the fluorescent dyes is slightly 
affecting the RNA folding, but in-line probing experiments indicate that these changes are 
fairly small. The binding affinity of these derivatives is reduced compared to the natural 
ligand AdoCbl, but still in the range of VitB12. B12-Sulfo-Cy3, and B12-SulfoCy5 are no 
suitable probes to study the folding behavior of the riboswitch with FRET. Nevertheless, both 
derivatives contributed to new insights helping to refine the picture of the riboswitch folding 
and interaction with the B12 metabolite. Furthermore, the new derivatives can be used for 
other fluorescence applications such as imaging of cobalamin receptors or pathways of B12. 
 
58 
2 Labeling of B12 
 
2.7 Outlook 
With the presented labeling strategy also other dyes can be attached to the B12. Like this 
fluorescence quantum yields could be further improved. A smaller and uncharged dye could 
even less affect the folding of the riboswitch. 
To address the problem of light-stability of the B12-dye compounds light stable derivatives 
which are not based on linkage by a Co-C bond can be designed. The Co-CN bond in CNCbl 
(VitB12) is known to be stable upon light irradiation. The cyanide ligand can then be further 
derivatized, e.g. by coordination of enPtCl2 to give [enPtCl-VitB12]+ to which additional groups 
can be coordinated by replacement of the chloride ligand (Scheme 5).[104] 
 
Scheme 5: Synthetic route of a light-stable B12-RhB derivative. a) DCC, NHS, acetonitrile, b) carbonate buffer 
at pH 8.3, c) AgNO3, DMF. 
The new route can be developed by using a cheap fluorophore such as rhodamine B and 
can later on be applied with other dyes. A synthetic pathway is proposed in Scheme 5. 
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Rhodamine B (RhB) is extended with aminopropylimidazole as linker group for a specific 
coordination to platinum using N-hydroxysuccinimide (NHS) ester chemistry.[105] In route A 
the modified RhB is coordinated to enPtCl-VitB12, in route B to enPt(II)Cl2 followed by 
coordination to vitamin B12. Reaction steps a) through c) have already been realized in 
preliminary experiments. In both pathways a last step is expected to lead to the final product. 
For further investigations of the btuB riboswitch of E.coli with the B12-dye derivatives 
(especially B12-Cy3, B12-Cy5 and B12-BHQ-2) by FRET, the RNA needs to be fluorescently 
labeled as well with either Cy3 or Cy5 to complete the FRET pair. A possible strategy to 
address this issue is given in Chapter 3. 
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3 Labeling of RNA 
3.1 Introduction 
Fluorophore labeling of large biomolecules such as proteins, RNAs or DNAs is the basis for a 
vast variety of applications especially in the field of fluorescence spectroscopy. Fluorescent 
labels can be used for imaging of pathways, cellular processes, and folding mechanism by 
ensemble and single-molecule fluorescence methods. One of these techniques is Förster 
Resonance Energy Transfer, a powerful tool to study the conformational dynamics of 
biomolecules, especially on the single molecule level (Chapter 1.2).[35,36] The site-specific 
internal labeling of large (> 200 nucleotides, nts) functional RNA molecules is challenging 
and often not practicable. Indirect labeling can be achieved by hybridization of fluorescently 
labeled DNA oligonucleotides to the RNA.[106] The introduction of modifications such as long 
loops within the RNA structure are necessary for an efficient binding of the label. Those 
modifications can disturb the structure and thus the functionality of the RNA. 
In the following an RNA system is introduced, a group II intron ribozyme, which serves as 
model system to investigate a new strategy for the fluorescence labeling of large RNAs. The 
folding behavior of this system is known with the commonly used labeling strategy and can 
therefore be used to evaluate the potential of the new strategy. 
3.2 Ribozymes 
As described previously, one function of RNA is the regulation of the gene expression, e.g. in 
the form of riboswitches (Chapter 2.3). Further functional RNAs are ribonucleic acid 
enzymes, so-called ribozymes, which are catalytically active.[107] For their discovery in 1982 
S. Altman and T. R. Cech were awarded with the Nobel Prize in Chemistry in 1989.[108,109] 
Since then the research interest in this field was increasing drastically. 
Several small ribozymes (40-160 nts) exist that are well studied and act as ideal model 
systems to study their structure function relationship like the hammerhead,[110] hairpin,[111] 
and the hepatitis delta virus (HDV) ribozyme[112] (Figure 42).[113] Large ribozymes (400-
3000 nts) such as the group I and II introns are more difficult to study due to their complex 
structure. Introns and exons are nucleotide sequences contained in genes. Intron sequences 
are the parts, which do not encode the protein sequence and interrupt the coding exons. 
They are removed by RNA splicing prior to translation. Afterwards only the joined exons are 
remaining to generate the protein. Introns can be classified in four categories: introns in 
nuclear protein-coding genes removed by the spliceosome, introns in tRNA genes removed 
by proteins,[114] self-splicing group I introns, and self-splicing group II introns. 
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Figure 42: Schematic representation of the structures of different small ribozymes. Schematic structures of 
the hammerhead, hairpin and HDV ribozyme. Substrates are depicted in grey, cleavage sites are indicated by 
arrows. Figure adapted from Ref. [115]. 
3.2.1 Classification and Function 
Ribozymes are a good example for the structure-function relationship. These catalytic RNA 
molecules adopt a certain geometry to support their activity. This characteristic is typically 
assisted by metal ions. Ribozymes can catalyze a diversity of reaction types such as 
phosphoryl transfer or peptidyl transferase as for naturally occurring ribozymes. In vitro-
selected species can for example catalyze alkylation, isomerization, metal transfer, and 
Diels-Alder cycloaddition.[115,116] 
Most of the ribozymes perform phosphoryl transfer with transesterification reactions, which 
are therefore in the following described more in detail. Transesterification is the exchange of 
an organic group of an ester with the organic group of an alcohol. Depending on the 
respective reaction mechanism the ribozymes have been categorized into different classes. 
The reaction is initiated by a nucleophilic attack on a phosphate by: 
 the adjacent 2’ hydroxyl (nucleolytic ribozymes). 
 the 3’ hydroxyl of an exogenous guanosine (group I introns). 
 a remote nucleotide (group II introns). 
Moreover, ribozymes can be ‘self-cleaving’ or ‘self-splicing’. Self-splicing ribozymes such as 
introns can cut themselves out of larger RNAs and ligate the cut ends.[107] Others, such as 
RNase P, cut off a sequence or precursor on tRNA.[109,117,118] 
The cleavage reactions can be achieved in general by two different mechanisms with 
different intermediates. Small ribozymes are self-cleaving. Their catalytic function is based 
on a site-specific internal reaction mechanism with a cleavage of the phosphodiester bond by 
an internal reaction from the 2’-hydroxyl of the sugar. Products formed in this reaction are a 
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2’,3’-cyclic phosphate as well as a 5’-hydroxyl terminus (Figure 43 a). The reverse reaction is 
a ligation involving two proton transfers. Although all small ribozymes catalyze the same 
chemical reaction of specific backbone cleavage, they differ mechanistically and 
structurally.[113] Large ribozymes catalyze by a mechanism involving an external nucleophile, 
typically a hydroxyl group, to cleave the phosphodiester in the backbone (Figure 43 b). 
RNase P for example catalyzes the hydrolysis reaction with water as nucleophile.[115] 
 
Figure 43: RNA cleavage mechanisms. a) Cleavage of phosphodiester linkage initiated by a nucleophilic attack 
of a base (B) at the 2’-hydroxyl of the sugar. The cleavage products are a 2’,3’-cyclic phosphate and a 5’-hydroxyl 
terminus. b) Hydrolysis (R = H for RNase P) or transesterification (R = organic residue, guanosine for group I 
introns, internal adenosine for group II introns).[115] 
Different functional elements can be involved in the ribozyme catalysis. One is the RNA 
structure which is responsible for the position and orientation of the corresponding substrate. 
Metal ions are involved, besides their structural role, as Lewis acids or source of water 
molecules for acid-base catalysis. Furthermore, nucleobases act as acids, bases or via 
electrostatic effects.[116,119] 
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Splicing 
As mentioned above introns are non-coding sequences which are removed to give a 
functional RNA sequence by different mechanisms. The ‘self-splicing’ group I and II introns 
vary in the splicing mechanism by the attacking nucleophile. In group I introns the 
nucleophile is the 3’-OH of a guanosine residue whereas in case of group II introns of an 
internal adenosine. 
 
Figure 44: Splicing reaction of group II intron ribozymes. Step 1 is a nucleophilic attack by the 2’-OH of an 
internal adenosine. In step 2 the newly generated 3’-OH of the 5’-splice site attacks the phosphate bond at the 3’-
splice site. The intron (solid black line) is released as lariat and the exons (grey bars) are ligated.[120] 
The splicing reaction of group II intron ribozymes includes two transesterification steps. 
Step 1 is a nucleophilic attack by the 2’-OH of an internal adenosine. In step 2 the newly 
generated 3’-OH of the 5’-splice site attacks the phosphate bond at the 3’-splice site. The 
intron is released as lariat and the exons are ligated (Figure 44). Tertiary interactions of the 
exon and intron binding sites (EBS-IBS) are crucial for the reaction. Typically the splicing 
reaction is reversible. However, besides this branching pathway alternative pathways exist 
based on hydrolysis which are irreversible. In this case a linear intron is formed rather than a 
cyclic lariat.[121–124] 
3.2.2 Group II Intron Ribozymes 
Group II introns are among the largest known catalytic RNA molecules (500 to > 1000 nts) 
and are found in bacteria and in organelles of various eukaryotes, especially fungi and 
plants, but not in animal genomes.[125] Depending on their secondary structure group II 
introns can be further divided into subclasses IIA, IIB, and IIC.[126,127] They have in general a 
conserved global secondary structure typically organized in six domains around a central 
wheel structure with several long-range tertiary interactions between the different domains 
(Figure 45).[124,127] Domain 1 (D1) is the largest domain and is essential for the recognition of 
the exonic substrate.[128,129] It forms a folding scaffold and provides key active-site elements. 
Together with domain 5 (D5), the catalytic center, D1 is crucial for the catalytic activity.[130,131] 
Domains 2 and 3 enhance the catalytic activity but are not essential.[132] D4 is the domain 
that varies most and can contain an open reading frame for translation of a multifunctional 
AOH- AO-
AO-
Step 1 Step 2
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protein involved in splicing.[133] D6 includes the adenosine residue branching point for the 
splicing.[121] 
Relevant tertiary interactions such as 
α-α’, ζ-ζ’, κ-κ’, λ-λ’ between the 
different domains help to compose 
the intron active site.[127,134–137] The 
exon binding site 1 (EBS1) is 
positioned within the catalytic heart 
whereas EBS2 is completely 
exposed.[129,138] The key interactions 
of the group II intron architecture 
have mainly been characterized in 
biochemical studies. Furthermore, 
single domains, tertiary interactions 
and metal-ion binding sites were 
elucidated by NMR.[139–141]
It has only been recently that a 
group II intron was successfully 
characterized by X-ray crystallography.[142] However, crystallization of such large and 
complex RNA structures remains to be challenging and time-consuming. Exemplarily, a 
three-dimensional crystal structure of the Oceanobacillus iheyensis intron is shown in  
Figure 46.[142] 
 
Figure 46: Crystal structure of the O. iheyensis intron. a) Overall structure of the intron in a ribbon 
representation. b) 90° rotation of the image shown in a). (Figure from Ref. [142]. Reprinted with permission from 
AAAS). 
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Figure 45: Schematic structure of group II introns with 
characteristic tertiary interactions. Group II introns (black) are 
organized in six domains (blue) and are located in the exonic 
sequence (green). Tertiary interactions (orange) are highly 
conserved.[124,125]
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Most of the tertiary interactions discussed above can indeed be observed in the structure of 
the Oceanobacillus iheyensis intron. This intron belongs to the group IIC introns which are 
highly reactive and smaller than the IIA and IIB introns. Furthermore, group IIC introns are 
supposed to splice via a hydrolytic pathway forming a linear intron instead of a cyclic lariat 
product (see Chapter 3.2.1).[142] 
3.2.3 Group II Intron Sc.ai5γ 
The mitochondrial group II intron ai5γ from Saccharomyces cerevisiae (Sc) is a well-studied 
system. This 900 nts large ribozyme self-splices by changing its structure.[124,125,143–145] The 
intron interrupts the cytochrome oxidase subunit I gene.[129,134] Many discoveries relevant for 
the tertiary interactions of group II introns in general are based on ai5γ. Sc.ai5γ is therefore a 
very interesting system to study the folding behavior of large RNA molecules.[42,143] 
A common approach to study large and complex systems is the use of smaller constructs as 
model systems. Results obtained with these model constructs can then be transferred back 
to the large systems. D135 is a deletion construct of ai5γ containing all components 
contributing to the active site. It folds into a uniform catalytically active compact structure and 
is able to perform the first step of the splicing pathway. D135 cleaves a short oligonucleotide 
complementary to the exon binding sequences EBS1 and 2. The reaction follows thereby a 
hydrolytic rather than a branching reaction (Chapter 3.2.1). Pyle and coworkers determined 
the fraction of active ribozyme molecules by active-site titration experiments under multiple 
turnover conditions where the product release is rate limiting with an excess of substrate. 
The conditions for highest catalytic activity were determined. It was found that 83 ± 5% of the 
D135 population is active at 42 °C. The best conditions for ensuring complete folding of 
ribozyme in vitro were found to be 100 mM MgCl2, 500 mM KCl at pH 7.0. For this reaction 
the burst rate (beginning of reaction before steady state is reached) of 0.48 ±0.1 min‒1 is 
equivalent to the single turnover rate with the burst population being the most active state of 
ribozyme.[138,145] 
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To elucidate the structural dynamics of the group II intron folding by smFRET Steiner et al. 
designed a new construct D135-L14 (Figure 47) which is based on D135. Two artificial loops 
L1 and L4 were additionally introduced into domains 1 and 4. These modifications allow the 
specific hybridization of two DNA oligonucleotides carrying the FRET dye pair Cy3 and Cy5 
(see Chapter 3.3). Furthermore, the 3’-end was extended for a hybridization of DNA-biotin to 
immobilize the construct to a surface via biotin-streptavidin linkage. 
 
Figure 47: Secondary structure of D135-L14 with hybridized DNA-labels. DNA oligonucleotides (grey) 
carrying Cy3 (green), Cy5 (red) or biotin hybridized to D135-L14 RNA. The numbering corresponds to the wild-
type Sc.ai5γ sequence and the tertiary interactions are indicated in Greek letters. Structural modification to D135 
are marked in orange.[42] 
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Figure 48: Schematic folding pathway of a group II intron. a) Schematic structure of D135-L14 with Cy3 
(green sphere), Cy5 (red sphere) and biotin (grey sphere) labels. b) Folding pathway of D135-L14. Figure 
adapted from Ref. [42]. 
Single-molecule studies in vitro revealed that the group II intron folds sequentially in three 
steps from the unfolded state U via intermediates I and F to a compact native state N (Figure 
48). Mg2+ has been found to be crucial for the folding. The native state N is stabilized upon 
substrate binding and has been proposed to be the catalytically active species.[42] 
3.3 Labeling of Large RNAs 
An efficient fluorescence labeling of the molecules of interest is the base for various 
fluorescence techniques, e.g. FRET (Chapter 1.2). Thus, the fluorophore labeling sites have 
to be chosen carefully for the investigation of molecule dynamics, as they are sensitive to 
relevant folding transitions. In particular, the labeling should not significantly perturb the 
folding or kinetics of the molecules under investigation. 
The site-specific internal labeling of large (> 100 nts) functional RNA molecules is 
challenging. Modifications within large RNAs are mainly post-synthetically, in contrast to 
shorter RNAs up to 100 nts in length where modified bases or reactive functionalities can be 
incorporated during solid phase synthesis.[146,147] A direct internal labeling is often not 
specific. To address the problem of specificity, direct post-transcriptional labeling methods 
involve the use of guides, e.g. complementary oligonucleotides, to introduce functionalities 
within the RNA. Another approach is the use of enzymes such as deoxyribozymes for the 
attachment of fluorescent reporter groups.[148,149] In general, those methods are mostly limited 
by an extensive preparation of the guide, further purification steps of the labeled molecule 
and consequently low labeling yields. Alternatively, large RNAs can be synthesized from 
separate short RNA sequences by ligation. This allows functionalizing small RNAs at the 3' 
or 5' terminus, respectively, or site-specifically label them following the established 
techniques for small RNAs (vide supra). However, it was observed that this approach can 
lead to a loss of function.[147,150] 
Pan and coworkers developed a method for indirect labeling by modification of the RNA with 
single stranded loops or extensions, to which complementary DNA oligonucleotides carrying 
the label can be hybridized.[106] To ensure the formation of a stable RNA-DNA duplex and a 
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sufficient labeling efficiency, an overlap of at least 18 nts is necessary implying large RNA 
modifications, which can influence the folding behavior. Alternatively, stronger binding non-
natural nucleic acids such as peptide nucleic acids (PNAs) could be used to overcome these 
drawbacks. PNA is already known from other applications to have several advantages 
compared to DNA. In the following will be evaluated if PNAs are suitable labeling probes to 
replace DNA oligonucleotides for hybridization to RNA. 
3.4 A Non-Natural Nucleic Acid Analog: Peptide Nucleic Acid 
In 1991 Nielsen, Egholm, and coworkers first invented/discovered the non-natural nucleic 
acid derivative peptide nucleic acid (PNA).[151] It consists of an uncharged pseudo-peptide 
backbone whereas DNA and RNA have the negatively charged phosphate groups. PNA 
binds therefore stronger to RNA than either DNA or RNA do, forming very stable Watson-
Crick paired complementary duplex structures. PNA serves as a structural mimic of DNA and 
RNA and was originally designed as a ligand for the recognition of double stranded DNA.[152] 
 
Figure 49: Comparison of chemical structures of DNA and PNA strands. a) DNA and b) PNA with 
characteristic units boxed in. DNA consists of a negatively charged sugar phosphate backbone. PNA has an 
uncharged pseudo-peptide backbone. 
The structure of PNA consists of repeating N-(2-aminoethyl)-glycine units linked by amide 
bonds. The bases are attached to the backbone by methylene carbonyl linkage. Unlike DNA 
or RNA no pentose sugar moieties or phosphate groups are present, which results in an 
acyclic, achiral and neutral backbone (Figure 49). The consequences of this neutral 
backbone lead to the important feature of PNA, its strong binding between complementary 
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PNA-DNA and PNA-RNA strands at low to medium ionic strength. The binding strength is 
stronger than between DNA-DNA or DNA-RNA due to the lack of charge repulsion. 
Furthermore, PNA has a much higher sequence specificity as mismatches in PNA-DNA or 
PNA-RNA duplexes are more destabilizing than in DNA-DNA or RNA-RNA.[153] Watson Crick 
base pair rules are strictly observed in the hybrids.[154] Like this, PNA can bind to 
complementary nucleic acids in an antiparallel orientation (C-terminus and 5’-end), which is 
strongly preferred, and a parallel orientation. The melting temperature of PNA-nucleic acid 
duplexes is largely independent of the salt concentration. Although PNA prefers a P-form 
conformation, it adapts the structure of its nucleic acid partner. An RNA-PNA duplex is in A-
form conformation, DNA-PNA in a B-like structure. A further benefit of PNA is, that PNA-RNA 
hybrids are not affected by degradation due to RNase H, in contrast to RNA-DNA 
duplexes.[155] This fact is of high importance in terms of studies in vivo. 
Following the convention, PNAs are depicted like peptides from the N-terminus at first 
position and C-terminus at right.[152] 
3.4.1 Principle of Solid Phase PNA Synthesis 
Another advantage of PNA is its straightforward synthesis, which is based on the well-
established solid phase peptide synthesis (SPPS). The robustness and flexibility of this 
synthesis allows an individual tunable design.[152] 
The general principle of solid phase PNA synthesis is shown in Scheme 6.[156] 
 
Scheme 6: Solid phase PNA synthesis. Free amine groups (red) react with activated esters to form a stable 
amine bond. The desired PNA sequence is synthesized by subsequent coupling of PNA monomers at a polymer 
resin support (brown) with Fmoc deprotection steps in between and final cleavage from the resin. 
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Usually, the PNA strand is synthesized from the C- to the N-terminus. The solid support on 
which the reactions are carried out is a polymer resin with adjustable functionalities. Starting 
from primary amines at the resin, activated PNA monomers are coupled to form stable amide 
bonds. Every monomer is Fmoc (fluorenylmethyloxycarbonyl) protected at its amine function 
to ensure that only the amine groups on the resin can react. Additionally, the particular bases 
are Bhoc (benzhydryloxycarbonyl) protected at their primary amine side chain functionalities. 
This strategy allows to selectively deprotect the backbone amine function for coupling without 
side reactions at the nucleobases. Monomers are coupled via active ester formation with 
HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexa-
fluorophosphate).[157] Completion of each coupling step can be monitored by the Kaiser 
test.[158,159] This test is based on a Schiff base reaction with a color change to blue if free 
amines are present. After Fmoc deprotection the next monomer can be coupled until the 
sequence is completed. The final product can be cleaved from the resin under acidic 
conditions, which simultaneously remove the Bhoc-protecting groups on the nucleobases. 
3.4.2 Applications of PNA 
With the above described useful properties PNA is already in use for a variety of 
applications. PNAs can be used in drug-discovery with the potential as gene-targeted 
drugs,[160–162] antisense agents,[163] genetic diagnostics,[164] molecular recognition,[165] DNA 
detection, and therapeutics.[152] Modified PNAs were investigated for template-accelerated 
chemical reactions for the detection of mRNA’s expression level or microRNAs in vivo.[166] 
PNA anti-miRs (oligonucleotide inhibitors complementary to miRNAs) together with 
intrinsically fluorescent PNA analogues are used for studies upon inhibition of miRNAs as 
potential therapeutics.[167] Furthermore, fluorescent PNA-based probes have been used to 
explore the splicing of an mRNA molecule by smFRET. To this end, the flanking splice sites 
were labeled by hybridization of dye-carrying PNAs and the spatial separation of the dyes 
was detected before and after splicing of the RNA.[168] PNA has many more applications in 
the field of chemistry, biology, and medicine. The studies described herein are focused on 
using PNAs as hybridization probes for fluorescence labeling to investigate the folding of 
large RNAs by smFRET. 
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3.5 Aim of the Chapter 
As mentioned before (Chapter 3.3), modifications within the RNA structure for an indirect 
labeling with DNA hybridization probes can disturb the structure and thus the functionality of 
the RNA. To overcome these drawbacks and improve the labeling strategy, we envisaged 
the use of the non-natural nucleic acid analogue Peptide Nucleic Acid (PNA) instead of DNA 
oligomers for efficient fluorescence labeling. A significant advantage of PNA over DNA is its 
higher mismatch sensitivity which makes it an extremely selective labeling agent.[153,154] 
Furthermore, PNA is known to bind much stronger to RNA than DNA does due to its 
uncharged backbone (Chapter 3.4).[154] Consequently, the PNA probes can be drastically 
shortened compared to the analogues DNA oligomers, and smaller or even no modifications 
of the RNA are necessary for the hybridization. Ideally, hybridization to the natural loops 
within the RNA structure would suffice. This leads to more flexibility in choosing the labeling 
position within the target construct and thereby less disturbance of the folding.  
In the following chapter, the investigation of the optimal label design together with a 
systematic comparison of the commonly used RNA-DNA labeling scheme with the 
complementary RNA-PNA system is described. To this end, new fluorescent PNA derivatives 
containing the FRET dyes Cy3 or Cy5 are synthesized and characterized including 
photophysical properties. Furthermore, the optimal length of the PNA sequence, the position 
of the dye, the labeling efficiency, and potential interference of PNA with the RNA structure, 
dynamics and activity is determined with various methods as a proof of concept study on the 
RNA model system Sc.ai5γ. 
 
Figure 50: Fluorescence labeling strategy for RNA using a model system. a) Schematic drawing of D135-
L14 (solid line) and D135-L1shL4 with shortened L1 (dotted line), and hybridized oligonucleotide labels Cy3 
(green), Cy5 (red), and biotin (grey) for immobilization. Modifications of D135 are depicted in orange (L1 = 
modified loop in domain 1, L4 = modified loop in domain 4). b) Sequence of artificial hairpin loops L1, L1sh (blue 
box in a) and L4 (green box in a) located in the RNA construct D135-L14 or D135-L1shL4. 
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Therefore, a truncated version of the mitochondrial group II intron ai5γ derived from S. 
cerevisiae (D135-L14) was chosen, because it is a well-characterized large RNA molecule 
(> 600 nts) with enzymatic activity (Figure 47, Figure 50, Chapter 3.2.3).[42] To demonstrate 
that the required structural modification of RNA for hybridization are minimized when using 
the shorter PNA labels, one or both of the artificially introduced loops (L1 and L4) of the 
D135-L14 construct are shortened by 9 nucleotides each, yielding D135-L14sh and D135-
L1shL4 (Figure 50). This labeling strategy thus allows investigating the folding behavior of 
large functional RNAs closer to the natural sequence. Finally, the applicability is proven by 
use of smFRET. 
After investigations of the PNA labeling scheme and systematic comparison using a model 
system, the labeling scheme is applied to a new RNA system, the btuB riboswitch of E. coli. 
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3.6 Results 
The following chapter is based on the manuscript accepted for publication: 
“Internal Labeling Strategy of Large RNAs with Minimal Perturbation Using Fluorescent PNA” 
by Anita G. Schmitz, Susann Zelger-Paulus, Gilles Gasser, and Roland K. O. Sigel in 
ChemBioChem, 2015.[169] 
3.6.1 Synthesis of PNA Derivatives 
The ribozyme construct D135-L14 was designed to bind DNA-dye oligomers functioning as 
indirect fluorescent labels (Chapter 3.2.3). To ensure a stable hybridization to the RNA the 
DNA oligomers (DNA1-Cy3, DNA2-Cy5) have a length of 18 nts (Figure 51). 
 
Figure 51: DNA-Cy and PNA-Cy derivatives complementary to loops L1 and L4 in D135-L14. Design and 
nomenclature of synthesized PNA derivatives carrying Sulfo-Cy3 (green) or Sulfo-Cy5 (red) in comparison to 
corresponding DNA derivatives. DNA and PNA sequences (grey) are complementary to L1 or L4 located in the 
D135-L14 RNA (black). PNA derivatives with an additional spacer group are indicated by an ‘S’. 
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Based on this, different PNA sequences were designed to carry the fluorescent cyanine dyes 
(Cy) Sulfo-Cy3 or Sulfo-Cy5 (FRET pair), and to be hybridized to the loops L1 and L4 in 
D135-L14. Due to the strong binding affinity of PNA to RNA (Chapter 3.4) the derivatives are 
shorter (10-mers and 14-mers) than the corresponding DNA (18-mer) oligonucleotides 
(Figure 51). 
The PNA derivatives were prepared by use of solid phase synthesis (see Chapter 3.4.1).[170] 
To these PNA sequences the cyanine dyes Sulfo-Cy3 or Sulfo-Cy5 were covalently attached 
at the N-terminus, which is analogous to the 5’ end in DNA, with or without a spacer group 
(2-(2-(amino)ethoxy)ethoxy]acetate, AEEA) in between. An additional C-terminal lysine 
residue was used to increase the solubility. All derivatives in this chapter contain the 
sulfonated cyanine dyes, which are abbreviated with Cy3 or Cy5 for simplicity. These 
negatively charged derivatives are commonly used in nucleic acids studies (Chapter 1.2.2) 
due to their low tendency to intercalate. 
The overall structural principle of the PNA-Cy derivatives is shown in Figure 52 from N- to C-
terminus containing a dye, a spacer, a PNA sequence built from monomers and lysine. 
 
Figure 52: Structure of a PNA-Cy5 derivative. Special subunits are highlighted in boxes. The derivatives 
consist of a cyanine dye, optionally a spacer group, various monomers coupled to give the desired sequence, and 
lysine for increased solubility. PNA bases are denoted in small letters from N- to C-terminus. 
The synthesis starts from a modified polymer resin with bound lysines that are Boc protected 
at the ε-amino function and Fmoc protected at the α-amino function (Scheme 7). Fmoc is 
cleaved from the lysines with piperidine in DMF to give free primary amine groups. The PNA 
monomers are activated with HATU in the presence of N,N-diisopropylethylamine (DIPEA) 
and 2,6-lutidine, and coupled to the primary amines. In a next step, Fmoc is removed from 
the terminal backbone amine groups to allow the next coupling step. The dyes Sulfo-Cy3 or 
Sulfo-Cy5 are used as NHS esters and coupled to the PNA sequence in the presence of 
DIPEA. Finally, Boc deprotection and cleavage of the completed PNA sequence from the 
resin is done under acidic conditions by use of TFA. 
Resins commonly used in SPPS are known to absorb activated fluorophores leading to a 
decreased labeling yield.[171] Hence, in an alternative approach the resin with the PNA1S 
sequence was saturated with Kiton Red, an inexpensive non-activated fluorophore, prior to 
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the addition of Sulfo-Cy3. In the present case, however, the procedure did not increase the 
yield significantly. 
 
Scheme 7: Solid phase synthesis of PNA-Cy derivatives. The synthesis starts from a lysine-modified resin 
(brown). a) Subsequent coupling of Fmoc protected PNA monomers. b) Fmoc cleavage with piperidine. Repetition 
of a) and b) until the sequence is completed. c) Dye coupling in the presence of DIPEA in DMF yielding product 
PNA-Cy which is cleaved from the resin with simultaneous Boc deprotection of the nucleobases. 
The 14-mer PNA1S-Cy derivative was synthesized in two variants, once carrying the donor 
Sulfo-Cy3 and once the acceptor Sulfo-Cy5 (see Figure 51). This offers the possibility to 
exchange the donor and acceptor positions within the RNA construct. The investigation of 
different labeling positions can help excluding artifacts in smFRET measurements. Ideally 
both positions give the same results. To minimize the modifications in the RNA structure 
needed for label hybridization, the PNA oligomers should be as short as possible while 
keeping sequence specificity and duplex stability. Therefore different PNA sequence lengths 
were investigated. PNA2 and PNA3 derivatives (Figure 51) are designed to be 10-mers, 
which are thus 4 nucleobases shorter than PNA1S and 8 nucleobases shorter than the DNA 
oligomers DNA1-Cy3 and DNA2-Cy5. To form stable PNA-RNA hybrids and reduce possible 
disruption of the stem-loop structure, the label should not be in close distance to the RNA 
duplex. To investigate the potential influence of the final position of the dye in PNA-RNA 
hybrids PNA2-Cy5 and PNA3-Cy5 derivatives differ in their sequence. PNA3-Cy5 ends at 
the same positions as DNA2-Cy5, whereas PNA3-Cy5 is shifted by two bases. Furthermore, 
the influence of a spacer group between the oligonucleotides and the dye was investigated. 
In general, commercially available dye-labeled DNA oligonucleotides can vary in the spacer 
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group between the DNA and the dye. For this reason, derivatives of the same sequence 
were prepared, once with the dye directly linked to the PNA (PNA2-Cy5/PNA3-Cy5) or with a 
spacer group in between (PNA2S-Cy5/PNA3S-Cy5). The spacer (Figure 52) has a similar 
length as the C6-linker in the DNA probes used in this study. 
Each PNA derivative was characterized by UV/Vis, HPLC, ESI-MS and MALDI-MS (Chapter 
3.6.2). 
3.6.2 Characterization of PNA Derivatives 
UV/Vis 
In UV/Vis spectra of the PNA-dye derivatives the characteristic absorption maxima of PNA at 
260 nm and Sulfo-Cy3 at 550 nm or Sulfo-Cy5 at 650 nm were observed. The fluorescence 
emission of Sulfo-Cy3 and Sulfo-Cy5 is similar to the free dyes at around 570 nm and 
670 nm (Figure 53). 
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Figure 53: Absorbance and emission spectra of PNA-Cy derivatives in comparison to DNA-Cy derivatives 
and free Cy dyes. Absorbance (black) and emission spectra (red) in aqueous solution of a) PNA4-Cy3 (solid 
line), DNA1-Cy3 (dotted line) and Sulfo-Cy3 (dashed line), and b) PNA3-Cy5 (solid line), DNA2-Cy5 (dotted line) 
and Sulfo-Cy5 (dashed line). Sulfo-Cy3 is excited at 500 nm, Sulfo-Cy5 at 580 nm. 
The results of the PNA-Cy derivatives are consistent with the ones of the corresponding 
DNA-dye derivatives. 
HPLC 
In HPLC experiments the respective product peaks of the PNA-dye derivatives were 
detected at 260 nm (absorbance PNA) and 550 nm (absorbance Sulfo-Cy3) or 650 nm 
(absorbance Sulfo-Cy5), and emission at 570 nm (Sulfo-Cy3) or 670 nm (Sulfo-Cy5). A 
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comparison of the chromatograms of PNA1S-Cy3 at different wavelength is shown in  
Figure 54. 
0 5 10 15 20
260 nm
550 nm
550-570 nm7  nm (ex. 550 nm)
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Figure 54: HPLC chromatograms of PNA1S-Cy3 at different wavelength. At 260 nm the absorption of the 
PNA is detected, at 550 nm the absorption of the Sulfo-Cy3. The Sulfo-Cy3 emission is detected at 570 nm upon 
excitation at 550 nm. The intensities are normalized. 
Mass Spectrometry 
In ESI-MS and MALDI-MS experiments product peaks of the different PNA-Cy derivatives 
were observed. The detection of differently charged species due to multiple protonation is 
characteristic for PNA oligomers (Figure 55 and Figure 56). 
500 1000 1500 2000
0
1x107
2x107
3x107
4x107
5x107
[M+7H]6+
[M+4H]3+
[M+6H]5+
In
te
ns
ity
m/z
[M+5H]4+
 
Figure 55: ESI-MS spectrum of PNA3-Cy5. Product peaks of PNA3-Cy5. Multiple protonated species are 
characteristic for PNA oligomers. 
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The ESI-MS spectrum of PNA3-Cy5 (Figure 55) reveals the product peaks of the four to 
seven times protonated species. 
 
Figure 56: MALDI-MS spectrum of PNA1S-Cy3. Product peaks of PNA1S-Cy3. 
In the MALDI-MS spectrum of PNA1S-Cy3 (Figure 56) the product peaks are detected as 
doubly or triply protonated species. 
3.6.3 Fluorescence Quantum Yields and Steady-State Anisotropy 
The PNA labels are designed for fluorescence applications, especially FRET. Provided that 
the photophysical properties of the probes are unaffected by the environment, variations in 
the measured FRET efficiency can then be interpreted in the line of conformational changes 
of the RNA (Chapter 1.2). The fluorescence quantum yields of Sulfo-Cy3 and Sulfo-Cy5 
attached to DNA and PNA oligonucleotides were therefore determined (Table 3). Quantum 
yields of PNA4-Cy3 (0.26 ± 0.03) in comparison to DNA1-Cy3 (0.26 ± 0.02), and PNA3-Cy5 
(0.32 ± 0.01) in comparison to DNA2-Cy5 (0.35 ± 0.01) revealed no differences between 
both labeling systems. DNA is known to enhance the fluorescence of attached cyanine dyes 
in comparison to free cyanine dyes. This enhancement is based on the reduction of the 
trans-cis isomerization from the first excited state to a ground state non-fluorescent 
photoisomer (Chapter 1.2.2).[21] The extent of the effect depends on the neighboring 
nucleobases.[20,28] In the herein presented studies the same enhancement effect was 
observed for the PNA hybrids. The effect is slightly reduced when the spacer group is 
present as the dye is further apart from the neighboring nucleobases. 
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Additionally, steady-state fluorescence anisotropy was measured to determine the changes 
of rotational freedom of the dye upon attachment to DNA or PNA. All derivatives showed 
similar anisotropies of around 0.20 (Table 3). Sulfo-Cy5 attached to PNA or DNA revealed a 
higher anisotropy value than the free dye. A similar behavior was observed for B12-Cy5/Sulfo-
Cy5 derivatives (Chapter 2.5.2). 
These results demonstrate that PNA-Cy derivatives have similar photophysical properties as 
the previously used DNA-Cy oligonucleotides. 
Table 3: Fluorescence quantum yields (Φs) and static fluorescence anisotropy values (r) of free Sulfo-Cy3 
(excited at 500 nm), free Sulfo-Cy5 (excited at 580 nm) or attached to DNA or PNA oligonucleotides at 22 °C in a) 
Reaction Buffer with 100 mM MgCl2 and b) water. The values given correspond to the arithmetic mean of at least 
three independent measurements with errors corresponding to one standard deviation. 
Compound Φs (a) Φs (b) r 
Sulfo-Cy3 0.071 ± 0.002 0.060 ± 0.002[a] 0.243 ± 0.005 
PNA1S-Cy3 - 0.24 ± 0.02 0.22 ± 0.01 
PNA4-Cy3 0.26 ± 0.03 0.25 ± 0.02 0.22 ± 0.01 
DNA1-Cy3 0.26 ± 0.02 0.15 ± 0.02 0.23 ± 0.01 
Sulfo-Cy5 0.23 ± 0.01 0.203 ± 0.006[b] 0.131 ± 0.009 
PNA1S-Cy5 0.30 ± 0.02 0.32 ± 0.02 0.204 ± 0.005 
PNA2-Cy5 0.35 ± 0.02 0.278 ± 0.004 0.193 ± 0.008 
PNA2S-Cy5 0.30 ± 0.02 0.26 ± 0.01 0.183 ± 0.005 
PNA3-Cy5 0.32 ± 0.01 0.34 ± 0.02 0.186 ± 0.010 
PNA3S-Cy5 0.29 ± 0.01 0.273 ± 0.001 0.188 ± 0.004 
DNA2-Cy5 0.35 ± 0.01 0.28 ± 0.02 0.217 ± 0.007 
 [a] Quantum yield provided by supplier Φ= 0.1 
 [b] Quantum yield provided by supplier Φ= 0.2 
The quantum yields of the PNA-Cy derivatives are mainly independent from the ionic 
strength of the solution. 
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3.6.4 UV Melting Experiments 
To assess the duplex stability of RNA-DNA in comparison to RNA-PNA, UV melting 
experiments were carried out with the hybrids formed between dye-labeled PNA or DNA 
oligonucleotides and the corresponding short complementary RNA sequences.[172] 
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Figure 57: Melting curves of DNA-RNA and PNA-RNA hybrids of different lengths. The melting temperature 
of DNA2-Cy5 (dotted line) is lower than the one of PNA1S-Cy5 (dashed line) and PNA3-Cy5 (solid line). 
A comparison of RNA hybrids with a 18 nts long DNA-Cy oligomer, a 14 nts PNA-Cy 
oligomer and a 10 nts long PNA-cy oligomer is shown in Figure 57. 
Furthermore, different synthesized PNA-Cy derivatives were used to study the influence of a 
spacer group between PNA and dye, as well as differences in the distance from the label to 
the stem in the D135-L14 structure (Chapter 3.6.1). All melting temperatures (Tm) of the 
RNA-PNA hybrids are at least 10 °C higher in comparison to the RNA-DNA duplexes, 
although the PNA sequences are 4-8 nucleobases shorter than the corresponding DNA 
oligomers (Table 4). This shows that the binding strength of the shortened PNA oligomers to 
the RNA is even higher than the one of the longer DNA oligomers. 
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Table 4: Melting temperatures of RNA-PNA and RNA-DNA hybrids with [RNA] = [DNA] = [PNA] = 2 µM in 
Reaction Buffer. The given Tm values are the average of at least six measurements. 
PNA/DNA Sequence[a] Tm [°C] 
PNA1S-Cy3 Cy3-spacer-gtagtccgaaatat-Lys-NH2 70 ± 1 
PNA1S-Cy5 Cy5-spacer-gtagtccgaaatat-Lys-NH2 72 ± 1 
PNA2-Cy5 Cy5-gtagtccgaa-Lys-NH2 69 ± 2 
PNA2S-Cy5 Cy5-spacer- gtagtccgaa-Lys-NH2 69 ± 1 
PNA3-Cy5 Cy5-acgtagtccg-Lys-NH2 67 ± 1 
PNA3S-Cy5 Cy5-spacer-acgtagtccg-Lys-NH2 66 ± 1 
PNA4-Cy3 Cy3-accaagagcg-Lys-NH2 69 ± 1 
DNA1-Cy3 5'-Cy3-ACCAAGAGCGTTATTAAT-3’ 57 ± 1 
DNA2-Cy5 5'-Cy5-ACGTAGTCCGAAATATAT-3’ 56 ± 1 
 [a] spacer = [2-(2-(amino)ethoxy)ethoxy]acetate 
A theoretically possible destabilization of the duplex by the close proximity of the dye to the 
hybrid, as it is the case in PNA2-Cy5, PNA3-Cy5 and PNA4-Cy3, was not observed. This 
indicates as well that the spacer group between the PNA and the dye does not influence the 
duplex stability. 
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3.6.5 New Constructs D135L1sh4 and D135L14sh 
PNA with its stronger binding affinity to RNA gives the opportunity to use shorter 
oligonucleotide labels of only 10 nts (see above) and hence, smaller modifications of the 
RNA are needed for the hybridization, leading to a RNA sequence closer to the natural one. 
To confirm this, the D135-L14 construct was modified to be more similar to its wild type 
structure by the deletion of 9 bp (5’-AAUUAAUAA-3’) in loop L1 yielding the RNA construct 
D135-L1shL4 (Figure 58). 
 
Figure 58: Secondary structure of D135-L1shL4 with PNA-dye labels. PNA oligonucleotides (red) carrying 
Sulfo-Cy3 (green) or Sulfo-Cy5 (red), and DNA-biotin (grey) are hybridized to D135-L1shL4 RNA. The numbering 
corresponds to the wild-type Sc.ai5γ sequence and the tertiary interactions are indicated in Greek letters. 
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Additional deletion of 9 bp (5’-AAUAUAUUU-3’) in loop L4 yielded the RNA construct D135-
L14sh (Figure 59). 
 
Figure 59: Secondary structure of D135-L14sh with PNA-dye labels. a) D135-L14sh. b) Close-up of desired 
structure of shortened loop L4 for binding of PNA-Cy labels. c) Predicted secondary structure with minimum free 
energy of loop L4 (-14.40 kcal/mol). 
However, fluorescence native gel experiments revealed that the complementary PNA 
derivatives were not binding to the new loop L4 (data shown in Chapter 3.6.6). Secondary 
structure prediction of the shortened loop L4 sequence did not confirm the presence of 12 
unpaired nucleotides as anticipated, but suggests that a stable G-C rich stem with a 
pentaloop (Figure 59) is formed.[173] This structure does not provide a sufficient hybridization 
platform for the PNA to bind. D135-L14sh was thus not used for smFRET studies. 
3.6.6 Fluorescence Native Gels 
To visualize the binding efficiency and specificity of the fluorescently labeled PNA oligomers 
to RNA in comparison to DNA oligomers native polyacrylamide gel electrophoresis assays 
were performed with D135-L14, D135-L14sh and D135-L1shL4 (Figure 60). The conditions 
were chosen to be optimal for folding of the ribozyme in vitro (Chapter 3.2.3) and are similar 
to the ones used for single-molecule FRET studies.[42,145] In a first step the labeling procedure 
was optimized. Due to the high binding affinity of PNA to RNA, PNA can be hybridized at 
42 °C, whereas DNA has to be annealed under denaturing conditions at 90 °C. High 
a)
b)
c)
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temperatures can lead to dye deactivation, RNA degradation as well as RNA aggregation. As 
this can be avoided with PNA, it is one reason for an increased labeling yield of PNA 
compared to DNA. Furthermore, the labeling procedure is faster without the denaturation 
step. 
Binding of PNA4-Cy3 and PNA3-Cy5, individually (Figure 60 a, lanes 8 and 9, respectively) 
and simultaneously (lane 10), to D135-L14 RNA was investigated in comparison to DNA1-
Cy3/DNA2-Cy5 (lanes 3-5, 11). PNA-Cy3/Cy5 oligonucleotides which carry a charge only at 
the dyes hardly enter the gel. The yellow bands indicate the presence of both, Cy3 and Cy5 
labels bound to the RNA (lanes 5, 10, 11). The three main bands (A, B, C) from top to bottom 
are aggregated/unfolded, intermediate and compact species of the RNA. Controls in lane 1, 
2 and 6, 7 are the DNA (D) or PNA oligonucleotides, respectively without RNA. 
 
Figure 60: Fluorescence native gels of D135-L14sh, D135-L1shL4, and D145-L14 RNA with DNA-dye or 
PNA-dye labels. Binding of DNA or PNA oligonucleotides carrying the label Sulfo-Cy3 (green) or Sulfo-Cy5 (red) 
to a) D135-L14 and b) D135-L14sh (lanes 1-3), D135-L1shL4 (lanes 4-6), and D135-L14 (lane 7) detected by 
fluorescence on native gels. Co-localized fluorescence emission of Sulfo-Cy3 and Sulfo-Cy5 appears in yellow. 
Grey bars indicate (A) unbound PNA oligomers or labeled RNA aggregates, (B) RNA intermediates, (C) compact 
RNA, and (D) unbound DNA-Cy3/Cy5 oligomers. Composition of samples depicted as present (+), absent (-) or in 
excess (++). 
The superior labeling efficiency of PNA over DNA is reflected in a much higher fraction of 
labeled RNA in case of PNA, a large fraction of unbound DNA (lowest bands) and almost no 
unbound PNA. With respect to FRET measurements, the higher fraction of labeled molecules 
leads to a reduced fluorescence background. Furthermore, less PNA is necessary for 
efficient labeling compared to DNA, since PNA showed the highest efficiencies at a ratio of 
-+ + +
-
+D135-L14sh
D135-L1shL4
D135-L14
PNA4-Cy3
PNA3-Cy5
-
-
+
-
-
-
+
-
-
+
-
-
+
1 32 74 5 6
+ +
+
-
+
- -
+
--
+ +
--
+
+
RNA
DNA1-Cy3
DNA2-Cy5
PNA4-Cy3
PNA3-Cy5
-
+
-
-
-
-
+
-
-
-
-
-
+
+
-
-
-
+
+
- +
-
-
+
+
-
-
-
+
-
-
- -
+ -
+
-
-
+
+
-
-
-
+
+
-
-
+
+
+
-
-
+
+
-
1 32 9874 5 6 10 11
+
+
A
B
C
D
A
B
C
a) b)
87 
3 Labeling of RNA 
 
1:1 RNA/PNA (Figure 61), whereas the efficiency of DNA is lower even in twofold excess 
(Figure 60 a, lane 11). 
Fluorescence native gels of D135-L1shL4 revealed as well a very good binding of the PNA to 
the loops L1sh and L4 (Figure 61 b). This construct containing the shortened loop L1sh 
cannot be labeled with DNA probes because the modified loop is too small to form a 
sufficiently stable RNA-DNA duplex. 
In experiments with D135-L14sh and PNA labels a binding of PNA to the shortened loop 
L1sh war observed (Figure 60 b). However, no labeling at loop L4sh was detected due to the 
unfavorable loop structure (Chapter 3.6.5). 
 
Figure 61: Fluorescence native gels of D135-L14 RNA with PNA-dye labels in different ratios. Increasing 
concentrations of PNA-Cy from lanes 1-5 with ratios of RNA:PNA 2:1, 1:1, 1:1.2, 1:1.5, 1:2. a) Binding of PNA4-
Cy3 (green) and PNA3-Cy5 (red) to D135-L14 detected by fluorescence on native gels. Co-localized 
fluorescence emission of Sulfo-Cy3 and Sulfo-Cy5 appears in yellow. b) EtBr staining of RNA bands detected by 
UV shadowing at 260 nm. 
In further studies with increasing concentrations of PNA hybridized to D135-L14 no folded 
RNA band was detected at ratios of RNA:PNA of 1:1.5 and higher (Figure 61). However, no 
RNA degradation bands were observed (Figure 61 b). This suggests that high concentrations 
of uncharged PNA could lead to an aggregation of the RNA. Due to its size aggregated RNA 
is hardly entering the gel and is consequently not fully detected. 
 
[PNA-Cy]a) b)
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[PNA-Cy]
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3.6.7 Single-Turnover Cleavage Assays 
It is of great interest to study the folding of functional RNAs. Therefore, the labeling method 
for RNA should not reduce the activity of the RNA. The effect of modifications within the 
intron sequence can be directly evaluated by measuring its catalytic activity. In a so-called 
cleavage assay mimicking the first step of splicing, an external substrate (17/7) is cleaved by 
group II intron under single turn-over conditions.[138] The substrate contains the last 17 
nucleotides of the 5'-exon sequence including both intron binding sites IBS1 and IBS2 and 
the first 7 nucleotides of the intron and thus the 5' splice site (Figure 62). The cleavage rate 
of the substrate reflects the activity of the ribozyme. 
 
Figure 62: Principle of ribozyme cleavage assay. The ribozyme RNA (schematic drawing of D135-L14 in black 
with hybridized DNA or PNA labels in grey) cleaves the exonic substrate 17/7, which contains the intron binding 
sites IBS1/2 into the fragment 17 and 7. The location of the substrate in the natural sequence is depicted in dotted 
lines. For visualization purpose, the substrate is [32P]-5'-end labeled (radioactive symbol). 
To avoid the presence of unlabeled ribozyme in the experiment, DNA-dye oligomers were 
added in a 6-fold excess. PNA-dye oligomers were added in a 1:1 ratio of PNA/RNA, as this 
was found to be the labeling condition with the highest efficiency (Chapter 3.6.6). The activity 
of the different in vitro transcribed ribozyme constructs D135, D135-L14, D135-L14sh and 
D135-L1shL4 was investigated by single-turnover cleavage experiments (STO). The 17/7 
substrate was [32P]-5'-end labeled for a sensitive detection, and the cleavage of the substrate 
by the ribozyme with or without hybridized DNA or PNA was analyzed (Figure 63). 
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Figure 63: Cleavage of substrate 17/7 by D135-L14 labeled with DNA-dye or PNA-dye. Cleavage of [32P]-5'-
end labeled substrate 17/7 by D135-L14 with hybridized DNA-dye oligomers or PNA-dye oligomers. a) Cleavage 
bands of substrate at different reaction time points detected on denaturing PAGE. Control C is unreacted 
substrate. b) Plot of fraction of cleaved product versus the reaction time and exponential fit (dotted line). 
Comparison of experiments with DNA-labeled (red squares) and PNA-labeled (black dots) D135-L14. 
As reported in the literature,[42] the modification of D135 in the two loops L1 and L4 for 
hybridization of DNA labels leads to a small decrease in activity (Table 5). D135-L14 with 
hybridized DNA-dye or PNA-dye oligonucleotides reveals a higher activity than D135-L14 
without labels. The rate constants of D135-L1shL4 are similar to the ones of D135-L14. As 
described previously (Chapter 3.6.5) D135-L14sh contains a stable G-C rich stem replacing 
loop L4. This structural motif influences the folding behavior of the ribozyme and 
consequently a reduced activity is observed for D135-L14sh compared to the other 
constructs. 
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Table 5: Cleavage rate constants kobs of D135, D135-L14, D135-L14sh and D135L1shL4 in min‒1 determined 
from single exponential fits. The values given correspond to the arithmetic mean of at least three independent 
measurements with errors corresponding to one standard deviation. 
RNA construct Unlabeled DNA labeled PNA labeled 
D135 0.109 ± 0.005 - - 
D135-L1shL4 0.100 ± 0.003 - 0.118 ± 0.002 
D135-L14 0.098 ± 0.003 0.115 ± 0.003 0.118 ± 0.004 
D135-L14sh 0.073 ± 0.002 - 0.088 ± 0.002 
Besides the increased cleavage rate upon label hybridization also the fraction of cleaved 
substrate is increased by almost 10 % when DNA or PNA labels are hybridized to D135-L14 
compared to unlabeled D135-L14 (Table 6). 
Table 6: Maximum cleavage of substrate 17/7 by D135, D135-L14, D135-L14sh and D135-L1shL4 in %. 
RNA construct Unlabeled DNA labeled PNA labeled 
D135 73 - - 
D135-L1shL4 71 - 76 
D135-L14 76 84 85 
D135-L14sh 69 - 74 
Hence, the observed activity of RNA-PNA and RNA-DNA hybrids is similar, confirming that 
PNA does not reduce the activity or influences the folding behavior of the ribozymes, 
respectively. 
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3.6.8 Single-Molecule FRET Experiments 
After demonstrating the efficient and non-destructive labeling by the use of PNA, the studies 
were completed by proving the applicability of the PNA labeling scheme in single-molecule 
FRET experiments. The group II intron model system has been investigated via smFRET 
using the D135-L14 construct with DNA-labels by Steiner et al. (Chapter 3.2.3).[42] Using the 
same conditions, the new labeling strategy with PNA labels was tested in comparison to DNA 
labels. Ideally, the new labeling scheme should not affect the folding pathway. The smFRET 
experiments were carried out with the D135-L14 and the new D135-L1shL4 model intron, 
prefolded at 42 °C  in the presence of 100 mM Mg2+ (optimal folding conditions in vitro, 
Chapter 3.2.3), and labeled with the respective oligonucleotides (Table 7). 
Table 7: DNA-Cy and PNA-Cy derivatives and label positions within the ribozyme RNA used for smFRET 
experiments. 
Experiment RNA Label Loop 
DNA D135-L14 DNA1-Cy3 DNA2-Cy5 
L1 
L4 
PNA3 D135-L14 PNA4-Cy3 PNA3-Cy5 
L1 
L4 
PNA3S D135-L14 PNA4-Cy3 PNA3S-Cy5 
L1 
L4 
D135-L1shL4 D135-L1shL4 PNA4-Cy3 PNA3-Cy5 
L1 
L4 
 
The donor dye Sulfo-Cy3 was placed in loop L1 via hybridization of DNA1-Cy3 or PNA4-
Cy3, respectively, and the acceptor dye Cy5 at loop L4 via hybridization of DNA2-Cy5, 
PNA3-Cy5 or PNA3S-Cy5. D135-L1shL4 was hybridized with PNA4-Cy3/PNA3-Cy5 (Figure 
58). The labeled RNA was then immobilized on a quartz surface via a biotin-streptavidin 
coupling (Chapter 1.2.3). For simplicity the experiments are named after their main difference 
(Table 7). 
Characteristic time trajectories of each experiment with applied Hidden Markov modeling[174] 
(HMM) are depicted in Figure 64. 
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Figure 64: Characteristic smFRET time trajectories of experiments DNA, PNA3, PNA3S, and D135-L1shL4. 
The different conformational states at 0.1, 0.2, 0.4 and 0.6 are detected by the software method vbFRET based 
on HMM (red line). 
For the DNA and the PNA dye labeling scheme, the same main FRET states of ≈ 0.1, 0.2, 
0.4, and 0.6 were observed (Figure 64). Besides transitions with longer dwell times, which is 
the time a molecule spends in a state before transiting to another state, fast transitions are 
detected. Possible intermediate states of fast transitions cannot be resolved by the 
experimental setup and can therefore not be distinguished from direct transitions between 
low and high states, e.g. 0.1 to 0.4. 
The observed states can be assigned to different RNA conformations from the unfolded state 
U via intermediates I1, I2 and F (0.1 0.2, 0.4) to a compact structure N (0.6) (Figure 65), 
known from the literature.[42] Differences to the literature values derive from applied filter 
corrections in the software. The 0.1 state could be assigned with the use of alternating laser 
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excitation (Chapter 5.4.7) and a refined background correction (20 darkest pixels per frame) 
as well as correction for donor bleed through and direct acceptor excitation.[42] 
 
Figure 65: Suggested folding pathway of D135-L14. D135-L14 labeled with DNA or PNA oligomers carrying 
Sulfo-Cy3 (green), Sulfo-Cy3 (red), and biotin (grey). Compaction of the individual domains and corresponding 
FRET states (in blue) are shown. Scheme is based on Ref. [42]. 
The FRET histograms built from single-molecule time traces and analyzed by 
bootstrapping[175] revealed overall similar distributions of FRET states in experiments with 
DNA and PNA labeled D135-L14, and PNA labeled D135-L1shL4 (Figure 66). 
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Figure 66: Normalized cumulated FRET histograms built from individual time trajectories of experiments 
DNA, PNA3, PNA3S, and D135-L1shL4. Histograms with bootstrapped Gaussian fits (black)[175] show the 
distribution of the different FRET states with standard deviation of the amplitude. 
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The relative occurrence of those FRET states (Figure 67 a) and their center of distribution 
determined by bootstrapped Gaussian fitting of the histograms (Figure 67 b), showed similar 
trends in all labeling schemes. However a slightly higher occurrence of the most compact 
state 0.6 can be observed together with a decrease of the 0.4 state in case for the PNA 
labeling compared to DNA labeling. 
 
Figure 67: FRET states and their relative occurrence from smFRET experiments DNA, PNA3, PNA3S, and 
D135-L1shL4. a) Relative occurrence of FRET states 0.1, 0.2, 0.4, and 0.6 determined from bootstrapped 
Gaussian fits[175] of histograms, with standard deviation. b) FRET states given by center of distribution of each 
Gaussian fit with standard deviation. The dotted lines indicate the observed FRET states 0.1, 0.2, 0.4, and 0.6. 
Besides the folding conformation of the RNA, its dynamic behavior was investigated. The 
occurrence of transitions between different states was calculated from the dwell times, and 
plotted as transition density plots (TDP, Figure 68).[43,174] For all labeling schemes, the main 
transitions were observed between the clustered states 0.1↔0.2, and 0.2↔0.4 (Figure 68). 
Additionally, in all experiments a second family of transitions (0.1↔0.2↔0.5) was observed. 
A mirror symmetry relative to the main diagonal shows the reversibility of the conformational 
changes. The folding of PNA labeled D135-L14 exhibited more dynamics observed in a 
broader distribution of the transition densities, especially in experiments with PNA3-Cy5. 
PNA-labeled D135-L1shL4 with shortened loop L1 was found to behave similarly to DNA-
labeled D135-L14. The PNA derivative PNA3S-Cy5 containing the spacer group between the 
PNA sequence and the Sulfo-Cy5 did not lead to a significantly changed behavior compared 
to the one without, PNA3-Cy5.  
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Figure 68: Transition density plots of smFRET experiments DNA, PNA3, PNA3S, and D135-L1shL4. TDPs 
calculated from the dwell-time analysis. The color bar depicts the normalized number of events. Main transitions 
are detected between 0.1 and 0.2, as well as 0.2 and 0.4. 
Additional smFRET experiments were carried out using the acceptor PNA labels PNA1S-
Cy5 (PNA1S), PNA2-Cy5 (PNA2) and PNA2S-Cy5 (PNA2S), and the donor PNA label 
PNA4-Cy3 hybridized to D135-L14. The derivatives carrying the acceptor were designed to 
hybridize to different positions within the loop L4, and differ in the presence of a spacer 
group (S) between the dye and the PNA. In the distribution histograms and TDPs, however, 
no significant differences compared to the other derivatives (PNA3-Cy5 and PNA3S-Cy5) 
were observed (Figure 69). The only variation is that experiments with DNA labels or 
PNA1S-Cy5 respectively show a distribution of the transition density closer to the diagonal. 
This indicates that the transitions occur mainly between FRET states close to each other, 
e.g. 0.1↔0.2 with small conformational changes. As seen before in experiments with PNA3-
Cy5 and PNA3S-Cy5, also no differences were observed with or without the presence of the 
space group. 
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Figure 69: Normalized cumulated FRET histograms built from individual time trajectories and TDPs of 
smFRET experiments PNA1S, PNA2, and PNA2S. a) Histograms with bootstrapped Gaussian fits (black)[175] 
show the distribution of the different FRET states. b) TDPs calculated from the dwell-time analysis. The color bar 
depicts normalized number of events. Main transitions are detected between 0.1 and 0.2, as well as 0.2 and 0.4. 
After investigations of the PNA labeling scheme and systematic comparison using a model 
system, the labeling scheme was applied to a new RNA system (following chapter). 
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3.6.9 Labeling of the btuB Riboswitch of E. coli 
To investigate interactions of the btuB riboswitch with the novel fluorescent B12 derivatives 
(Chapter 2) by use of FRET, the RNA needs to be fluorescently labeled as well. The btuB 
riboswitch construct pPC4 by Choudhary et al.[176] was originally designed for labeling by the 
hybridization method introduced in Chapter 3.3. The construct comprises an artificial loop 
similar to L4 in D135-L14 which replaces the natural tetraloop in P11 (Figure 70, Appendix). 
An 18 nucleotide long DNA oligomer with a dye, e.g. Cy3 or Cy5 can thus be hybridized to 
the RNA. Fluorescence native gel studies were carried out to verify the labeling efficiency of 
a DNA-Cy5 oligonucleotide binding to the modified riboswitch pPC4. However, an insufficient 
labeling yield was detected by native fluorescence gels (Figure 70 b and c). In this way bulk 
FRET measurements are not possible without a further purification step, since unbound 
labeled DNA oligomers in solution lead to substantial background fluorescence. 
 
Figure 70: PAGE experiments of the btuB riboswitch construct pPC4. a) Schematic drawing of the pPC4 
riboswitch RNA with a modification in loop P11 (orange) to hybridize oligonucleotide labels (grey) carrying Sulfo-
Cy5 (red). Binding of DNA-Cy5 or PNA-Cy5 to pPC4 detected by fluorescence on native gels with b) high contrast 
and c) low contrast. d) Denaturing PAGE gel (10 %) of pPC4 RNA detected by UV shadowing. Lane 1: lower 
fraction of purification gel, lane 2: upper fraction of purification gel. 
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Furthermore, a misfolding of the RNA was detected in native and denaturing PAGE 
experiments. Denaturing PAGE experiments did not reveal distinct RNA bands but a broad 
smear. A refolding of the misfolded RNA by annealing for 60 s at 90 °C resulted in a more 
distinct band. However, in native PAGE experiments with the refolded RNA several RNA 
species were detected. A further purification of the RNA by denaturing PAGE excising only 
the lowest part of the band yielded one distinct band (Figure 70 d). The misfolding is most 
likely caused by the modified loop. The G-C rich stem leads to a very stable duplex and the 
loop itself is fairly large compared to other structural elements. Consequently, a correct 
folding of the riboswitch was not granted and the construct was not used for further studies. 
To overcome these drawbacks of low labeling yields and misfolding of the RNA, the 
investigated Peptide Nucleic Acid labeling strategy (vide supra) was used. This strategy 
gives the opportunity to drastically reduce the modifications of the RNA and thus avoid a 
misfolding, while at the same time increasing the labeling efficiency. Fluorescence native gel 
studies of PNA1S-Cy5 hybridized to the modified loop in the pPC4 riboswitch RNA showed a 
significantly increased labeling efficiency compared to DNA-Cy5 (Figure 70 b and c). 
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3.7 Discussion and Conclusion 
In Chapter 2 it was shown how a metabolite can be labeled with fluorophores to investigate 
its interaction with a functional RNA using the FRET technique. The present chapter, on the 
other hand, addressed how the RNA can be fluorescently labeled. 
For fluorescence applications large RNAs are usually labeled indirectly by hybridization of 
fluorescent DNA oligonucleotides. Typically the oligonucleotides are ~18 nucleotides long to 
effectively label the RNA. Consequently, modifications within the RNA are necessary to 
provide a hybridization platform for the DNA oligomers. These modifications can lead to 
misfolding of the RNA. Furthermore, the labeling yields using this method can be low 
depending on the RNA system. Based on this the labeling strategy was improved by use of 
Peptide Nucleic Acids. New PNA derivatives carrying sulfonated Cy3 or Cy5 FRET dyes 
were synthesized by solid phase synthesis and further characterized. It is a quick and 
effective method to obtain individual sequences and allows introducing dyes specifically at 
the desired position. The PNA sequences were designed to label a model system, the group 
II intron ribozyme D135-L14, which has already been investigated with the DNA labeling 
scheme by smFRET. This allows a direct comparison of the two strategies. 
Fluorescent probes are typically depended on environmental effects that can influence the 
fluorescence and consequently careful investigations of the photophysical properties are 
necessary. Fluorescence quantum yield and steady-state anisotropy experiments 
demonstrated that the main photophysical properties of the dyes do not change if the 
labeling system is varied from DNA oligomers to PNA oligomers. The effect of fluorescence 
enhancement of the cyanine dyes bound to nucleic acids is as well observed for PNAs. This 
is a consequence of the reduced photoisomerization process, which deactivates the first 
excited state. Furthermore steady-state anisotropy measurements reveal a similar behavior 
as observed for the attachment of Cy3 and Cy5 to B12 (Chapter 2). The anisotropy value of 
Cy3 is unchanged whereas the value upon Cy5 attachment is increased compared to the 
free dyes. This indicates once more that steady-state anisotropy can be rather insensitive 
and time-resolved studies such as lifetime measurements and dynamic anisotropy could give 
more details.[20,21,28] 
In melting experiments it was shown that short PNAs with a length of 10 nts form a more 
stable duplex with RNA than the 18 nts long DNA oligonucleotides. This suggests that even 
shorter PNA sequences are possible. However, system depended sequence specificity has 
to be considered for each RNA as shorter sequences are more likely to be repeated in the 
RNA sequence. The shorter PNA hybridization probes allow minimizing the modifications 
within the RNA necessary for the binding of the label. To underline this, the artificially 
elongated loop in the intron model system D135-L14, to which the labels are bound, was 
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shortened to make the construct more similar to the natural structure, yielding the new 
construct D135-L1shL4. Additional shortening of loop L4 led to a decreased ribozyme 
cleavage activity and a low labeling efficiency due to base pair formation in the loop leading 
to an unfavorable structure. This can be avoided by a redesign of the loop with a non self-
complementary single-stranded structure. 
DNA oligonucleotides typically need to be annealed to the RNA at high temperatures (90 °C) 
at which the RNA is fully denatured. Due to the stronger binding affinity of PNA the 
hybridization procedure could be optimized. The PNA is hybridized after the folding of the 
ribozyme at 42 °C. Consequently, dye decomposition and RNA degradation can be reduced 
as well as RNA aggregation, which may occur while annealing at high temperatures. In 
fluorescence native gels a higher labeling efficiency of PNA derivatives over DNA was 
observed in a higher fraction of labeled RNA and less unbound label. No excess of PNA is 
needed compared to DNA. With the high labeling efficiencies of the PNAs further purification 
steps from the unbound label, which decrease the labeling yield, can be avoided compared 
to DNA. Consequently the superior labeling properties of PNA reduce background issues in 
fluorescence applications and give a higher fraction of detectable molecules with less 
amount of probe needed. 
In cleavage assays mimicking the first step of splicing was confirmed that folding and activity 
of the ribozyme RNA remain basically unaffected by the PNA label, and are similar to the 
labeling with DNA. 
In smFRET experiments the same FRET states 0.1, 0.2, 0.4 and 0.6 and overall similar 
trends of the state distributions were observed for DNA or PNA labeled ribozyme. Marginal 
variations in the FRET states could derive from different spatial positions of the fluorophores. 
Moreover, Gaussian fitting of such a complex system with overlapping distributions leads to 
fairly large deviations. The lower occurrence of the 0.4 state and higher occurrence of the 0.6 
state in experiments with PNA compared to DNA shows that the RNA spends less time in 
this intermediate state. Consequently, with the shorter PNA sequences and a shortened loop 
L1 the RNA favors the more compact structure. Nevertheless, the folding behavior of the 
RNA is not changed by the PNA. Also, the dynamics of the RNA system show similar trends 
in all labeling schemes. In TDPs, main transitions between the states 0.1↔0.2↔0.4 were 
observed. The transitions to higher FRET states, i.e. 0.6, were detected less often due to a 
lower occurrence of the high state. Also slower kinetics are generally underrepresented in 
TDPs.[43] Additionally in all experiments a second family of transitions (0.1↔0.2↔0.5) is 
observed which might derive from an alternative folding pathway. The RNA folding of PNA 
labeled D135-L14 exhibited slightly more dynamics observed in a broader distribution of the 
transition densities. This might also be due to the more flexible loop structure. The loop was 
designed to bind 18 nts, but the PNA sequences are drastically shorter (10 nts). With the 
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shortened loops adjusted to the shorter sequences the dynamics are decreased and again 
similar to DNA labeling. Underlining this hypothesis the density distribution around the 
diagonal while labeled with the 14-mer PNA derivative is similar to DNA labeling. Hence, as 
observed for the folding, also variations in the dynamics do not derive from the DNA or PNA, 
respectively. More likely small variations are due to differences in the loop structure where 
the labels are bound, and from the general folding heterogeneity of the construct. The latter 
can also be observed in the native fluorescence gel studies by broadening of the bands. It is 
not surprising that complex systems like this large group II intron ribozyme show a high 
variability, e.g. due to a sample conformational heterogeneity. With the presented studies 
could be demonstrated that PNA labels can be used for smFRET experiments since they do 
not change the folding and dynamics of the RNA in comparison to DNA. 
To evaluate the possible influence of the distance between the fluorophores and the PNA the 
experiments were carried out with different derivatives with or without a spacer group 
between the cyanine dye and the PNA. No significant differences in the duplex stability, 
rotational freedom, fluorescence emission or folding of the RNA were observed. 
Finally, the investigated PNA labeling strategy was applied to the btuB riboswitch of E.coli. 
The labeling efficiency was remarkably higher using a labeling with PNA instead of DNA. 
This system suffers from large modifications which can consequently be reduced or avoided 
with the PNA labeling scheme. 
In this proof of concept study, we demonstrated that PNA oligonucleotides can be used as 
specific internal labeling agents for large RNA systems to study their folding mechanism 
without influencing the latter. Consequently, PNA-dye derivatives can be employed as a fast, 
efficient and easy to handle labeling probes for various fluorescence applications including 
smFRET for imaging of processes in vitro. Moreover, as RNA-PNA hybrids are not affected 
by RNase H degradation, contrary to RNA-DNA, they are suitable for RNA folding studies in 
vivo.[155] 
In a next step, one could envision systems that are labeled at natural occurring positions 
without further modifications. At the same time, we observed that the folding and dynamics 
depend on the structure of the modification where the label is bound. These findings are 
important for future studies of various nucleic acid systems to avoid structural modifications 
of natural RNA and hence hybridize PNA directly to existing structural elements. PNA 
labeling has a great potential in particular for systems, where modifications play a 
tremendous role, e.g. the btuB riboswitch of E. coli. 
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4 Collaborations 
4.1 Imaging of an RNA-Splicing Process Using Fluorescent PNA 
Labels 
The following chapter is based on collaboration with Susann Zelger-Paulus in the group of 
Prof. Roland K. O. Sigel at the University of Zürich. 
4.1.1 Introduction 
Herein, an application of the investigated labeling strategy for RNA by using PNA 
hybridization probes described in Chapter 3 is shown. The RNA system of interest is the 
group II intron Sc.ai5γ originated from Saccharomyces cerevisiae. As described previously 
this RNA folds in a defined three dimensional structure and actively induces its self-cleavage 
reaction during RNA maturation. PNA labels are used in these studies to investigate the 
splicing process by bulk FRET measurements, fluorescence microscopy and native 
fluorescent gel assays. To this end, PNAs carrying the relevant FRET dyes, either Sulfo-Cy3 
or Sulfo-Cy5, are hybridized to the intron flanking regions. FRET occurs when the intron is 
self-spliced as the exons are ligated and the two fluorophores attached to the PNA come 
nearby (Figure 71). With regard towards in vivo studies of the splicing mechanism, this 
labeling strategy is very promising. 
 
Figure 71: Imaging of the splicing process of a group II intron ribozyme with fluorescent PNA labels. The 
exon sites (grey bars) of a ribozyme (black) are labeled by hybridization of fluorescent PNA oligomers (green 
donor, red acceptor). If splicing occurs donor and acceptor get close and FRET occurs. 
 
FRET
104 
4 Collaborations 
 
4.1.2 Synthesis and Characterization of Fluorescent PNA Derivatives 
Two PNA derivatives PNA-Ex1-Cy3 and PNA-Ex2-Cy5 were designed to carry the 
fluorescent cyanine dyes Sulfo-Cy3 or Sulfo-Cy5 (FRET pair), and to be complementary for 
hybridization to the intron flanking regions of the group II intron Sc.ai5γ. 
The PNA derivatives were prepared by use of solid phase synthesis (see Chapter 3).[170] The 
cyanine dye Sulfo-Cy3 was covalently attached at the N-terminus of the PNA sequences 
PNA-Ex1, and Sulfo-Cy5 at the C-terminus of the PNA sequences PNA-Ex2. Additionally 
lysine was used to increase the solubility. For in vivo studies a signal peptide for the delivery 
into mitochondria can be attached to the PNA. To keep the N-terminus of PNA-Ex2-Cy5 
available for the peptide coupling and have the dye at the right position for the necessary 
FRET distance, the synthetic procedure was adjusted. The resin was functionalized with N-α-
Fmoc-N-ε-4-methyltrityl-L-lysine (Fmoc-Lys(Mtt)-OH) to allow coupling of Sulfo-Cy5 to the C-
terminus of the PNA sequence. The N-ε-Mtt function was removed under conditions (1 % 
TFA in DCM) at which tert-butyl type groups and peptide ester bonds to the TFA-labile resin 
remain intact.[177] 
 
Scheme 8: Synthesis of PNA-Ex2-Cy5. Starting from a LysMtt functionalized resin (brown) PNA-Ex2-Cy5 (Sulfo-
Cy5 red) was synthesized by SPPS. 
PNA-Ex1-Cy3 and PNA-Ex2-Cy5 derivatives were characterized by HPLC, ESI-MS and 
MALDI-MS. Chromatograms of PNA-Ex1-Cy3 reveal peaks at 260 nm (absorbance PNA), 
550 nm (absorbance Sulfo-Cy3) and emission at 570 nm (excitation at 550 nm) with a 
retention time of 9.0 min. PNA-Ex2-Cy5 is detected at 260 nm, 650 nm (absorbance Sulfo-
Cy5), and emission at 670 nm (excitation at 650 nm) with a retention time of 8.8 min  
(Figure 72). 
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Figure 72: HPLC chromatograms of PNA-Ex2-Cy5 at different wavelength. At 260 nm the absorption of the 
PNA is detected, at 650 nm the absorption of the Sulfo-Cy5. The Sulfo-Cy5 emission is detected at 670 nm upon 
excitation at 650 nm. The intensities are normalized. 
In MALDI-MS measurements PNA-Ex1-Cy3 is detected at m/z = 3492.4 (calcd. for 
C145H185N64O38S2+ ([M+2H]+) 3492.4) and PNA-Ex2-Cy5 at 3486.5 (calcd. for 
C145H183N64O36S2+ ([M+2H]+) 3486.4). In ESI-MS are the characteristic differently charged 
species observed due to multiple protonations of the PNA oligomers. 
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4.2 RNA Interaction with Rhenium Compounds 
The following chapter is based on the publication: 
“Photo-induced uncaging of a specific Re(I) organometallic complex in living cells” 
by Anna Leonidova, Vanessa Pierroz, Riccardo Rubbiani, Yanjun Lan, Anita G. Schmitz, 
Andres Kaech, Roland K. O. Sigel, Stefano Ferrari, and Gilles Gasser in Chemical Science, 
2014.[178] 
4.2.1 Introduction 
In the last decades, a large number of organometallic complexes have shown promising anti-
proliferative activity towards different cancer cell lines. However, these compounds generally 
had low cellular uptake and low selectivity towards cancer cells over healthy cells. The use of 
external triggers (e.g. light, ultra-sound, temperature, etc.) to modify the cytotoxic effect of a 
prodrug and the coupling of a targeting vector (e.g. peptides, antibodies, etc.) to a drug were 
found to be very successful techniques to tackle these drawbacks. Here, we envisioned 
combining these two methods, namely an external trigger (i.e. light activation) and a targeting 
vector, in an organometallic compound. 
 
Figure 73: Structure of bioconjugated organometallic photo-caged derivatives Re-PLPG-NLS and Re-
PLPG-Bombesin. 
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More specifically, a Re(I) tricarbonyl N,N-bis(quinolinoyl) complex (Re-NH2) was derivatised 
with a photo-labile protecting group (PLPG) to cage Re-NH2 by formation of Re-PLPG. For 
organelle/cellular specificity, Re-PLPG was then further coupled to a nuclear localization 
sequence (NLS) or a bombesin peptide derivative to give Re-PLPG-NLS or Re-PLPG-
Bombesin, respectively (Figure 73). 
Photolysis experiments in PBS buffer (pH 7.4) demonstrated that Re-NH2 was completely 
photo-released from Re-PLPG-NLS and Re-PLPG-Bombesin using a very low irradiation 
dose (1.2 J cm−2). To the best of our knowledge, these are the first two examples of the 
selective photo-release of an intact organometallic compound from a bioconjugate. Of high 
interest, both derivatives showed toxicity comparable to that of cisplatin towards cervical 
cancer cells (HeLa) upon light irradiation, although the phototoxic index (PTI) varied greatly 
with the targeting peptide. The cell death mechanism of Re-PLPG-NLS was explored using 
different techniques, including fluorescence microscopy, ICP-MS, gel electrophoresis, flow 
cytometry and transmission electron microscopy (TEM). It could be demonstrated that HeLa 
cells treated with Re-PLPG-NLS in the dark and upon irradiation showed severe cell stress 
(nucleolar segregation, pyknosis and vacuolation). The data obtained from an 
Annexin V/propidium iodide (PI) assay indicated that, after an early apoptotic stage, the 
onset induced by Re-PLPG-NLS led to cell death, with features ascribable to late apoptosis 
and necrosis, which were more marked for the treatment involving irradiation. 
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4.2.2 Effect of Re-PLPG-NLS on Nucleic Acids 
As RNA is one of the major components of nucleoli, the effect of Re-PLPG-NLS on a 638 
nucleotide long RNA sequence (D135-L14 ribozyme derived from the Sc.ai5γ group II intron 
of S. cerevisiae, see Chapter 3)[42] was investigated. Denaturing polyacrylamide gel 
electrophoresis revealed a considerable decrease in intensity and shift of the RNA band due 
to Re-PLPG-NLS/RNA interactions and formation of non-migrating RNA agglomerates 
(Figure 74) at high concentrations of Re-PLPG-NLS (100 μM). This effect occurred both in 
the absence and the presence of light, and no difference was observed for UVA-irradiated 
samples. 
 
Figure 74: Denaturing polyacrylamide gel electrophoresis of D135-L14 ribozyme from S. cerevisiae 
incubated with Re-PLPG-NLS. Denaturing polyacrylamide gel electrophoresis of D135-L14 incubated with        
a) Re-PLPG-NLS visualized by UV shadowing, b) Re-PLPG-NLS visualized by ethidium bromide staining of RNA 
bands detected by UV shadowing at 260 nm. 
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Re-NH2 or Re-PLPG alone did not affect the RNA (Figure 75). Given the localization of Re-
PLPG-NLS in RNA-rich nucleoli, it is possible that the strong dark toxicity of this compound 
is linked to its effect on RNA. 
 
Figure 75: Denaturing polyacrylamide gel electrophoresis of D135-L14 ribozyme from S. cerevisiae 
incubated with Re-PLPG or Re-NH2. Denaturing polyacrylamide gel electrophoresis of D135-L14 incubated with 
a) Re-PLPG, and b) Re-NH2, visualized by UV shadowing. 
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5 Experimental Section 
5.1 Instrumentation and Materials 
All chemicals and solvents were of reagent-grade purity or better, and used as obtained from 
the commercial suppliers Sigma-Aldrich, and Thermo Fisher Scientific. Peptide nucleic acid 
(PNA) monomers and [2-(2-(Fmoc-amino)ethoxy)ethoxy]acetic acid (Fmoc-AEEA-OH 
spacer) were purchased from Link Technologies Ltd. (Lanarkshire, Scotland), and TentaGel 
S RAM-Lys(Boc)Fmoc resin beads from Rapp Polymers GmbH (Tübingen, Germany). 
(Balgach, Switzerland). Cy3 N-hydroxysuccinimide (NHS) ester, Cy5 NHS ester, sulfonated 
(Sulfo) Cy3 NHS ester, and Sulfo-Cy5 NHS ester were purchased from Lumiprobe 
(Hallandale Beach, USA). 
Thin layer chromatography (TLC) was performed with Merck TLC Silicagel 60 F254 plates and 
visualized by UV light (254, 365 nm). Flash chromatography was carried out using Merck 
silica gel 60 (0.04-0.063 mm). 
Enzymes and purification kits were obtained from Promega, Thermo Scientific or Qiagen. 
DNA-oligonucleotides with either Sulfo-Cy3 (5'-Sulfo-Cy3-ACCAAGAGCGTTATTAAT-3' ≡ 
DNA1-Cy3), Sulfo-Cy5 (5'-Sulfo-Cy5-ACGTAGTCCGAAATATAT-3' ≡ DNA2-Cy5) or Biotin 
(5'-Biotin-TGCATGCCTGCAGGTCGACTCTA-3' ≡ DNA-biotin) were purchased from IBA 
(Göttingen, Germany). RNA oligonucleotides (HPLC grade) for UV/Vis melting experiments 
and primer for PCR were obtained from Microsynth (Balgach, Switzerland). 
Water was treated with a TKA GenPure water purification system and autoclaved. All buffers 
and salt solutions were filtrated through 0.2 µm filters before use. RNA isolation was 
performed using an Elutrap electro-elution apparatus with BT1 and BT2 membranes from 
Whatman (London, UK). Accugel (40 % (w/v), 29:1 Acrylamide-Bisacrylamide) and 10xTBE 
(0.89 M Tris Borate pH 8.3, 0.2 M Na2EDTA) buffer from National Diagnostics (Atlanta, USA) 
were used for polyacrylamide gel electrophoresis (PAGE). Gels were visualized with a Bio-
Vision system from Vilber (Eberhardzell, Germany). For radioactive labeling of the RNA [γ-
32P]-ATP (150 mCi/mL, 6000 Ci/mmol) from PerkinElmer (Schwerzenbach, Switzerland) was 
used. Scintillation counts were performed on a scintillation counter 22000CA Liquid 
Scintillation Analyzer from Canberra Packard. The Centrifuges Sorvall RC 6 Plus from 
Thermo Scientific with rotors SA-600, SH-3000 and SLA-3000, and Eppendorf 5804R with 
rotor A-4-44 were used. Samples were vacuum dried with a Concentrator 5301 from 
Eppendorf or a freeze dryer Alpha 2-4 LDplus from Christ (Osterode am Harz, Germany).  
pH-Measurements were carried out using a Metrohm (Herisau, Switzerland) 605 pH-meter 
and a Minitrode glass electrode from Hamilton. 
Sample irradiation in the UV-reactor was done with a Rayomet RMR-200 photo-reactor. 
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HPLC analyses were performed on a Dionex Ultimate 3000 system (Olten, Switzerland; now 
part of Thermo Fisher Scientific) equipped with a DAD and fluorescence detector, or on a 
Hitachi LaChrom Elite system. Analytical HPLC was done with a Waters XTerra RP8 5 µm 
column. Preparative HPLC was carried out on a Varian ProStar sytem with two solvent 
delivery system units model 215 and a UV-Vis detector model 320 equipped with a Zorbax 
Prep HT 300SB-C18 (5 µm) column from Agilent or a Waters XTerra Prep RP8 (5 µm) 
column.  
MALDI-MS spectra were recorded on a Bruker Autoflex I, ESI-MS and LC-MS spectra on a 
Bruker Daltonics HCT instrument in combination with an Acquity Ultra Performance LC 
system from Waters equipped with a Zorbax 300SB-C18 column (3.5 µm) from Agilent.  
NMR spectra were recorded on a Bruker Avance 500 spectrometer using a cryo BBO probe 
and referenced to an internal standard of residual deuterated solvent. 
UV/Vis measurements were carried out on Varian, now part of Agilent (Basel, Switzerland), 
UV Cary 100 Bio and UV Cary 500 Scan instruments or a PerkinElmer Lamda 25 
spectrophotometer using a quartz cuvette of 10 mm path length. Concentrations of nucleic 
acids were determined using a Nanodrop 2000 from Thermo Scientific.  
Fluorescence spectra were recorded on a Varian Cary Eclipse fluorescence 
spectrophotometer, equipped with an automated polarizer.  
Fluorescence native gels and storage phosphor screens were scanned on a Typhoon 
Scanner FLA-9500 and quantified with Image Quant TL from GE Healthcare.  
Single-molecule FRET measurements were performed on a total internal reflection 
fluorescence microscope (TIRFM) system using a setup according to Rueda and 
coworkers.[41] The setup mainly includes an IX71 microscope from Olympus, a green laser at 
532 nm and a red laser 640 nm from CrystaLaser (Reno, USA). Signals were recorded with 
an EMCCD camera DU 897 from Andor (South Windsor, USA). Data analysis was done 
using the home-written MATLAB-based software MASH (Multifunctional Analysis Software 
for Heterogeneous smFRET data).[179] 
5.2 Buffers 
The pH was adjusted by addition of either NaOH or HCl. 
Reaction Buffer: 80 mM MOPS (pH 6.9), 500 mM KCl.  
Elution Buffer: 10 mM MOPS (pH 6.0), 1 mM EDTA, 250 mM NaCl.  
Transcription Buffer: 40 mM Tris-HCl (pH 7.5), 40 mM DTT, 2 mM spermidine, 0.01 % 
Triton X-100. 
ME Buffer: 10 mM MOPS (pH 6.0), 1 μM EDTA. 
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Denaturing Loading Buffer: 11.7 M urea, 40 mM Tris-HCl (pH 7.5), 0.1 % xylene cyanol (XC), 
0.1 % bromphenol blue (BB), 230 mM sucrose, 0.8 mM EDTA pH 8.0. 
Native Buffer: 3 mM MgOAc, 66 mM HEPES, 34 mM Tris-HCl (pH 7.4). 
PBS Buffer: 0.1 M phosphate buffer (pH 7.4), 0.1 M NaCl. 
5.3 Methods Chapter 2 (Labeling of B12) 
5.3.1 General Methods 
HPLC method 1a (analytical): column Waters XTerra RP8; flow-rate 1 mL/min; detection 
wavelength 360 nm, 550 nm or 650 nm, excitation at 550 nm and emission at 570 nm or 
excitation at 650 nm and emission at 670 nm; solvent A: Triethylammonium acetate TEAA 
(100 mM, pH 7), solvent B: ACN/ H2O 9:1; gradient: 0-2 min 0 % B, 2-20 min 0-55 % B, 20-
23 min 55-0 % B, 23-25 min 0 % B. 
HPLC method 1b (analytical): column Waters XTerra RP8; flow-rate 1 mL/min; detection 
wavelength 360 nm or 600 nm; solvent A: Triethylammonium acetate TEAA (100 mM, pH 7), 
solvent B: ACN/ H2O 9:1; gradient: 0-2 min 0 % B, 2-20 min 0-55 % B, 20-25 min 55-5 % B, 
25-27 min 5-0 % B, 27-28 min 0 % B. 
HPLC method 2 (preparative): column Waters XTerra RP8; flow-rate 30 mL/min; detection 
wavelength 360 nm; solvent A: Triethylammonium acetate TEAA (100 mM, pH 7), solvent B: 
ACN/ H2O 9:1; gradient: 0-5 min 0 % B, 5-30 min 0-50 % B, 30-35 min 50-5 % B, 35-38 min 
5-0 % B, 38-40 min 0 % B. 
Purities were determined from the HPLC UV/Vis traces at 360 nm, 550 nm or 650 nm. 
The atom numbering used for NMR peak assignment of B12 is shown in Figure 15. Reactions 
and analyses of B12 derivatives and dyes were done in the dark to prevent from 
decomposition or deactivation. 
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5.3.2 Synthesis of B12 Derivatives 
Cy3: 2-[3-[1-(5-Carboxypentyl)-1,3-dihydro-3,3-dimethyl-2H-indol-2-ylidene]-1-
propenyl]-1,3,3-trimethyl-3H-indolium 
2-Methylene-1,3,3-trimethylindoline (0.12 mL, 0.65 mmol), 
N,N'-diphenylformamidine (0.13 g, 0.65 mmol), 1-(5-
carboxypentyl)-2,3,3-trimethyl-3H-indolium chloride (0.23 g, 
0.65 mmol) and sodium acetate (67 mg, 0.81 mmol) were 
dissolved in ethanol (50 mL). The reaction mixture was 
stirred at 85 °C for 24 h. The solvent was removed under 
reduced pressure and the crude reaction mixture was purified by flash chromatography 
(silica gel, DCM/MeOH) to give Cy3 (55 mg, yield: 17 %).  
1H-NMR (500 MHz, MeOD-d4, 300 K): δ = 8.54 (t, Ja,b = Jb,c = 13.5 Hz, 1 H, b), 7.54 (d, J = 
7.4 Hz, 2 H, 4, 4'), 7.44 (m, 2 H, 6, 6'), 7.36 (m, 2 H, 7, 7'), 7.31 (m, 2 H, 5, 5'), 6.48, 6.45 
(dd, Ja,b = Jb,c = 13.5 Hz, 2 H, a, c), 4.15 (t, J = 7.5 Hz, 2 H, NCH2), 3.69 (s, 3 H, NCH3), 2.24 
(t, J = 7.3 Hz, 2 H, COCH2), 1.86 (m, 2 H, NCH2CH2), 1.76 (s, 12 H, 3-CH3, 3'-CH3), 1.70 (m, 
2 H, COCH2CH2), 1.52 (m, 2 H, NCH2CH2CH2) ppm. 
13C{1H}-NMR (125 MHz, MeOD-d4, 300 K): δ = 180.58 (CO), 176.55, 175.93 (2, 2'), 152.06 
(b), 144.09, 143.36 (7a, 7a'), 142.17, 142.06 (3a, 3a'), 130.00, 129.93 (6, 6'), 126.70 (2 C, 5, 
5'), 123.49, 123.39 (4, 4'), 112.48, 112.24 (7, 7'), 103.82, 103.71 (a, c), 50.62, 50.54 (3, 3'), 
45.13 (NCH2), 37.33 (COCH2), 31.76 (NCH3), 28.29, 28.17 (3-CH3, 3'-CH3), 27.56 
(NCH2CH2), 27.11 (NCH2CH2CH2), 26.66 (COCH2CH2) ppm. 
ESI-MS m/z: 457.3 [M]+. 
Cy5: 2-[5-[1-(5-Carboxypentyl)-1,3-dihydro-3,3-dimethyl-2H-indol-2-ylidene]-1,3-
pentadien-yl]-1,3,3-trimethyl-3H-indolium 
2-Methylene-1,3,3-trimethylindoline (0.95 mL, 
5.36 mmol), N-((1E)-3-(phenylimino)prop-1-
enyl)benzenamine hydro-chloride (1.38 g, 5.36 mmol), 
1-(5-carboxypentyl)-2,3,3-trimethyl-3H-indolium chloride 
(1.90 g, 5.36 mmol) and sodium acetate (0.53 g, 
6.51 mmol) were dissolved in ethanol (300 mL). The 
reaction mixture was stirred at 85 °C for 24 h. The solvent was removed under reduced 
pressure and the crude reaction mixture was purified by flash chromatography (silica gel, 
DCM/MeOH) to give Cy5 (yield could not be determined). 
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1H-NMR (500 MHz, D2O, 300 K): δ = 7.90 (t, Ja,b = Jb,c = Jc,d = Jd,e = 12.6 Hz, 2 H, b, d), 7.41 
(m, 2 H, 4, 4'), 7.32 (m, 2 H, 6, 6'), 7.17 (m, 4 H, 7, 7', 5, 5'), 6.45 (t, Jb,c = Jc,d = 11.3 Hz, 1 H, 
c), 6.14 (m, 2 H, a, e), 3.96 (m, 2 H, NCH2), 3.46 (s, 3 H, NCH3), 2.06 (m, 2 H, COCH2), 1.72 
(m, 2 H, NCH2CH2), 1.56 (s, 12 H, 3-CH3, 3'-CH3), 1.30 (m, 2 H, COCH2CH2), 1.16 (m, 2 H, 
NCH2CH2CH2) ppm. 
ESI-MS m/z: 483.3 [M]+. 
B12-linker: β-(3-aminopropyl)cobalamin 
β-(3-aminopropyl)cobalamin (B12-linker) was prepared according to the 
literature.[94] Hydroxocobalamin (0.20 g, 0.14 mmol) was dissolved in 
10 mL water and subsequently 3-aminopropylchloride HCl (37 mg, 
0.29 mmol) and NH4Cl (77 mg, 1.44 mmol) were added. The solution 
was degassed with N2(g) for 20 min, followed by addition of zinc dust 
(94 mg, 1.44 mmol). The reaction mixture was stirred for 5 h under nitrogen atmosphere and 
filtrated (Whatman filter paper). The filtrate was transferred to a Waters C-18 Sep-Pak 
cartridge (10 g; activated with 60 mL MeOH and 100 mL H2O, successively). After washing 
with 100 mL H2O, the product B12-linker was eluted with 20 mL MeOH. The solvent was 
removed under reduced pressure and dried by lyophilization. The crude was dissolved in 
2 mL MeOH and added to 100 mL rapidly stirring 1:1 DCM/Et2O. The crystalline product was 
filtrated, washed with 3x5 mL of each DCM, acetone, and Et2O and dried in vacuo (164 mg, 
yield: 82 %). 
1H-NMR (500 MHz, MeOD-d4, 300 K): δ = 7.15 (s, 1 H, B12-7N), 7.05 (s, 1 H, B12-2N), 6.35 
(s, 1 H, B12-4N), 6.19 (d, J = 3.1 Hz, 1 H, B12-1R), 6.05 (s, 1 H, B12-10), 4.68 (m, 1 H, B12-
3R), 4.35 (m, 1 H, B12-176), 4.28 (d, J = 9.1 Hz, 1 H, B12-3), 4.19 -4.12 (m, 1 H, B12-2R, 1 
H, B12-4R, 1 H, B12-19), 3.90, 3.87 (dd, J = 12.5 Hz, 3.0 Hz, 1 H, B12-5R), 3.76, 3.73 (dd, J 
= 12.4 Hz, 4.2 Hz, 1 H, B12-5R), 3.60, 3.54 (m, 1 H, B12-8, 1 H, B12-175), 3.27 (m, 1 H, 
B12-13), 2.99 (m, 1 H, B12-175), 2.78 (m, 1 H, B12-18), 2.65, 2.61 (m, 2 H, B12-181, 2 H, 
B12-L3), 2.55, 2.53 (s, 3 H, B12-151, s, 3 H, B12-51), 2.59 - 2.30 (m, 2 H, B12-32, 2 H, B12-
132, 1 H, B12-171,1 H, B12-172, 1 H, B12-21, 1 H, B12-71), 2.26 (m, 1 H, B12-21, 3 H, 
B12-10N, 3 H, B12-11N), 2.12 (m, 2 H, B12-131, 2 H, B12-31, 1 H, B12-171, 1 H, B12-71, 1 
H, B12-81), 1.80 (m, 3 H, B12-7A, 1 H, B12-172, 1 H, B12-82), 1.47 (s, 3 H, B12-12A), 1.37 
(m, 3 H, B12-2A, 3 H, B12-17B), 1.31 (m, 1 H, B12-82), 1.22 (d, J = 6.4 Hz, 3 H, B12-177), 
1.15 (m, 3 H, B12-12B, 1 H, B12-81), 0.69 (m, 1 H, B12-L2), 0.48 (s, 3 H, B12-1A), 0.43 (m, 
1 H, B12-L1), -0.06 (m, 1 H, B12-L1) ppm.  
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13C{1H}-NMR (125 MHz, MeOD-d4, 300 K): δ = 177.93, 177.66, 177.22 (B12-133, B12-33, 
B12-83), 177.22 (B12-4), 177.12 (B12-16), 176.24, 175.84 (B12-22, B12-182), 175.11 (B12-
11), 174.93, 174.85 (B12-173, B12-72), 172.49 (B12-9), 165.29 (B12-14), 164.97 (B12-6), 
143.30 (B12-2N), 139.93 (B12-9N), 134.15 (B12-6N), 132.21, 132.10 (B12-5N, B12-8N), 
119.68 (B12-4N), 111.60 (B12-7N), 107.26, 105.05 (B12-5, B12-15), 95.15 (B12-10), 87.62 
(B12-1R), 86.82 (B12-1), 83.29, 83.23 (B12-4R), 75.59, 75.55, 75.50 (B12-19, B12-3R), 
73.57, 73.52 (B12-176), 70.97 (B12-2R), 62.76 (B12-5R), 59.32 (B12-17), 57.23 (B12-3), 
56.68 (B12-8), 54.32 (B12-13), 50.96 (B12-7), 48.07 (B12-12), 47.55 (B12-2), 46.36 (B12-
175), 45.18 (B12-71), 44.04 (B12-21), 40.56 (B12-18), 39.53 (B12-L3), 36.65, 35.76 (B12-
32, B12-132), 33.46, 33.40 (B12-172, B12-82), 32.68, 32.62, 32.49 (B12-12B, B12-181, 
B12-L1, B12-171), 29.31 (B12-131), 27.69, 27.23 (B12-81, B12-31), 21.87 (B12-1A), 21.66 
(B12-12A), 20.77, 20.33 (B12-10N, B12-11N), 20.55 (B12-7A), 20.03, 19.99 (B12-177), 
18.23, 17.85 (B12-2A, B12-17B), 16.71, 16.57 (B12-151, B12-51) ppm. 
ESI-MS m/z: 1387.7 [M]+, 694.4 [M+H]2+. 
HPLC: tR = 7.0 min, 87 % purity. 
UV/Vis (H2O): λ = 266, 281, 349, 375, 526 nm. 
B12-Cy3: [Cy3]-β-(3-amidopropyl)cobalamin 
Variant A: In situ preparation of Cy3 N-
hydroxysuccinimidyl ester was done by addition of 
Cy3 (25 mg, 0.05 mmol) and N,N'-disuccinimidyl 
carbonate (21 mg, 0.08 mmol) to a solution of DIPEA 
(20 µL) in dry DMF (1.5 mL) under nitrogen 
atmosphere. The reaction mixture was stirred at 
60 °C for 2 h. B12-linker (56 mg, 0.04 mmol) and 
N,N-diisopropylethylamine (10 µL) were added and 
the mixture was stirred for 12 h at room temperature. 
Completeness of the reaction was indicated by 
analytical HPLC analysis. The solvent was removed under reduced pressure. The crude 
reaction mixture was purified by preparative HPLC and the product B12-Cy3 was dried in 
vacuo (24 mg; yield over two steps: 32 %).  
Variant B: Commercially available Cy3 N-hydroxysuccinimidyl ester (20 mg, 0.03 mmol) and 
B12-linker (57 mg, 0.04 mmol) were added to DIPEA (15 µL) in DMF (1 mL). The reaction 
mixture was stirred for 24 h at room temperature under nitrogen atmosphere. Completeness 
of the reaction was indicated by analytical HPLC analysis. The solvent was removed under 
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reduced pressure. The crude reaction mixture was purified by preparative HPLC and the 
product B12-Cy3 was dried in vacuo (30 mg; yield 47 %).  
1H-NMR (500 MHz, MeOD-d4, 300 K): δ = 8.54 (t, Ja,b = Jb,c = 13.5 Hz, 1 H, b), 7.54 (m, 2 H, 
4, 4'), 7.45 (m, 2 H, 6, 6'), 7.34 (m, 4 H, 7, 7', 5, 5'), 7.13 (s, 1 H, B12-7N), 7.04 (s, 1 H, B12-
2N), 6.47, 6.44 (dd, Ja,b = Jb,c = 13.6 Hz, 2.4 Hz, 2 H, a, c), 6.35 (s, 1 H, B12-4N), 6.17 (d, J = 
3.1 Hz, 1 H, B12-1R), 6.04 (s, 1 H, B12-10), 4.66 (m, 1 H, B12-3R), 4.35 (m, 1 H, B12-176, 1 
H, B12-3), 4.19 (m, 1 H, B12-2R), 4.11 (m, 1 H, B12-4R, 1 H, B12-19, 2 H, NCH2), 3.89, 
3.87 (dd, J = 12.6 Hz, 2.9 Hz, 1 H, B12-5R), 3.75, 3.72 (dd, J = 12.4 Hz, 4.2 Hz, 1 H, B12-
5R), 3.69 (s, 3 H, NCH3), 3.59 (m, 1 H, B12-8, 1 H, B12-175), 3.22 (m, 1 H, B12-13), 2.98 
(m, 1 H, B12-175), 2.78 (m, 1 H, B12-18), 2.67 (m, 2 H, B12-181, 2 H, B12-L3), 2.54, 2.49 
(s, 3 H, B12-151, s, 3 H, B12-51), 2.54 - 2.45 (m, 2 H, B12-32, 2 H, B12-132, 1 H, B12-
171,1 H, B12-172, 1 H, B12-21, 1 H, B12-71), 2.25 (m, 1 H, B12-21, 3 H, B12-10N, 3 H, 
B12-11N), 2.05 (m, 2 H, B12-131, 2 H, B12-31, 1 H, B12-171, 1 H, B12-71, 1 H, B12-81, 2 
H, COCH2), 1.82 (m, 3 H, B12-7A, 1 H, B12-172, 2 H, NCH2CH2), 1.76 (s, 12 H, 3-CH3, 3'-
CH3), 1.70 (m, 1 H, B12-82), 1.56 (m, 2 H, COCH2CH2), 1.45 (s, 3 H, B12-12A), 1.41 (m, 2 
H, NCH2CH2CH2), 1.36 (m, 6 H, B12-2A, B12-17B, 1 H, B12-82), 1.20 (d, J = 6.3 Hz, 3 H, 
B12-177), 1.06 (m, 3 H, B12-12B, 1 H, B12-81), 0.49 (s, 3 H, B12-1A), 0.43 (m, 1 H, B12-
L1), -0.10 (m, 1 H, B12-L1) ppm. 
13C{1H}-NMR (125 MHz, MeOD-d4, 300 K): δ = 177.91, 177.74, 177.19 (B12-133, B12-33, 
B12-83), 177.10 (B12-4,), 176.90 (B12-16), 176.66 (Cy3-2'), 176.23, 175.92, 176.04, 175.38 
(B12-22, B12-182, Cy3-2, Cy3-CO), 174.94, 174.89 (B12-173, B12-72), 174.65 (B12-11), 
172.19 (B12-9), 165.24 (B12-14), 165.05 (B12-6), 152.09 (Cy3-b), 144.10, 143.39 (Cy3-7a, 
7a'), 143.28 (B12-2N), 142.18, 142.09 (Cy3-3a, 3a'), 139.93 (B12-9N), 134.04 (B12-6N), 
132.14 (B12-5N, B12-8N), 130.04, 130.02 (Cy3-6, 6'), 126.83, 126.74 (Cy3-5, 5'), 123.55, 
123.41 (Cy3-4, 4'), 119.76 (B12-4N), 112.45, 112.36 (Cy3-7, 7'), 111.52 (B12-7N), 106.78, 
105.14 (B12-5, B12-15), 103.88, 103.66 (Cy3-a, c), 95.37 (B12-10), 87.60 (B12-1R), 86.80 
(B12-1), 83.31, 83.25 (B12-4R), 75.78 (B12-19), 75.61 (B12-3R), 73.52, 73.47 (B12-176), 
70.98 (B12-2R), 62.80 (B12-5R), 59.32 (B12-17), 57.18 (B12-3), 56.12 (B12-8), 54.40 (B12-
13), 51.00 (B12-7), 50.62, 50.61 (Cy3-3, 3'), 48.11 (B12-12), 47.53 (B12-2), 46.33 (B12-
175), 45.07 (Cy3-NCH2), 43.86 (B12-71), 43.56 (B12-21), 40.53 (B12-18), 38.85 (B12-L3), 
36.84 (Cy3-COCH2), 36.69, 35.70 (B12-32, B12-132), 33.71 (B12-172), 33.46 (B12-82), 
32.76, 32.71, 32.65 (B12-12B, B12-181, B12-L1), 32.50 (B12-171), 31.86 (Cy3-NCH3), 
29.42 (B12-131), 28.35, 28.34, 28.27, 28.20, 28.16 (Cy3-3-CH3, 3'-CH3, Cy3-NCH2CH2), 
27.74 (B12-81, B12-31), 27.47 (Cy3-NCH2CH2CH2), 26.86 (Cy3-COCH2CH2), 21.98 (B12-
1A), 21.30 (B12-12A), 20.75, 20.32 (B12-10N, B12-11N), 20.13 (B12-7A), 20.01, 19.97 
(B12-177), 18.38, 17.68 (B12-2A, B12-17B), 16.68, 16.62 (B12-151, B12-51) ppm. 
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ESI-MS m/z: 1825.9 [M]+, 924.9 [M+Na]2+. 
HR-ESI-MS m/z: calcd. for C96H135CoN16O16PNa2+ ([M+Na+MeOH]2+) 940.96159, found 
940.94318. 
HPLC: tR = 15.3 min, 98 % purity. 
UV/Vis (H2O): λ = 269, 279, 315, 346, 378, 514, 545 nm. 
B12-Cy5: [Cy5]-β-(3-amidopropyl)cobalamin 
Variant A: Preparation of Cy5 N-
hydroxysuccinimidyl ester was done by addition 
of Cy5 (72 mg, 0.14 mmol) and N,N'-
disuccinimidyl carbonate (53 mg, 0.21 mmol) to 
a mixture of anhydrous pyridine (0.1 mL) in dry 
DMF (4 mL) under nitrogen atmosphere. The 
reaction mixture was stirred for 2 h at 60 °C. 
After the solvent was removed under reduced 
pressure, the crude product was purified by 
column chromatography (silica gel, 
DCM/Hex/MeOH). Cy5 N-hydroxysuccinimidyl ester (20 mg, 0.03 mmol) and B12-linker 
(40 mg, 0.03 mmol) were added to a mixture of DIPEA (16 µL), DMF (1 mL) and water 
(4 mL). The reaction mixture was stirred overnight at room temperature. Completeness of the 
reaction was indicated by analytical HPLC analysis. The solvent was removed under reduced 
pressure. The crude reaction mixture was purified by preparative HPLC and the product B12-
Cy5 was dried in vacuo (14 mg; yield over two steps: 26 %).  
Variant B: Commercially available Cy5 N-hydroxysuccinimidyl ester (20 mg, 0.03 mmol) and 
B12-linker (54 mg, 0.04 mmol) were added to DIPEA (15 µl) in DMF (1 mL). The reaction 
mixture was stirred for 24 h at room temperature under nitrogen atmosphere. Completeness 
of the reaction was indicated by analytical HPLC analysis. The solvent was removed under 
reduced pressure. The crude reaction mixture was purified by preparative HPLC and the 
product B12-Cy5 was dried in vacuo (24 mg; yield 40 %).  
1H-NMR (500 MHz, MeOD-d4, 300 K): δ = 8.25 (t, Ja,b = Jb,c = Jc,d = Jd,e = 13.0 Hz, 2 H, b, d), 
7.50 (m, 2 H, 4, 4'), 7.41 (m, 2 H, 6, 6'), 7.28 (m, 4 H, 7, 7', 5, 5'), 7.13 (s, 1 H, B12-7N), 7.04 
(s, 1 H, B12-2N), 6.62 (t, Jb,c = Jc,d = 12.4 Hz, 1 H, c), 6.34 (s, 1 H, B12-4N), 6.29, 6.27 (dd, 
Ja,b = Jd,e = 13.7 Hz, 7.7 Hz, 2 H, a, e), 6.17 (d, J = 2.9 Hz, 1 H, B12-1R), 6.04 (s, 1 H, B12-
10), 4.67 (m, 1 H, B12-3R), 4.34 (m, 1 H, B12-176), 4.28 (m, 1 H, B12-3), 4.19 (m, 1 H, B12-
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2R), 4.09 (m, 2 H, B12-19, 1 H, B12-4R, 2 H, NCH2), 3.87 (m, 1 H, B12-5R), 3.74, 3.72 (dd, 
J = 12.6 Hz, 4.0 Hz, 1 H, B12-5R), 3.64 (s, 3 H, NCH3), 3.59 (m, 1 H, B12-8, 1 H, B12-175), 
3.23 (m, 1 H, B12-13), 2.96 (m, 1 H, B12-175), 2.78 (m, 1 H, B12-18), 2.67 (m, 2 H, B12-
L3), 2.60 (m, 2 H, B12-181), 2.55, 2.50 (s, 3 H, B12-51, s, 3 H, B12-151), 2.56 - 2.27 (m, 1 
H, B12-171, 1 H, B12-172, 2 H, B12-21, 1 H, B12-71, 2 H, B12-32, 2 H, B12-132), 2.25 (m, 
6 H, B12-10N, B12-11N), 2.16 - 1.83 (m, 2 H, B12-31, 2 H, B12-131, 1 H, B12-81, 1 H, B12-
171, 1 H, B12-71, 2 H, COCH2), 1.83 (m, 3 H, B12-7A, 1 H, B12-172, 1 H, B12-82, 2 H, 
NCH2CH2), 1.73 (s, 12 H, 3-CH3, 3'-CH3,), 1.54 (m, 2 H, COCH2CH2), 1.45 (s, 3 H, B12-12A), 
1.38 - 1.33 (m, 3 H, B12-2A, 2 H, NCH2CH2CH2, 3 H, B12-17B, 1 H, B12-82), 1.20 (m, 3 H, 
B12-177), 1.08 (m, 3 H, B12-12B, 1 H, B12-81), 0.50 (m, 3 H, B12-1A, 1 H, B12-L2), 0.39 
(m, 1 H, B12-L1), -0.13 (m, 1 H, B12-L1) ppm. 
13C{1H}-NMR (125 MHz, MeOD-d4, 300 K): δ = 177.89, 177.68, 177.17 (B12-133, B12-33, 
B12-83), 177.08 (B12-4), 176.85 (B12-16), 176.08 , 175.78 (B12-22, B12-182), 175.57 
(Cy5-2'), 175.37 (Cy5-CO), 174.85, 174.82 (B12-173, B12-72), 174.73 (B12-11), 174.48 
(Cy5-2), 172.30 (B12-9), 165.27, 165.18 (B12-14, B12-6), 155.66, 155.42 (Cy5-b, d), 
144.24, 143.61 (Cy5-7a, 7a'), 143.28 (B12-2N), 142.62, 142.57 (Cy5-3a, 3a'), 139.93 (B12-
9N), 134.07 (B12-6N), 132.14 (B12-5N, B12-8N), 129.78 (2 C, Cy5-6, 6'), 126.58 (Cy5-c), 
126.39, 126.20 (Cy5-5, 5'), 123.46, 123.32 (Cy5-4, 4'), 119.74 (B12-4N), 111.95 (2 C, Cy5-
7, 7'), 111.55 (B12-7N), 106.83 (B12-5), 105.10 (B12-15), 104.53, 104.14 (Cy5-a, e), 95.41 
(B12-10), 87.58 (B12-1R), 86.80 (B12-1), 83.32, 83.25 (B12-4R), 75.62 (B12-19, 3R), 73.54, 
73.49 (B12-176), 70.99 (B12-2R), 62.79 (B12-5R), 59.25 (B12-17), 57.21 (B12-3), 56.14 
(B12-8), 54.40 (B12-13), 51.03 (B12-7), 50.58, 50.51 (Cy5-3, 3'), 48.10 (B12-12), 47.52 
(B12-2), 46.30 (B12-175), 44.70 (Cy5-NCH2), 44.04, 43.76 (B12-71, B12-21), 40.53 (B12-
18), 38.89 (B12-L3), 36.84 (Cy5-COCH2), 36.66, 35.70 (B12-32, B12-132), 33.53, 33.45 
(B12-172, B12-82), 32.76, 32.68 (B12-12B, B12-181, B12-L1), 32.39 (B12-171), 31.58 
(Cy5-NCH3), 29.40 (B12-131), 28.20 (Cy5-NCH2CH2), 27.97, 27.78 (3-CH3, 3'-CH3), 27.73 
(B12-31, B12-81), 27.51 (Cy5-NCH2CH2CH2), 26.88 (Cy5-COCH2CH2), 21.97 (B12-1A), 
21.39 (B12-12A), 20.76, 20.31 (B12-10N, B12-11N), 20.21 (B12-7A), 20.02, 19.97 (B12-
177), 18.19, 17.73 (B12-2A, B12-17B), 16.68, 16.63 (B12-151, B12-51) ppm. 
ESI-MS m/z: 1852.9 [M]+, 926.9 [M+H]2+.  
HR-ESI-MS m/z: calcd. for C98H137CoN16O16PNa2+ ([M+Na+MeOH]2+) 953.96942, found 
953.95183; 942.96065 [M+H+MeOH]2+. 
HPLC: tR = 16.5 min, 98 % purity. 
UV/Vis (H2O): λ = 268, 283, 317, 357, 378, 599, 642 nm. 
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B12-Sulfo-Cy3: [Sulfo-Cy3]-β-(3-amidopropyl)cobalamin 
Sulfo-Cy3 N-hydroxysuccinimidyl ester (20 mg, 
0.03 mmol) and B12-linker (45 mg, 0.03 mmol) 
were added to a solution of DIPEA (15 µl) in DMF 
(1 mL). The reaction mixture was stirred for 24 h 
at room temperature under nitrogen atmosphere. 
Completeness of the reaction was indicated by 
analytical HPLC analysis. The solvent was 
removed under reduced pressure. The crude 
reaction mixture was purified by preparative 
HPLC and the product B12-Sulfo-Cy3 was dried 
in vacuo (33 mg; yield: 61 %). 
1H-NMR (500 MHz, MeOD-d4, 300 K): δ = 8.54 (t, Ja,b = Jb,c = 13.5 Hz, 1 H, b), 7.93 (m, 4 H, 
4, 4', 6, 6'), 7.42, 7.38 (dd, J = 20.8 Hz, 8.3 Hz, 2 H, 7, 7'), 7.13 (s, 1 H, B12-7N), 7.04 (s, 1 
H, B12-2N), 6.48, 6.46 (dd, Ja,b = Jb,c = 13.6 Hz, 1.9 Hz, 2 H, a, c), 6.35 (s, 1 H, B12-4N), 
6.17 (d, J = 3.0 Hz, 1 H, B12-1R), 6.03 (s, 1 H, B12-10), 4.67 (m, 1 H, B12-3R), 4.35 (m, 1 
H, B12-176), 4.29 (m, 1 H, B12-3), 4.19 - 4.08 (m, 1 H, B12-2R, 1 H B12-19,1 H, B12-4R, m, 
2 H, NCH2), 3.89, 3.87 (dd, J = 12.6 Hz, 2.8 Hz, 1 H, B12-5R), 3.75, 3.72 (dd, J = 12.6 Hz, 
4.1 Hz, 1 H, B12-5R), 3.70 (s, 3 H, NCH3), 3.56 (m, 2 H, B12-8, B12-175), 3.31 (m, 1 H, 
B12-13), 3.03 (m, 1 H, B12-175), 2.78 (m, 1 H, B12-18), 2.69 - 2.35 (m, 2 H, B12-L3, 2 H, 
B12-181, 1 H, B12-172, 1 H, B12-171, 1 H, B12-71, 2 H, B12-32, 2 H, B12-132, 2 H, B12-
21), 2.55, 2.49 (s, 3 H, B12-51, s, 3 H, B12-151), 2.25 (m, 3 H, B12-10N, 3 H, B12-11N), 
2.16 - 2.01 (m, 2 H, B12-31, 2 H, B12-131, 1 H, B12-71, 1 H, B12-171, 1 H, B12-81, 2 H, 
COCH2), 1.83 (m, 1 H, B12-172, 3 H, B12-7A 2 H, NCH2CH2), 1.77 (s, 12 H, 3-CH3, 3'-CH3, 
1 H, B12-82), 1.55 (m, 2 H, COCH2CH2),1.44 (s, 3 H, B12-12A), 1.37-1.29 (m, 3 H, B12-2A, 
2 H, NCH2CH2CH2, 3 H, B12-17B, 1 H, B12-82), 1.21 (d, J = 6.3 Hz, 3 H, B12-177), 1.05 (m, 
3 H, B12-12B, 1 H, B12-81), 0.53 (m, 1 H, B12-L2), 0.48 (s, 3 H, B12-1A), 0.29 (m, 1 H, 
B12-L1), -0.20 (m, 1 H, B12-L1) ppm. 
13C{1H}-NMR (125 MHz, MeOD-d4, 300 K): δ = 177.86, 177.73, 177.20 (B12-133, B12-33, 
B12-83), 177.45, 177.11, 176.91, 176.88, 176.10, 175.86, 175.04 (Cy3-2', B12-4, B12-16, 
Cy3-2, B12-22, B12-182, Cy3-CO), 174.92, 174.86 (B12-173, B12-72), 174.73 (B12-11), 
172.30 (B12-9), 165.26 (B12-14), 165.12 (B12-6), 152.69 (Cy3-b), 145.35, 144.75 (Cy3-5, 
5'), 144.09, 144.12 (Cy3-7a, 7a'), 143.24 (B12-2N), 142.13, 142.12 (Cy3-3a, 3a'), 139.94 
(B12-9N), 134.03 (B12-6N), 132.15, 132.12 (B12-5N, B12-8N), 128.22 (Cy3-6, 6'), 121.46, 
121.37 (Cy3-4, 4'), 119.76 (B12-4N), 112.33, 112.05 (Cy3-7, 7'), 111.49 (B12-7N), 106.90 
(B12-5), 105.10 (B12-15), 104.83, 104.79 (Cy3-a, c), 95.38 (B12-10), 87.56 (B12-1R), 86.78 
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(B12-1), 83.25, 83.19 (B12-4R), 75.51 (B12-3R, B12-19), 73.54 (B12-176), 71.01 (B12-2R), 
62.72 (B12-5R), 59.24 (B12-17), 57.14 (B12-3), 56.17 (B12-8), 54.45 (B12-13), 51.01 (B12-
7), 50.76, 50.68 (Cy3-3, 3'), 48.04 (B12-12), 47.52 (B12-2), 46.25 (B12-175), 45.20 (Cy3-
NCH2), 43.95, 43.75 (B12-71, B12-21), 40.43 (B12-18), 38.86 (B12-L3), 36.64, 36.53, 35.72 
(Cy3-COCH2, B12-32, B12-132), 33.57, 33.52 (B12-172, B12-82), 32.77, 32.57, 32.43 (B12-
12B, B12-181, B12-L1, B12-171), 32.07 (Cy3-NCH3), 29.34 (B12-131), 28.27, 28.27, 28.25, 
28.14, 28.08 (Cy3-3-CH3, 3'-CH3, Cy3-NCH2CH2), 27.77, 27.70, 27.03 (Cy3-NCH2CH2CH2, 
B12-81, B12-31), 26.32 (Cy3-COH2CH2), 21.96 (B12-1A), 21.40 (B12-12A), 20.75, 20.32 
(B12-10N, B12-11N), 20.19 (B12-7A), 20.01, 19.97 (B12-177), 18.28, 17.65 (B12-2A, B12-
17B), 16.74, 16.61 (B12-151, B12-51) ppm. 
HR-ESI-MS m/z: calcd. for C95H128CoN16O21PS2- ([M-H]2-) 991.89978, found 991.89869. 
HPLC: tR = 10.6 min, 92 % purity. 
UV/Vis (H2O): λ = 268, 281, 291, 317, 343, 376, 518, 551 nm. 
B12-Sulfo-Cy5: [Sulfo-Cy5]-β-(3-amidopropyl)cobalamin 
Sulfo-Cy5 N-hydroxysuccinimidyl ester 
(20 mg, 0.03 mmol) and B12-linker (34 mg, 
0.03 mmol) were added to a solution of 
DIPEA (15 µL) in DMF (1 mL). The reaction 
mixture was stirred for 8 h at room 
temperature under nitrogen atmosphere. 
Completeness of the reaction was indicated 
by analytical HPLC analysis. The solvent 
was removed under reduced pressure. The 
crude reaction mixture was purified by 
preparative HPLC and the product B12-Sulfo-Cy5 was dried in vacuo (36 mg; yield: 71 %). 
1H-NMR (500 MHz, MeOD-d4, 300 K): δ = 8.31 (m, Ja,b = Jb,c = Jc,d = Jd,e = 13.0 Hz, 2 H, b, d), 
7.87 (m, 4 H, 4, 4', 6, 6'), 7.36 - 7.30 (m, 2 H, 7, 7'), 7.13 (s, 1 H, B12-7N), 7.05 (s, 1 H, B12-
2N), 6.66 (t, Jb,c = Jc,d = 12.3 Hz, 1 H, c), 6.36 (s, 1 H, B12-4N), 6.33, 6.30 (dd, Ja,b = Jd,e = 
13.6 Hz, 5.9 Hz, 2 H, a, e), 6.17 (d, J = 3.1 Hz, 1 H, B12-1R), 6.04 (s, 1 H, B12-10), 4.68 (m, 
1 H, B12-3R), 4.35 (m, 1 H, B12-176), 4.28 (m, 1 H, B12-3), 4.19 (m, 1 H, B12-2R), 4.11 (m, 
1 H, B12-19, 1 H, B12-4R, 2 H, NCH2), 3.89, 3.87 (dd, J = 12.7 Hz, 2.9 Hz, 1 H, B12-5R), 
3.74, 3.72 (dd, J = 12.6 Hz, 4.1 Hz, 1 H, B12-5R), 3.65 (s, 3 H, NCH3), 3.59 (m, 1 H, B12-8, 
1 H, B12-175), 3.31 (m, 1 H, B12-13), 3.03 (m, 1 H, B12-175), 2.79 (m 1 H, B12-18), 2.67 
(m, 2 H, B12-L3), 2.60 (m, 2 H, B12-181), 2.55, 2.50 (m, 3 H, B12-51, 3 H, B12-151), 2.59 - 
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2.36 (m, 1 H, B12-172, 1 H, B12-171, 1 H, B12-71, 2 H, B12-32, 2 H, B12-132, 2 H, B12-
21), 2.25 (m, 3 H, B12-10N, 3 H, B12-11N), 2.14 - 1.89 (m, 2 H, B12-31, 2 H, B12-131, 1 H, 
B12-71, 1 H, B12-171, 1 H, B12-81, 2 H, COCH2), 1.83 (m, 3 H, B12-7A, 1 H, B12-172, 2 H, 
NCH2CH2), 1.75, 1.73 (m, 12 H, 3-CH3, 3'-CH3, 1 H, B12-82), 1.53 (m, 2 H, COCH2CH2), 
1.45 (s, 3 H, B12-12A), 1.38, 1.34 (m, 3 H, B12-2A, 2 H, NCH2CH2CH2, 3 H, B12-17B, 1 H, 
B12-82), 1.21 (d, J = 6.3 Hz, 3 H, B12-177), 1.06 (m, 3 H, B12-12B, 1 H, B12-81), 0.51 (m, 1 
H, B12-L2), 0.49 (s, 3 H, B12-1A), 0.31 (m, 1 H, B12-L1), -0.17 (m, 1 H, B12-L1) ppm. 
13C{1H}-NMR (125 MHz, MeOD-d4, 300 K): δ = 177.84, 177.72, 177.18 (B12-133, B12-33, 
B12-83), 177.05 (B12-4), 176.85 (B12-16), 176.16 (Cy5-2'), 176.10, 175.87 (B12-22, B12-
182), 175.15, 175.11 (Cy5-2, Cy5-CO), 174.92, 174.86 (B12-173, B13-72), 174.70 (B12-11), 
172.25 (B12-9), 165.23, 165.09 (B12-14, B12-6), 156.34, 156.09 (Cy5-b, d), 145.55, 145.05, 
143.47, 143.32 (Cy5-5, 5', Cy5-7a, 7a'), 143.24 (B12-2N), 142.51, 142.49 (Cy5-3a, 3a'), 
139.94 (B12-9N), 134.00 (B12-6N), 132.12, 132.10 (B12-5N, B12-8N), 128.00, 127.68 (2 C, 
Cy5-6, 6', Cy5-c), 121.28, 121.22 (Cy5-4, 4'), 119.74 (B12-4N), 111.73 (B12-7N), 111.53, 
111,48 (2 C, Cy5-7, 7'), 106.85 (B12-5), 105.41, 105.18 (Cy5-a, e), 105.11 (B12-15), 95.36 
(B12-10), 87.55 (B12-1R), 86.79 (B12-1), 83.23, 83.16 (B12-4R), 75.58, 75.53 (B12-19, 3R), 
73.51, 73.47 (B12-176), 71.00 (B12-2R), 62.68 (B12-5R), 59.25 (B12-17), 57.21 (B12-3), 
56.16 (B12-8), 54.46 (B12-13), 50.99 (B12-7), 50.56, 50.51 (Cy5-3, 3'), 49.83 (B12-12), 
48.04 (B12-2), 46.28 (B12-175), 44.81 (Cy5-NCH2), 43.92, 43.62 (B12-71, B12-21), 40.45 
(B12-18), 38.82 (B12-L3), 36.61, 36.58 (B12-32, B12-132), 35.70 (Cy5-COCH2), 33.61, 
33.51 (B12-172, B12-82), 32.66, 32.58 (B12-12B, B12-181, B12-L1), 32.41 (B12-171), 
31.78 (Cy5-NCH3), 29.32 (B12-131), 28.01 (Cy5-NCH2CH2), 27.88, 27.87, 27.69, 27.68 (3-
CH3, 3'-CH3, B12-31, B12-81), 27.14 (Cy5-NCH2CH2CH2), 26.43 (Cy5-COCH2CH2), 21.95 
(B12-1A), 21.37 (B12-12A), 20.74, 20.30 (B12-10N, B12-11N), 20.17 (B12-7A), 19.99, 
19.95 (B12-177), 18.30, 17.63 (B12-2A, B12-17B), 16.71, 16.60 (B12-151, B12-51) ppm. 
HR-ESI-MS m/z: calcd. for C97H130CoN16O21PS2- ([M-H]2-) 1004.90760, found 1004.90741. 
HPLC: tR = 11.5 min, 96 % purity. 
UV/Vis (H2O): λ = 267, 281, 319, 332, 360, 604, 648 nm.  
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B12-BHQ-2: [BHQ-2]-β-(3-amidopropyl)cobalamin 
A solution of BHQ-2 N-
hydroxysuccinimidyl ester (10 mg, 
0.02 mmol) in DMSO (0.4 mL) 
was added to a solution of B12-
linker (75 mg, 0.04 mmol) in 
0.5 mL carbonate-bicarbonate 
buffer at pH 8.3 (0.1 M). The 
reaction mixture was stirred 
overnight at room temperature. Completeness of the reaction was indicated by analytical 
HPLC analysis (method 1b). The solvent was removed under reduced pressure. The crude 
reaction mixture was purified by preparative HPLC and the product B12-BHQ-2 was dried in 
vacuo (15 mg; yield: 48 %). 
1H-NMR (500 MHz, MeOD-d4, 300 K): δ = 8.40 (d, J = 9.1 Hz, 2 H, BHQ-Q15), 8.08 (d, J = 
9.1 Hz, 2 H, BHQ-Q14), 7.89 (d, J = 9.2 Hz, 2 H, BHQ-Q7), 7.53, 7.47 (s, 1 H, BHQ-Q10, s, 
1 H, BHQ-Q10'), 7.12 (s, 1 H, B12-7N), 7.03 (s, 1 H, B12-2N), 6.84 (d, J = 9.3 Hz, 2 H, BHQ-
Q6), 6.34 (s, 1 H, B12-4N), 6.15 (d, J = 3.0 Hz, 1 H, B12-1R), 5.99 (s, 1 H, B12-10), 4.67 (m, 
1 H, B12-3R), 4.33 (m, 1 H, B12-176), 4.25 (m, 1 H, B12-3), 4.18 (m, 1 H, B12-2R), 4.09 (m, 
1 H, B12-19, 1 H, B12-4R), 4.06 (s, 3 H, BHQ-OMe), 4.01 (s, 3 H, BHQ-OMe), 3.87, 3.85 
(dd, J = 12.6 Hz, 2.9 Hz, 1 H, B12-5R), 3.73, 3.71 (dd, J = 12.6 Hz, 4.2 Hz, 1 H, B12-5R), 
3.57 (m, 2 H, B12-8, B12-175), 3.45 (m, 2 H, BHQ-Q4), 3.16 (m, 1 H, B12-13), 3.09 (s, 3 H, 
BHQ-NMe), 2.98 (m, 1 H, B12-175), 2.77 (m, 1 H, B12-18), 2.71 (m, 2 H, B12-L3), 2.58 (m, 
2 H, B12-181), 2.56 - 2.36 (m, 1 H, B12-172, 2 H, B12-32, 2 H, B12-132, 1 H, B12-171, 1 H, 
B12-71, 2 H, B12-21), 2.53, 2.47 (s, 3 H, B12-51, s, 3 H, B12-151), 2.25, 2.24 (s, 3 H, B12-
10N, 3 H, B12-11N), 2.09 (m, 2 H, B12-131, 1 H, B12-31, 1 H, B12-171, 1 H, B12-71, 2 H, 
BHQ-Q2), 1.93 (m, 1 H, B12-81), 1.83 (m, 2 H, BHQ-Q3, 3 H, B12-7A, 1 H, B12-31, 1 H, 
B12-172), 1.70 (m, 1 H, B12-82), 1.41 (s, 3 H, B12-12A), 1.38 (s, 3 H, B12-2A), 1.32 (m, 3 
H, B12-17B, 1 H, B12-82, 1 H, B12-L2), 1.19 (d, J = 6.2 Hz, 3 H, B12-177), 1.06 (m, 3 H, 
B12-12B, 1 H, B12-81), 0.49 (m, 1 H, B12-L2, s, 3 H, B12-1A), 0.42 (m, 1 H, B12-L1), -0.12 
(m, 1 H, B12-L1) ppm. 
13C{1H}-NMR (125 MHz, MeOD-d4, 300 K): δ = 177.84, 177.70, 177.10, 177.05, 176.82, 
176.09, 175.77 (B12-133, B12-33, B12-83, B12-22, B12-182, B12-4, B12-16), 174.91, 
174.87, 174.82, 174.74 (B12-173, B12-172, B12-11, BHQ-Q1), 172.27 (B12-9), 165.19, 
165.18 (B12-14, B12-6), 157.65 (BHQ-Q13), 154.95 (BHQ-Q11/11'), 153.74 (BHQ-Q5), 
152.21 (BHQ-Q11/11'), 149.95 (BHQ-Q16), 147.85 (BHQ-Q12/9),145.53 (BHQ-Q8), 143.38 
(BHQ-Q12/9), 143.24 (B12-2N), 139.92 (B12-9N), 134.07 (B12-6N), 132.16, 132.12 (B12-
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5N, B12-8N), 127.29 (BHQ-Q7), 125.83 (BHQ-Q15), 124.69 (BHQ-Q14), 119.74 (B12-4N), 
112.73 (BHQ-Q6), 111.52 (B12-7N), 106.91, 105.10 (B12-5, B12-15), 102.09, 101.17 (BHQ-
Q10', BHQ-Q10), 95.41 (B12-10), 87.57 (B12-1R), 86.80 (B12-1), 83.26, 83.21 (B12-4R), 
75.61 (B12-19), 75.57, 75.54 (B12-3R), 73.51, 73.47 (B12-176), 71.01 (B12-2R), 62.72 
(B12-5R), 59.23 (B12-17), 57.27, 57.22, 57.17 (B12-3, BHQ-OMe), 56.31 (B12-8), 54.48 
(B12-13), 52.66 (BHQ-Q4), 51.11 (B12-7), 48.09 (B12-12), 47.52 (B12-2), 46.29 (B12-175), 
44.15 (B12-71), 43.76 (B12-21), 40.53 (B12-18), 39.02 (BHQ-NMe), 38.97 (B12-L3), 36.62, 
35.77 (B12-32, B12-132), 34.11 (BHQ-Q2), 33.53 (B12-172), 33.41 (B12-82), 32.76, 32.72, 
32.67 (B12-12B, B12-181, B12-L1), 32.39 (B12-171), 29.37 (B12-131), 27.71, 27.65 (B12-
81, B12-31), 25.19 (B12-L2), 24.50 (BHQ-Q3), 21.97 (B12-1A), 21.30 (B12-12A), 20.75, 
20.32 (B12-10N, B12-11N), 20.21 (B12-7A), 20.01, 19.97 (B12-177), 18.19 (B12-17B), 
17.72 (B12-2A), 16.65, 16.60 (B12-151, B12-51) ppm. 
ESI-MS m/z: 1875.8 [M+H]+, 1898.7 [M+Na]+. 
HPLC: tR = 18.0 min, 99 % purity. 
UV/Vis (H2O): λ = 266, 280, 321, 351, 559 nm. 
5.3.3 Fluorescence Quantum Yields and Steady-State Anisotropy 
The procedure for the determination of the fluorescence quantum yields and static 
fluorescence anisotropy of the free dyes and the dyes attached to B12 follows the established 
techniques. All spectra were recorded at 22 °C. Cresyl violet perchlorate (Φ = 0.54) and 
rhodamine 6G (Φ = 0.94) in ethanol were used as references.[17] All samples were dissolved 
in PBS buffer. Stock solutions were diluted to different concentrations chosen such that the 
absorption at the excitation wavelength (500 nm Cy3, 580 nm Cy5) did not exceed 0.1. 
Absorbance and fluorescence spectra were recorded. The quantum yield was calculated 
according to the following equation: 
Φୱ ൌ Φ୰ IୱI୰
OD୰
ODୱ
ηୱଶ
η୰ଶ (4)
s and r refer to the sample and reference, respectively. Φ is the fluorescence quantum yield, 
I is the integrated fluorescence intensity, OD is the optical density at the excitation 
wavelength and η is the refractive index of the solvent. 
For static fluorescence anisotropy measurements an automated polarizer was used to record 
fluorescence intensities of polarized excitation and emission in vertical (v, 0°) and horizontal 
(h, 90°) positions. 
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Stability measurements were done exciting a solution of B12-Cy3 in PBS buffer at 532 nm for 
10 min. The absorbance and emission was measured before and after irradiation. 
5.3.4 Preparation of RNA (btuB Riboswitch of E.coli) 
Plasmid Isolation 
The btuB riboswitch sequences of Escherichia coli pPC4 (270 nts, Appendix) designed by 
Choudhary et al.,[176] and pSG1 (202 nts, Appendix) designed by Gallo et al., [87] are encoded 
on plasmids derived from the pRZ-vector.[180] Glycerol stocks with cells (E. coli, DH5α) 
carrying the plasmid (pPC4 or pSG1) were used to inoculate an LB culture containing the 
appropriate amount of ampicillin (100 mg/mL) and incubated overnight at 37 °C, 210 rpm. 
Purification was done using a PureYield Plasmid Maxiprep System (Promega).  
Transcription of pPC4 and pSG1 
In order to obtain a linear DNA template all plasmids were digested with EcoR1 at the 
restriction site located downstream of the riboswitch region. After purification the plasmids 
were transcribed by in vitro transcription using self-made T7 RNA polymerase according to 
the literature.[87,181] More specifically, 15 μg/mL EcoR1 digested plasmid, 20 mM MgCl2 
(pPC4) or 30 mM MgCl2 (pSG1), respectively, 5 mM of each NTP (ATP, CTP, GTP, and 
UTP), and 20 μL/mL T7 RNA polymerase were mixed in 1x Transcription Buffer. The reaction 
was allowed to proceed for 5-6 h at 37 °C and shaking (300 rpm). For pSG1 the MgCl2 
concentration was increased to 40 mM and a thermal cycling method was applied (2 min 
90 °C, 5 min 65 °C, 10 min 37 °C; repeated three times) to cleave the hammerhead ribozyme 
at the 5’- and the hepatitis delta virus ribozyme at the 3’- flanking regions of the riboswitch 
sequence. Transcription products were purified via ethanol precipitation, denaturing PAGE 
(10 % w/v, 7 M urea), and eluted by electroelution. After ethanol precipitation the RNA was 
dissolved in water and concentrated by Vivaspin centrifugation. The RNA concentration was 
determined spectroscopically from the absorbance at 260 nm using the extinction coefficients 
of the RNA nucleobases yielding 0.6 nmol RNA/mL transcription. 
5.3.5 Fluorescence Native Gels 
Fluorescence native gel electrophoresis was performed with the btuB riboswitch RNA (pPC4) 
and DNA2-Cy5 (5'-Sulfo-Cy5-ACGTAGTCCGAAATATAT-3') or PNA1S-Cy5 (Lys-
tataaagcctgatg-spacer-Sulfo-Cy5, synthesis described in Chapter 5.4.1). Samples containing 
pPC4 (3 µM) and DNA1-Cy5 (3 µM) or PNA1S-Cy5 (3 µM), were denatured in 50 mM Tris-
HCl (pH 7.5), 100 mM KCl for 60 s at 90 °C. MgCl2 (20 mM) was added and the RNA was 
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allowed to prefold for 15 min at 37 °C (smFRET conditions). An equal amount of glycerol was 
added and the samples were loaded onto a 6 % (w/v) gel containing 3 mM MgOAc, 66 mM 
HEPES, and 34 mM Tris-HCl at pH 7.4. Electrophoresis was performed at 4 °C using a 
running buffer of the same conditions as described. Fluorescence bands of Cy5 in the gels 
were detected on a Typhoon scanner. 
5.3.6 In-line Probing Experiments 
Prior to in-line probing experiments pPC1 RNA (Appendix) which carries a 5’-triphosphate 
was dephosphorylated. The RNA pPC1 or pSG1, respectively, was 5'-end labeled with [32P]-
γ-ATP for a sensitive detection. In-line probing titration experiments were carried out using 
the [32P]-5'-labeled RNA in the final concentration noted below for each experiment. The RNA 
was incubated in the dark for 40 h at 25°C in 50 mM Tris-HCl (pH 8.3), 100 mM KCl, and 
20 mM MgCl2 in presence or absence of different cobalamin derivatives. The cleaved bands 
were separated by 10 % (w/v, 7 M urea) denaturing PAGE, visualized by phosphor imaging, 
and analyzed with ImageQuantTL. For every experiment ladders and controls were 
used.[49,87] 
5’-Labeling of RNA 
The RNA pPC1 (480 pmol) was dephosphorylated with 0.16 U/μL Thermosensitive Alkaline 
Phosphatase (TSAP) for 30 min at 37 °C, and purified by chloroform-phenol extraction.[176] 
pPC1 or pSG1 (240 pmol), respectively, in ME buffer were 5’-labled with [32P]-γ-ATP 
(15 μCi/μL) by addition of T4 polynucleotide kinase (PNK, 1 U/μL) in PNK buffer. The 
reaction was allowed to proceed for 30 min at 37 °C and shaking (300 rpm). The RNA was 
purified via denaturing PAGE (8 % w/v, 7 M urea), visualized by phosphor imaging, eluted 
with Elution buffer, and concentrated by ethanol precipitation. After dissolving the RNA in 
water the concentration was determined by scintillation counting. 
Ladders and Controls 
The alkaline hydrolysis cleavage ladder (OH‒) was generated by incubation of the 5’-labeled 
RNA (same concentration as used in corresponding experiment) in 50 mM Na2CO3 and 
1 mM EDTA at pH 9.0 for 5 min at 90 °C. 
The T1 cleavage ladder (T1) which cleaves the RNA at each guanine residue was generated 
by incubation of the 5’-labeled RNA (same concentration as used in corresponding 
experiment) and ribonuclease T1 (100 mU) in 25 mM sodium citrate at pH 5.0 for 5 min at 
55 °C. 
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The uncleaved 5’-labeled RNA (same concentration as used in corresponding experiment) is 
used as unreacted control (c). A negative control (‒) was generated by incubation without 
cobalamin and a positive control (+) by addition of 10 µM AdoCbl to the in-line probing 
experiment under the above described conditions. 
Titration Experiments 
Titration experiments were performed using pPC1 RNA at a final concentration of 38 nM of 
which 5 nM were 32P-labeled under the described conditions (vide supra) and addition of: 
B12-Cy3: 0.3 µM, 1.2 µM, 9.2 µM, 27.7 µM, 55.3 µM, 0.1 mM, 0.2 mM, 0.3 mM, 0.5 mM, 
0.7 mM, 1.0 mM, 1.5 mM.  
B12-Sulfo-Cy3: 0.3 µM, 1.2 µM, 9.4 µM, 28.1 µM, 56.3 µM, 0.1 mM, 0.2 mM, 0.3 mM, 
0.5 mM, 0.7 mM, 1.0 mM, 1.5 mM. 
B12-Cy5: 0.3 µM, 2.0 µM, 7.9 µM, 15.9 µM, 31.8 µM, 63.5 µM, 0.1 mM, 0.2 mM, 0.3 mM, 
0.5 mM, 0.7 mM, 0.9 mM. 
B12-Sulfo-Cy5: 0.3 µM, 1.9 µM, 7.5 µM, 15.0 µM, 30.0 µM, 60.0 µM, 0.1 mM, 0.2 mM, 
0.3 mM, 0.5 mM, 0.7 mM, 0.9 mM. 
B12-linker: 0.3 µM, 3.4 µM, 13.6 µM, 27.2 µM, 54.3 µM, 0.1 mM, 0.2 mM, 0.3 mM, 0.5 mM, 
0.7 mM, 1.0 mM, 1.5 mM. 
Titration experiments were performed with pSG1 RNA at a final concentration of 38 nM of 
which 3.5 nM were 32P-labeled under the described conditions (vide supra) and addition of: 
B12-BHQ-2: 1.2 µM, 2.3 µM, 4.7 µM, 9.4 µM, 18.8 µM, 37.5 µM, 75.0 µM, 0.2 mM, 0.3 mM, 
0.6 mM, 1.2 mM, 1.8 mM. 
Evaluation of the Titration Experiments 
A background correction for intensity changes due to differing loading volumes was done by 
applying a correction factor (R). R is calculated per lane by the intensity of a distinct constant 
region relative to the most intense lane. 
Intensities of each band were quantified, divided by R and plotted versus the concentration of 
each B12 derivative.  
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The affinity constant Ka was determined for each characteristic cleavage site by fitting the 
mean of three independent titration experiments to a 1:1 binding isotherm: 
ܫ௥௘௟ ൌ ߜܨ ൅ ሺߜܤ െ ߜܨሻ ∙
ቀሾܴܰܣሿ ൅ ሾܤଵଶሿ ൅ 1ܭ௔ቁ െ ඨቀሾܴܰܣሿ ൅ ሾܤଵଶሿ ൅
1
ܭ௔ቁ
ଶ
െ 4 ∙ ሾܴܰܣሿ ∙ ሾܤଵଶሿ
2 ∙ ሾܴܰܣሿ  
 
(5)
with δF and δB being intensity of free (F) and bound (B) RNA, and Ka the affinity constant.[97] 
The final dissociation constant KD for each derivative was calculated as weighted mean with 
standard deviation from the single cleavage sites that could be fitted, derived from at least 
three independent experiments. Cleavage sites 1, 2b, 3, 4 and 8 were used in B12-Cy3 
experiments, cleavage sites 1 and 8 in B12-Cy5 experiments, and cleavage sites 1, 2, 2b, 3, 
4 and 8 in B12-BHQ-2 experiments. For B12-Sulfo-Cy3, B12-Sulfo-Cy5 and B12-linker no KD 
values could be calculated. 
Control Experiments 
Overview gels were performed with pPC1 RNA at a final concentration of 38 nM of which 
5 nM were 32P-labeled under the described conditions (vide supra) and addition of: 
B12-Cy3, B12-Sulfo-Cy3: 0.1, 0.5, 1.5 mM; B12-Cy5, B12-Sulfo-Cy5: 0.1, 0.5, 0.8 mM. 
Control experiments were performed with pSG1 RNA at a final concentration of 38 nM of 
which 3.5 nM were 32P-labeled under the described conditions (vide supra) and addition of: 
Cy3, Cy5: 0.3 µM, 0.5 mM, 1.0 mM; Sulfo-Cy3, Sulfo-Cy5: 0.3 µM, 0.7 mM, 1.5 mM. 
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5.4 Methods Chapter 3 (Labeling of RNA) 
The following chapter is based on the manuscript accepted for publication: 
“Internal Labeling Strategy of Large RNAs with Minimal Perturbation Using Fluorescent PNA” 
by Anita G. Schmitz, Susann Zelger-Paulus, Gilles Gasser, and Roland K. O. Sigel in 
ChemBioChem, 2015.[169] 
5.4.1 PNA Synthesis 
General Procedure for Solid Phase PNA Synthesis (SPPS) 
The procedure for SPPS was performed according to Anstaett et al.[170] More specifically, the 
reaction was carried out manually in 5 mL polypropylene one-way syringes as reaction 
vessels, which were equipped with a frit at the bottom. They were filled with 100 mg of 
polystyrene resin beads TentaGel® S RAM-Lys(Boc)Fmoc (0.23 mmol/g). The resin was 
swollen in dimethylformamide (DMF) for 1 h before use. All reactions were performed on a 
mechanical shaker with 600 rpm, soaking approximately 2.5–3.5 mL of freshly prepared 
solutions into the syringe. Fluorenylmethoxycarbonyl (Fmoc)/benzhydryloxycarbonyl (Bhoc) 
protected PNA monomers (5 equiv.) were pre-activated in Eppendorf tubes before each 
coupling step for 5 min with O-(7-azobenzotriazol-1-yl)-1,1,3,3-tetramethyluronium 
hexafluorophosphate (HATU) (4.5 equiv.) in DMF, adding N,N-diisopropylethylamine 
(DIPEA) and 2,6-lutidine (10 equiv. each) under sonication. For each coupling step the resin 
beads were treated with the activated acid (1.5 h) and subsequently washed with DMF and 
dichloromethane (DCM). The coupling step was monitored with the Kaiser test.[158,159] 
Substances other than the usual PNA monomers were coupled in the same way, unless 
noted otherwise. Double Fmoc deprotection was performed with piperidine in DMF (2:8, v/v; 
2 min, 10 min). The resin beads were then washed successively with DMF, dichloromethane 
(DCM) and DMF. The whole procedure (deprotection, coupling, monitoring) was repeated for 
every monomer until the sequence was completed. The resin was then shrunk with methanol 
(30 min) and dried under vacuum. Final cleavage of the PNA oligomer from the resin and the 
deprotection of all Bhoc and tert-butyloxycarbonyl (Boc) side chain protecting groups were 
simultaneously performed in trifluoroacetic acid (TFA)/triisopropylsilane (TIS)/H2O (38:2:1, 
v/v/v; 3x 2 h). Following the removal of TFA under reduced pressure, the crude product was 
purified by preparative HPLC (method 4). MALDI-MS spectra, and LC-MS (method 3) were 
recorded and the purities were determined from the HPLC UV traces at 260 nm. 
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HPLC method 3 (analytical): column Agilent Zorbax SB300-C18; flow-rate 0.5 mL/min; 
solvent A: 0.1 % formic acid in water, solvent B: ACN; gradient: 0-3 min 5 % B, 3-17 min 5-
100 % B, 17-20 min 100 % B, 20-21 min 100-5 % B, 21-25 min 5 % B. 
HPLC method 4 (preparative): column Agilent Zorbax SB300-C18; flow-rate 21 mL/min; 
solvent A: 0.1 % TFA in water, solvent B: ACN; gradient: 0-21 min 5-45 % B, 21-25 min 45-
100 % B, 25-30 min 100 % B, 30-32 min 100-0 % B. 
In the following PNA sequences are denoted NC terminus in small letters. 
Precursor PNA1S: Fmoc-spacer-gtagtccgaaatat-Lys-resin 
SPPS was performed according to the general procedure (vide supra), until the last coupling 
of the PNA sequence was completed. After deprotection a Fmoc-AEEA-OH spacer (5 equiv.) 
was coupled to the sequence. 
PNA1S-Cy5: Sulfo-Cy5-spacer-gtagtccgaaatat-Lys-NH2 
 
For the subsequent coupling of the dye Sulfo-Cy5 NHS ester (1.5 equiv.) in DMF/DIPEA 30:1 
was added to ½ of deprotected precursor PNA1S and shaken for 5 h. After washing with 
DMF and DCM the coupling step was repeated. The cleavage and purification were 
performed as described in the general procedure. 
MALDI-MS: calcd. for C196H249N88O52S2+ ([M+2H]+) 4730.9, found 4730.9.  
ESI-MS m/z: 1184.0 (6, [M+5H]4+), 947.7 (71, [M+6H]5+), 789.9 (100, [M+7H]6+), 677.2 (27, 
[M+8H]7+), 592.6 (2, [M+9H]8+).  
HPLC: tR = 8.8 min, 95 % purity. 
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PNA1S-Cy3: Sulfo-Cy3-spacer-gtagtccgaaatat-Lys-NH2 
For the subsequent coupling of the dye Sulfo-Cy3 NHS ester (1.5 equiv.) in DMF/DIPEA 30:1 
was added to ½ of deprotected precursor PNA1S and shaken for 5 h. After washing with 
DMF and DCM the coupling step was repeated. The cleavage and purification were 
performed as described in the general procedure. 
In an alternative approach the resin with the PNA sequence was saturated with Kiton Red S 
(14 equiv.) in DMF/DIPEA 30:1 for 30 min prior to the addition of Sulfo-Cy3.[171] 
MALDI-MS: calcd. for C194H247N88O52S2+ ([M+2H]+) 4704.9, found 4704.7. 
ESI-MS m/z: 942.0 (3, [M+6H]5+), 785.3 (100, [M+7H]6+), 673.3 (36, [M+8H]7+), 587.9 (4, 
[M+9H]8+).  
HPLC (method 3, flow-rate 0.3 mL/min): tR = 10.8 min, 95 % purity. 
Precursor PNA2: Fmoc-gtagtccgaa-Lys-resin 
SPPS was performed according to the general procedure (vide supra) until the last coupling 
of the PNA sequence was completed. 
PNA2-Cy5: Sulfo-Cy5-gtagtccgaa-Lys-NH2 
For the subsequent coupling of the dye Sulfo-Cy5 NHS ester (1.5 equiv.) in DMF/DIPEA 30:1 
was added to ½ of deprotected precursor PNA2 and shaken for 5 h. After washing with DMF 
and DCM the coupling step was repeated. The cleavage and purification were performed as 
described in the general procedure. 
MALDI-MS: calcd. for C146H184N65O37S2+ ([M+2H]+) 3503.4, found 3503.4.  
ESI-MS m/z: 1169.3 (9, [M+4H]3+), 877.2 (53, [M+5H]4+), 702.0 (100, [M+6H]5+), 585.1 (32, 
[M+7H]6+).  
HPLC: tR = 8.7 min, 95 % purity. 
PNA2S-Cy5: Sulfo-Cy5-spacer-gtagtccgaa-Lys-NH2 
Fmoc-AEEA-OH spacer (5 equiv.) was coupled to ½ of precursor PNA2 according to the 
general SPPS procedure. For the subsequent coupling of the dye Sulfo-Cy5 NHS 
(1.5 equiv.) in DMF/DIPEA 30:1 was added and shaken for 5 h. After washing with DMF and 
DCM the coupling step was repeated. The cleavage and purification were performed as 
described in the general procedure. 
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MALDI-MS: calcd. for C152H195N66O40S2+ ([M+2H]+) 3648.5, found 3648.5.  
ESI-MS m/z: 1217.3 (2, [M+4H]3+), 913.5 (35, [M+5H]4+), 731.1 (100, [M+6H]5+), 609.4 (44, 
[M+7H]6+).  
HPLC: tR = 8.8 min, 95 % purity. 
Precursor PNA3: Fmoc-acgtagtccg-Lys-resin 
SPPS was performed according to the general procedure (vide supra) until the last coupling 
of the PNA sequence was completed. 
PNA3-Cy5: Sulfo-Cy5-acgtagtccg-Lys-NH2 
For the subsequent coupling of the dye Sulfo-Cy5 NHS ester (1.5 equiv.) in DMF/DIPEA 30:1 
was added to ½ of deprotected precursor PNA3 and shaken for 5 h. After washing with DMF 
and DCM the coupling step was repeated. The cleavage and purification were performed as 
described in the general procedure. 
MALDI-MS: calcd. for C145H184N63O38S2+ ([M+2H]+) 3479.4, found 3479.3.  
ESI-MS m/z: 1161.2 (6, [M+4H]3+), 871.2 (47, [M+5H]4+), 697.2 (100, [M+6H]5+), 581.1 (25, 
[M+7H]6+).  
HPLC: tR = 8.6 min, 100 % purity. 
PNA3S-Cy5: Sulfo-Cy5-spacer-acgtagtccg-Lys-NH2 
Fmoc-AEEA-OH spacer (5 equiv.) was coupled to ½ of precursor PNA3 according to the 
general SPPS procedure. For the subsequent coupling of the dye Sulfo-Cy5 NHS ester 
(1.5 equiv.) in DMF/DIPEA 30:1 was added and shaken for 5 h. After washing with DMF and 
DCM the coupling step was repeated. The cleavage and purification were performed as 
described in the general procedure. 
MALDI-MS: calcd. for C151H195N64O41S2+ ([M+2H]+) 3622.5, found 3624.4.  
ESI-MS m/z: 1209.4 (5, [M+4H]3+), 907.4 (44, [M+5H]4+), 726.2 (100, [M+6H]5+), 605.3 (44, 
[M+7H]6+), 519.0 (4, [M+8H]7+).  
HPLC: tR = 8.8 min, 97 % purity. 
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Precursor PNA4: Fmoc-accaagagcg-Lys-resin 
SPPS was performed according to the general procedure (vide supra) until the last coupling 
of the PNA sequence was completed. 
PNA4-Cy3: Sulfo-Cy3-accaagagcg-Lys-NH2 
For the subsequent coupling of the dye Sulfo-Cy3 NHS ester (1.5 equiv.) in DMF/DIPEA 30:1 
was added to ½ of deprotected precursor PNA4 and shaken for 5 h. After washing with DMF 
and DCM the coupling step was repeated. The cleavage and purification were performed as 
described in the general procedure. 
MALDI-MS: calcd. for C143H180N69O34S2+ ([M+2H]+) 3471.4, found 3471.3.  
ESI-MS m/z: 1158.5 (8, [M+4H]3+), 869.1 (38, [M+5H]4+), 695.6 (100, [M+6H]5+), 579.8 (71, 
[M+7H]6+), 497.2 (5, [M+8H]7+).  
HPLC: tR = 8.2 min, 95 % purity. 
5.4.2 Preparation of RNA (Group II Intron Ribozyme) 
Polymerase Chain Reaction PCR for D135-L1sh4, and D135-L14sh[182] 
The truncated version D135-L14 (638 nts) of the group II intron Sc.ai5γ from Saccharomyces 
cerevisiae is encoded on the plasmid named pT7D135-L14, designed by Steiner et al.[42] 
D135-L14 was modified by the deletion of 9 bp (5’-AAUUAAUAA-3’) in loop L1 and 9 bp (5’-
AAUAUAUUU-3’) in loop L4 using site-directed mutagenesis PCR giving the plasmids 
pSPA7a and pSPA7b. 
More specifically, the PCR reactions were carried out using 0.04 U/μL Phusion High-Fidelity 
DNA polymerase (Phu). For the deletion in loop L1 300 ng of the initial plasmid pT7D135-
L14, 0.25 μM each forward primer P1 and reverse primer P2 (Table 8), and 200 μM of each 
dNTP were mixed with Phu polymerase in 1x Phu buffer. The method described in Table 9 
was applied. The methylated DNA was digested with DpnI (0.2 U/μL) for 1 h at 37 °C. 
Afterwards, the plasmid pSPA7a was transformed into chemically competent cells 
(Escherichia coli XL1-Blue) via heat shock and further isolated by using the PureYield 
Plasmid Miniprep System (Promega) following the manufactures instructions. 
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Table 8: Primer sequences used for PCR. 
Name Sequence 
P1 5’-GTCTGATATTCAATTATTATCCCACGCTCTTGGTAGGGATAAAATGG-3’ 
P2 5’-CCATTTTATCCCTACCAAGAGCGTGGGATAATAATTGAATATCAGAC-3’ 
P3 5’-GCTAACTTATACTATAGGTGATACCCACGGACTACGTAGGGTATTGCG-3’ 
P4 5’-CGCAATACCCTACGTAGTCCGTGGGTATCACCTATAGTATAAGTTAGC-3’ 
 
Table 9: PCR program. 
Reaction time temperature  
Initial denaturation 5 min 95 °C  
Denaturation 45 s 95 °C  
Primer annealing 45 s 55 °C 20 cycles 
Elongation 3 min 72 °C  
Final elongation 10 min 72 °C  
The deletion in loop L4 was performed using pSPA7a (300 ng), 0.25 μM each forward primer 
P3 and reverse primer P4 (Table 8), 200 μM of each dNTP, Phu polymerase (0.04 U/μl) and 
1x Phu buffer. The method described in Table 9 was applied. Digestion of the reaction 
mixture was done with DpnI (0.2 U/μL) for 1 h at 37 °C. The plasmid was inserted into 
chemically competent cells (E. coli XL1-Blue) via heat shock transformation and further 
isolated by using the PureYield Plasmid Miniprep System (Promega) following the 
manufactures instructions. 
Plasmid Isolation 
Cells carrying the plasmid (pT7D135, pT7D135-L14, pSPA7a, or pSPA7b) were used to 
inoculate an LB culture containing the appropriate amount of ampicillin (100 mg/mL) and 
incubated overnight at 37 °C, 210 rpm. Purification was done using a PureYield Plasmid 
Maxiprep System (Promega).  
Transcription of D135, D135-L14, D135-L1shL4, and D135-L14sh 
In order to obtain a linear DNA template all plasmids were digested with HindIII (10 U/μL) at 
the restriction site located downstream of the intron region. The purified plasmids were 
transcribed by in vitro transcription using self-made T7 RNA polymerase according to the 
literature.[42,181] More specifically, 7.5 μg/mL HindIII digested plasmid, 25 mM MgCl2, 5 mM of 
each NTP (ATP, CTP, GTP, and UTP), and 20 μL/mL T7 RNA polymerase were mixed in 1x 
Transcription Buffer. The reaction was allowed to proceed for 5-6 h at 37 °C and shaking 
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(300 rpm). Transcription products were purified via ethanol precipitation, denaturing PAGE 
(5 % w/v, 7 M urea), and eluted by electroelution. The RNA was concentrated by ethanol 
precipitation and dissolved in water. The RNA concentration was determined 
spectroscopically from the absorbance at 260 nm using the extinction coefficients of the 
single RNA nucleobases yielding 0.75 nmol RNA/mL transcription. 
5.4.3 UV Melting Experiments 
UV melting experiments of RNA-PNA and RNA-DNA hybrids were undertaken in order to 
obtain the respective melting temperature Tm. All complementary RNA strands were 
extended by three uracil residues on the 3'- and 5'-end (Table 10) to avoid terminal group 
effects. The PNA concentration was determined in PBS buffer (0.1 M phosphate buffer, 
0.1 M NaCl, pH 7.4) at 260 nm and 70 °C using the extinction coefficients of the PNA 
nucleobases (εPNA,A = 13700 M‒1cm‒1, εPNA,G = 11700 M‒1cm‒1, εPNA,C = 6600 M‒1cm‒1, εPNA,T = 
8600 M‒1cm‒1).[152] Solutions of PNA1S-Cy3, PNA1S-Cy5, PNA2-Cy5, PNA2S-Cy5, PNA3-
Cy5, PNA3S-Cy5, DNA1-Cy3 or DNA2-Cy5 together with the complementary RNA1–RNA5 
were used at a concentration of 2 µM in degassed Reaction Buffer. Prior to the experiment 
the duplexes were denatured at 90 °C for 1 min and then cooled down to room temperature. 
The thermal program was applied by heating to 90 °C, cooling to 10 °C, both at 0.5 °C/min 
with a starting and returning temperature of 90 °C. The procedure was repeated three 
times.[172] The absorption was recorded at 260 nm, and the data was analyzed by the 
derivative method. 
Table 10: RNA sequences used for UV melting experiments with PNA-dye or DNA-dye derivatives. 
Name Sequence Loop PNA/DNA 
RNA1 5'-UUUAUUAAUAACGCUCUUGGUUUU-3' L1 DNA1-Cy3 
RNA2 5'-UUUCGCUCUUGGUUUU-3' L1 PNA4-Cy3 
RNA3 5'-UUUAUAUAUUUCGGACUACGUUUU-3' L4 DNA2-Cy5 
RNA4 5'-UUUAUAUUUCGGACUACUUU-3' L4 PNA1S-Cy3, PNA1S-Cy5, PNA2-
Cy5, PNA2S-Cy5 
RNA5 5'-UUUCGGACUACGUUUU-3' L4 PNA3-Cy5, PNA3S-Cy5 
 
5.4.4 Fluorescence Native Gels 
Fluorescence native gel electrophoresis was performed according to the literature.[42] More 
specifically, samples containing the ribozyme RNA D135-L14 (2 µM), DNA1-Cy3 (2 or 4 µM, 
as indicated), and DNA2-Cy5 (2 or 4 µM, as indicated) were denatured in Reaction Buffer for 
45 s at 90 °C. MgCl2 (100 mM) was added and the RNA was allowed to prefold for 20 min at 
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42 °C (smFRET conditions). For experiments with PNA-dye oligonucleotides the procedure 
was modified. Samples containing the ribozyme D135-L14, D135-L14sh or D135-L1shL4 
(2 µM) were denatured in Reaction Buffer for 45 s at 90 °C, followed by addition of MgCl2 
(100 mM) and prefolding for 10 min at 42 °C. PNA3-Cy5 (2 µM), and PNA4-Cy3 (2 µM) were 
added and the samples were incubated for 10 min at 42 °C. An equal amount of glycerol was 
added and the samples were loaded onto a 5 % (w/v) gel containing 3 mM MgOAc, 66 mM 
HEPES, and 34 mM Tris-HCl at pH 7.4. Electrophoresis was performed at 4 °C using a 
running buffer of the same conditions as described. Fluorescence bands of Sulfo-Cy3 and 
Sulfo-Cy5 in the gels were detected on a Typhoon scanner. Additionally, RNA bands were 
stained with ethidium bromide (EtBr) and detected by UV excitation at 260 nm. 
5.4.5 Fluorescence Quantum Yields and Steady-State Anisotropy 
The procedure for the determination of the fluorescence quantum yields and static 
fluorescence anisotropy of the free dyes and the dyes attached to the DNA or PNA 
oligonucleotides follows the established techniques (see Chapter 5.3.3).[17] All spectra were 
recorded at 22 °C. Cresyl violet perchlorate (Φ = 0.54) and Rhodamine 6G (Φ = 0.94) in 
ethanol were used as references.[17] All samples were dissolved in water or Reaction Buffer 
with 100 mM MgCl2. Stock solutions were diluted to different concentrations chosen such that 
the absorption at the excitation wavelength did not exceed 0.1. Absorbance and fluorescence 
spectra were recorded. 
5.4.6 Single-Turnover Cleavage Assays 
Single-turnover cleavage assays were performed according to the literature.[42] More 
specifically, the ribozyme substrate called 17/7 (5'-CGUGGUGGGACAUUUUC▼GAGCGGU-
3') contains the last 17 nts of the 5'-exon sequence (including the intron binding sites IBS1 
and IBS2) and the first 7 nts of the intron including the 5'-splice site. 17/7 was 5'-labeled with 
[32P]-γ-ATP and T4 polynucleotide kinase using standard procedures. DNA-dye-
oligonucleotides were used in 6 fold excess over RNAs (D135, D135-L14, D135L1shL4, and 
D135-L14sh). PNA-dye oligonucleotides (PNA3-Cy5 and PNA4-Cy3) were used in a 1:1 
ratio of RNA:PNA. DNA1-Cy3, DNA2-Cy5 and DNA-biotin (1.2 μM) were heat-annealed to 
the ribozyme (200 nM) at 90 °C for 45 s in Reaction Buffer followed by MgCl2 addition 
(100 mM) and incubation at 42 °C for 20 min. In experiments with PNA, DNA-biotin (1.2 μM) 
was heat-annealed to the ribozyme (200 nM) at 90 °C for 45 s in Reaction Buffer followed by 
MgCl2 addition (100 mM) and incubation at 42 °C for 10 min. Afterwards PNA4-Cy3 and 
PNA3-Cy5 (200 nM) were added and the sample was incubated at 42 °C for 10 min. 32P-
labeled 17/7 (2 nM) was separately incubated in Reaction Buffer and MgCl2 (100 mM) and 
then added to biotinylated and Cy3/Cy5-labeled ribozyme in a 1:1 ratio to start the cleavage 
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reaction. Aliquots (1 μL) were removed from the reaction mixture at specific time points. The 
cleaved bands were separated on 18 % (w/v, 7 M urea) denaturing polyacrylamide gels, 
visualized by phosphor imaging and analyzed with ImageQuantTL. Reaction rate constants 
were determined by quantification of the gels and fitting to a single exponential expression: 
݂ݎܽܿ	ሺ݌ݎ݋݀ݑܿݐሻ ൌ ሺ1 െ ܣଵሻ െ ܣଶ ൈ ݁ି௞௧  (6)
with A1 being the fraction of uncleaved substrate, A2 the fraction of product formed, and k the 
first order rate constant in min–1. Values of kobs are calculated as arithmetic mean with 
standard deviation from at least three independent experiments.  
5.4.7 Single-Molecule FRET Experiments 
Single-Molecule FRET measurements were conducted at room temperature according to the 
procedure by Steiner et al.[42] More specifically, samples containing the ribozyme construct 
D135-L14 or D135-L1shL4 (0.5 µM), and DNA-biotin (2.5 µM) for surface immobilization 
were denatured in Reaction Buffer containing Trolox ((±)-6-Hydroxy-2,5,7,8-
tetramethylchromane-2-carboxylic acid) for 45 s at 90 °C. MgCl2 (100 mM) was added and 
samples were allowed to prefold for 10 min at 42 °C. PNA-Cy3 (PNA4-Cy3) and PNA-Cy5 
(PNA1S-Cy5, PNA2-Cy5, PNA2S-Cy5, PNA3-Cy5 or PNA3S-Cy5) each 0.5 µM were 
added and the samples were incubated for another 10 min at 42 °C. For control experiments 
2.5 µM of each DNA-Cy3 (DNA1-Cy3) and DNA-Cy5 (DNA2-Cy5) were added to D135-L14 
(0.5 µM), and DNA-biotin (2.5 µM) in Reaction Buffer containing Trolox, followed by 
incubation for 45 s at 90 °C. MgCl2 (100 mM) was added and samples were allowed to 
prefold for 15 min at 42 °C. Each sample was diluted to 15 pM and bound to a BSA-biotin-
streptavidin-coated quartz slide surface. Excess oligomers were removed from the slide by a 
washing step with Reaction Buffer. The system was flushed with an oxygen-scavenging 
system containing 10 % (w/v) glucose, 50 µg/mL glucose oxidase, and 10 µg/mL catalse to 
reduce photobleaching. All experiments were carried out in home-built flow chambers. The 
donor (ID) and acceptor (IA) fluorescence signals of optically resolved single molecules were 
recorded. Alternating laser excitation (ALEX) of the green and the red laser was used to 
check for a constant acceptor signal to clearly distinguish between photobleaching events 
and actual conformational changes.[183] For every experiment at least 100 dynamic molecules 
were analyzed. In the data analysis, filter, background (20 darkest pixels), and bleed-through 
(7 %) corrections were applied. A smoothing function was not used for the evaluated time 
trajectories. Apparent EFRET values were accumulated in histograms and the distributions 
were analyzed with multiple Gaussian fits combined with bootstrapping in the software BOBA 
FRET[175] to reveal reoccurring mean FRET values. Dwell-time analysis was done using the 
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method vbFRET based on Hidden Markov modeling (HMM) implemented in the software 
MASH.[179] 
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5.5 Methods Chapter 4 (Collaborations) 
5.5.1 Imaging of an RNA-Splicing Process Using Fluorescent PNA Labels 
Synthesis of precursor PNA-Ex1: Fmoc-gtagtaagtc-Lys-resin 
SPPS was performed according to the general procedure (Chapter 5.4.1) until the last 
coupling of the PNA sequence was completed. 
Synthesis of PNA-Ex1-Cy3: Sulfo-Cy3-gtagtaagtc-Lys-NH2 
For the subsequent coupling of the dye Sulfo-Cy3-NHS ester (1.5 equiv.) in DMF/DIPEA 30:1 
was added to ½ of deprotected precursor PNA-Ex1 and shaken for 5 h. After washing with 
DMF and DCM the coupling step was repeated. The cleavage and purification were 
performed as described in the general procedure. 
MALDI-MS: calcd. for C145H185N64O38S2+ ([M+2H]+) 3492.4, found 3492.4. 
ESI-MS m/z: 1164.9 (8, [M+4H]3+), 874.1 (100, [M+5H]4+), 699.5 (5, [M+6H]5+). 
HPLC: tR = 9.0 min, 100 % purity. 
Synthesis of precursor PNA-Ex2: Fmoc-taatacatag-LysMtt-resin 
To obtain the precursor PNA-Ex2 100 mg TentaGel® S RAM (0.24 mmol/g) were used. In a 
first step 5 equiv. of N-α-Fmoc-N-ε-4-methyltrityl-L-lysine (Fmoc-Lys(Mtt)-OH)[177] were 
coupled to the resin followed by coupling of the monomers according to the general 
procedure (SPPS, Chapter 5.4.1) until the last coupling of the PNA sequence was 
completed. 
Synthesis of PNA-Ex2-Cy5: NH2-taatacatag-Lys(Sulfo-Cy5)-NH2 
Mtt deprotection of the precursor PNA-Ex2 was performed in TFA/TIS/DCM (1:5:94, v/v/v) 
for 2 min and three times repeated including a washing step with DCM. After washing with 
DMF Sulfo-Cy3 NHS ester (1.5 equiv.) in DMF/DIPEA 30:1 was added to ½ of Mtt and Fmoc 
deprotected precursor PNA-Ex2 and shaken for 5 h. After washing with DMF and DCM the 
coupling step was repeated. The cleavage and purification were performed as described in 
the general procedure. 
MALDI-MS: calcd. for C145H183N64O36S2+ ([M+2H]+) 3486.4, found 3486.5. 
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ESI-MS m/z: 1163.5 (5, [M+4H]3+), 872.9 (45, [M+5H]4+), 698.5 (100, [M+6H]5+), 582.3 (31, 
[M+7H]6+). 
HPLC: tR = 8.8 min, 95 % purity. 
5.5.2 RNA Interaction with Rhenium Compounds 
The interactions of a series of rhenium compounds, which can be activated by light, were 
tested on the D135-L14 RNA construct. D135-L14 (1 μM) was incubated with increasing 
concentrations of each rhenium compound Re-PLPG-NLS, Re-PLPG, or Re-NH2 in buffer 
(50 mM Tris-HCl, 18 mM NaCl, pH 7.2) for 30 min at room temperature and irradiated at 
350 nm for 5 min. Control experiments were carried out in the dark. An equal volume of 
Denaturing Loading Buffer was added to each samples and denaturing polyacrylamide gel 
electrophoresis was performed (5 % w/v, 7 M urea) for 3 h at room temperature in TBE 1x 
buffer. RNA bands were detected by UV shadowing. Additionally RNA bands were stained 
with ethidium bromide and detected by UV excitation at 260 nm.[178] 
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6 Summary 
Ribonucleic acid (RNA) is a multifunctional biomolecule, which is essential for living organism 
as it is involved in countless fundamental processes (Chapter 1). 
The focus of this work is on the investigation of fluorescence labeling strategies to elucidate 
complex folding processes of RNAs, in particular the btuB riboswitch of Escherichia coli. This 
RNA possesses a gene regulating function based on a structural rearrangement upon 
specific binding of its metabolite coenzyme B12 (adenosylcobalamin). The folding mechanism 
of this particular RNA and metabolite binding are not fully clarified yet and their elucidation 
could give additional details about the functionality of riboswitches and related systems. 
Many applications could arise from this knowledge, e.g. usage as highly selective 
antibacterial drug targets, or intracellular sensors. Förster Resonance Energy Transfer 
(FRET) is the technique applied in the herein presented studies to elucidate the RNA folding 
and metabolite binding. FRET is a distance dependent energy transfer from an excited donor 
fluorophore to a corresponding acceptor dye. With this technique distance changes between 
the fluorophores can be monitored by detecting changes of the fluorescence intensities upon 
energy transfer. Thus, conformational and kinetic information about labeled molecules in 
motion can be obtained. On the single-molecule level (sm) this method reveals especially 
detailed information about folding pathways that are hidden in ensemble measurements due 
to averaging of individual folding events. 
 
Figure 76: New labeling strategies to investigate the folding of large RNAs via FRET. a) Labeling of the btuB 
riboswitch and its metabolite B12 with dyes. b) Labeling of a group II intron ribozyme by hybridization of 
fluorescent PNA or DNA derivatives. 
For fluorescence detection suitable labels need to be present at the molecules of interest. 
Chapter 2 focuses on the dye labeling of the metabolite to study metabolite binding to the 
RNA and metabolite induced folding of the RNA (Figure 76 a). In the case of the btuB 
riboswitch the metabolite, cobalamin (B12), is fairly large. B12 itself is not fluorescent and can 
Co
FRET
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therefore not be visualized by fluorescence techniques. However, its structure gives the 
opportunity to fluorescently label the metabolite by direct attachment of dyes. For FRET a 
suitable dye pair is needed with overlapping emission spectrum of the donor fluorophore and 
absorption spectrum of the acceptor. The fluorescent dyes of choice are Cy3 (donor) and 
Cy5 (acceptor), a common FRET pair, which are well established for nucleic acid 
investigations. Alternatively Cy5 can be replaced by the non-fluorescent ‘black hole 
quencher‘ BHQ-2. The use of fluorescence quenchers minimizes possible background 
problems due to fluorescence of the labeled metabolite in high concentrations. The donor 
dye can be located at the RNA and the acceptor dye at the B12, or vice versa. The axial 
position of the cobalamin was chosen for the attachment of the dye since this position of the 
cobalamin has been found to influence only the binding affinity of the B12 to the riboswitch but 
not to alternate the folding behavior of the RNA. Modifications at the corrin ring on the other 
hand would lead to a changed folding of the RNA. Thus, a linker group was introduced to the 
cobalt center at the β-side of the B12 to which the dyes were coupled via NHS ester 
chemistry. 
An important prerequisite using this methodology is that the modified B12 derivatives do not 
change the riboswitch folding drastically. Therefore, in addition to the synthesis and 
characterization of novel dye-labeled B12 derivatives, their interactions with the btuB 
riboswitch were investigated with in-line probing experiments in comparison to the natural 
ligand adenosylcobalamin. B12 derivatives labeled with sulfonated, and thus negatively 
charged, cyanine dyes were found to be no suitable probes for FRET experiments with the 
btuB riboswitch. B12-Sulfo-Cy3 is changing the folding behavior drastically, and B12-Sulfo-
Cy5 does not bind at all to the riboswitch. These results underline the specificity of the 
riboswitch towards different B12 derivatives. As expected, the binding affinities of B12-Cy3, 
B12-Cy5 and B12-BHQ-2 are reduced compared to adenosylcobalamin, and are in the range 
of vitamin B12 (~ 200 μM). Furthermore, it was observed that the attachment of the bulky 
dyes (Cy3, Cy5 or BHQ-2) to the B12 is slightly affecting the RNA conformational switch. 
However, the changes in the riboswitch folding are fairly small. B12-Cy3, B12-Cy5 and B12-
BHQ-2 are, therefore, promising candidates for FRET experiments. 
Fluorescence measurements showed that for choosing the measuring conditions in FRET 
experiments potential photolysis of the Co-C bond has to be considered as it can lead to a 
loss of the fluorophore. Furthermore, it was observed that B12 can quench the fluorescence of 
the attached dye by itself up to a certain degree. 
Nevertheless, this new strategy of fluorescently labeled metabolites gives the opportunity to 
get insights into the binding mechanism to RNA, which are otherwise inaccessible. In 
addition, the investigations of the modified B12 derivatives with the btuB riboswitch revealed, 
that negative charges at the B12 are affecting the folding of the riboswitch. 
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Chapter 3 deals with the fluorescence labeling of the RNA (Figure 76 b). Site-specific internal 
labeling methods for large RNAs exist, but they suffer from insufficient labeling yields and an 
extensive synthesis. Commonly used indirect methods on the other hand require fairly large 
modifications of the RNA for a hybridization of DNA-fluorophore conjugates, which can lead 
to misfolding of the RNA. Based on this known scheme, we improved the labeling strategy by 
using Peptide Nucleic Acid (PNA) instead of DNA. PNA is an uncharged non-natural nucleic 
acid analog, which is known to bind stronger to RNA than DNA does. Thus, modifications of 
the RNA can be minimized to bind the label. 
New PNA derivatives carrying sulfonated Cy3 or Cy5 FRET dyes, linked directly or via an 
additional spacer, were synthesized by solid phase synthesis and then characterized. The 
dye-conjugates were tested on a well-studied RNA model system, which allows a direct 
comparison of the previously used labeling scheme to the improved one. To this end, we 
chose a truncated version of the mitochondrial group II intron Sc.ai5γ derived from 
Saccharomyces cerevisiae (D135-L14, Figure 76 b). It is a catalytic active large RNA 
molecule (> 600 nts), which has already been successfully characterized by smFRET. 
Therefore potential interference between the PNA-labels and the RNA folding would easily 
be detected. 
The fluorescence properties of the samples are among the effects that have to be considered 
for an optimal fluorescence labeling. An important aspect is their dependency on 
environmental influences. Fluorescence quantum yields and steady-state anisotropy 
measurements demonstrated that the main photophysical properties of the dyes do not 
change if varying the labeling system from DNA to PNA. For both systems a fluorescence 
enhancement of the cyanine dyes bound to nucleic acids compared to free dyes is observed. 
Melting experiments were carried out to investigate the minimum length needed for efficient 
oligonucleotide-RNA binding. It was shown that shorter PNAs of 10 nts form a more stable 
duplex with RNA than the conventionally employed 18 nts long DNA oligonucleotides. 
Consequently, this allowed a reduction of the modification of the RNA, needed to bind the 
labels, towards a structure closer to the natural one. This was proven by the successful 
labeling of a new construct, D135-L1shL4 with an artificial loop L1sh shortened by 9 nts 
compared to D135-L14. 
Additionally, an optimized annealing procedure for PNA-labels was developed, which leads 
to reduced dye and RNA degradation as well as RNA aggregation by avoiding the high 
temperatures needed for the annealing of DNA-labels. Furthermore, the labeling does not 
require an excess of PNA, in contrast to DNA. Together with the stronger binding affinity, this 
results in a higher labeling efficiency of PNA compared to DNA, observed in fluorescence 
native gels by a higher fraction of labeled molecules and less unbound labels. With regard to 
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FRET experiments this implies a decreased fluorescence background and a higher density of 
detectable molecules. 
To confirm an unchanged activity of the RNA, cleavage assays were conducted. The activity 
of the ribozyme constructs (D135-L14, D135-L1shL4) was found to be similar when labeled 
with DNA or PNA. 
The final interest for the PNA labels is their use for the study of RNA folding behavior by 
smFRET. Therefore, comparative smFRET experiments of the ribozyme model labeled with 
PNA or DNA dye conjugates were conducted. A similar folding pathway of the RNA for both 
labeling schemes was observed in the same FRET states 0.1, 0.2, 0.4 and 0.6 and overall 
similar trends of the state distributions. A more compact RNA structure is favored with the 
short PNAs in comparison to DNA, detected as shift to a higher FRET state. Nevertheless, 
the general folding behavior of the RNA is not changed by the PNA. Small variations are 
most likely due to the different structure of the loop carrying the label and from the folding 
heterogeneity of the construct. The dynamics of the RNA system also show similar trends in 
all labeling schemes. Notably, in all experiments, i.e. with DNA and with PNA labels, a 
previously unreported second family of transitions (0.1↔0.2↔0.5) was observed. These 
results indicate the existence of an additional alternative folding pathway.  
A significant influence, e.g. on the free rotation of the dye, the labeling efficiency or the 
folding of the RNA by the presence or absence of a spacer group between the fluorophore 
attached to the PNA was not observed. 
In summary, in this proof of concept study could be demonstrated that PNA oligonucleotides 
are perfect specific internal labeling agents for large RNA systems to study their folding 
mechanism without influencing the latter. 
The remarkable potential of the PNA labeling has an effect in particular on RNA systems 
where modifications within the structure have a strong influence. For example, the folding of 
the btuB riboswitch of E. coli has been shown to be affected by internal sequence 
modifications and revealed very low labeling yields with DNA oligonucleotides. The above 
described labeling strategy was thus applied to the riboswitch. The labeling efficiency was 
remarkably higher when labeled with PNA instead of DNA. This gives the opportunity to 
investigate the riboswitch requiring reduced or even no modifications with the use of PNA 
labels. 
Consequently, PNA can be employed in a fast, efficient and easy to handle labeling 
technique for various fluorescence applications, including smFRET for imaging of RNA 
folding processes in vitro and in living cells. 
Chapter 4 covers two collaborative projects. In another successful application of the PNA 
labeling scheme (vide supra), new PNA derivatives were synthesized to image the splicing 
reaction of a group II intron ribozyme by fluorescence techniques. 
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Finally a study is described which was undertaken with the aim to characterize the interaction 
of organometallic Rhenium-compounds with RNA by using the group II intron ribozyme 
construct D135-L14 as a model for large RNAs. It is shown that the Rhenium complexes, 
which are derivatized with a photo-labile protecting group and a nuclear localization 
sequence, can interact with RNA and reveal toxicity towards cervical cancer cells. 
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7 Zusammenfassung 
Die Ribonucleinsäure (RNS) ist ein multifunktionelles Biomolekül, das für lebende 
Organismen essentiell ist, da es in unzähligen fundamentalen Prozessen involviert ist 
(Kapitel 1). 
Der Fokus dieser Arbeit liegt auf der Untersuchung von Strategien zur Fluoreszenz-
Markierung um komplexe Faltungsprozesse von RNS, im speziellen des btuB Riboschalter 
aus Escherichia coli, aufzuklären. Diese RNS besitzt eine genregulierende Funktion, die auf 
einer strukturellen Änderung aufgrund der spezifischen Bindung ihres Metaboliten Coenzym 
B12 (Adenosylcobalamin) basiert. Der Faltungsmechanismus dieser speziellen RNA und das 
Anbinden des Metaboliten sind noch nicht vollständig entschlüsselt und ihre Aufklärung 
könnte zusätzliche Details über die Funktionsweise von Riboschaltern und verwandter 
Systeme liefern. Aus diesem Wissen könnten sich viele Anwendungen ergeben, wie z.B. ihre 
Verwendung als hochgradig selektive antibakterielle Wirkstoffziele oder intrazelluläre 
Sensoren. Förster Resonanzenergietransfer (FRET) ist die Technik, die in den hier 
vorgestellten Studien zur Aufklärung der RNS-Faltung und der Metabolitenbindung 
angewendet wird. FRET ist ein distanzabhängiger Energietransfer von einem angeregten 
Donor-Fluorophor zu einem entsprechenden Akzeptor-Farbstoff. Mit dieser Technik können 
Abstandsänderungen zwischen den Fluorophoren nachverfolgt werden durch die Erfassung 
von Änderungen der Fluoreszenzintensitäten aufgrund des Energietransfers. Folglich kann 
man Informationen über Konformationen und Kinetiken von markierten Molekülen, die sich 
bewegen, erhalten. Diese Methode zeigt auf der Einzelmolekülebene besonders detaillierte 
Informationen über Faltungswege auf, die in Ensemblemessungen aufgrund der Mittelung 
einzelner Faltungsereignisse verborgen sind. 
 
Abbildung 1: Neue Markierungsmethoden um die Faltung großer RNS mittels FRET zu untersuchen.        
a) Markierung des btuB Riboschalters und seines Metaboliten B12 mit Farbstoffen. b) Markierung eines Gruppe II 
Intron Ribozyms durch die Hybridisierung von fluoreszierenden PNS- oder DNS-Derivaten. 
Co
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Für die Fluoreszenzdetektion müssen geeignete Marker am gefragten Molekül angebracht 
sein. Kapitel 2 setzt den Schwerpunkt auf die Farbstoffmarkierung des Metaboliten um sein 
Anbinden an die RNS und die Metabolit-induzierte Faltung der RNS zu untersuchen 
(Abbildung 1 a). Im Fall des btuB Riboschalters ist der Metabolit, Cobalamin (B12), relativ 
groß. B12 selbst ist nicht fluoreszierend und kann deshalb mit Fluoreszenztechniken nicht 
sichtbar gemacht werden. Allerdings gibt seine Struktur die Möglichkeit den Metaboliten 
durch direktes Verknüpfen mit einem Farbstoffe fluoreszierend zu markieren. Für FRET wird 
ein geeignetes Farbstoffpaar benötigt, bei dem das Emissionsspektrum des Donor-
Fluorophors und das Absorptionsspektrum des Akzeptors überlappen. Die fluoreszierenden 
Farbstoffe der Wahl sind Cy3 (Donor) und Cy5 (Akzeptor), ein bekanntes FRET-Paar, die für 
Untersuchungen von Nukleinsäuren etabliert sind. Alternativ kann Cy5 durch den nicht 
fluoreszierenden „Schwarzlochauslöscher“ BHQ-2 (vom englischen black hole quencher) 
ersetzt werden. Die Verwendung von Fluoreszenzauslöschern minimiert mögliche 
Hintergrundprobleme ausgelöst durch die Fluoreszenz des markierten Metaboliten in hoher 
Konzentration. Der Donorfarbstoff kann an der RNS und der Akzeptorfarbstoff am B12 
angebracht sein, oder umgekehrt. Die axiale Position wurde zur Anbringung des Farbstoffes 
ausgewählt, da es sich gezeigt hat, dass diese Position des Cobalamins zwar die 
Bindungsstärke des B12 zum Riboschalter beeinflusst, nicht aber das Faltungsverhalten der 
RNA verändert. Modifikationen am Corrinring hingegen würden zu einer veränderten Faltung 
der RNS führen. Deshalb wurde eine verknüpfende Gruppe am Kobaltzentrum auf der β-
Seite des B12 angebracht, an die die Farbstoffe mittels NHS-Ester-Chemie gekoppelt 
wurden. 
Eine wichtige Annahme bei der Verwendung dieser Methodik ist, dass die modifizierten B12-
Derivate die Faltung des Riboschalters nicht drastisch verändern. Daher wurden zusätzlich 
zur Synthese und Charakterisierung der neuen farbstoffmarkierten B12-Derivate, deren 
Wechselwirkungen mit dem btuB Riboschalter mittels „in-line probing“ Experimenten im 
Vergleich zum natürlichen Liganden Adenosylcobalamin untersucht. Es wurde 
herausgefunden, dass mit sulfonierten, und damit negativ geladenen, Cyaninfarbstoffen 
markierte B12-Derivate keine geeigneten Proben für FRET Experimente mit dem btuB 
Riboschalter sind. B12-Sulfo-Cy3 verändert das Faltungsverhalten drastisch und B12-Sulfo-
Cy5 bindet überhaupt nicht an den Riboschalter. Diese Resultate unterstreichen die 
Spezifität des Riboschalters gegenüber unterschiedlichen B12-Derivaten. Die 
Bindungsaffinitäten von B12-Cy3, B12-Cy5 und B12-BHQ-2 sind, wie erwartet, reduziert 
verglichen mit Adenosylcobalamin, aber sind im Bereich von Vitamin B12 (~ 200 µM). 
Desweiteren wurde beobachtet, dass das Anbringen der sperrigen Farbstoffe (Cy3, Cy5 oder 
BHQ-2) an das B12 die konformelle RNS-Schaltung geringfügig beeinflusst. Allerdings sind 
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die Änderungen der Riboschalterfaltung ziemlich gering. B12-Cy3, B12-Cy5 und B12-BHQ-2 
sind deshalb vielversprechende Kandidaten für FRET Experimente. 
Fluoreszenzexperimente haben gezeigt, dass bei der Wahl der Messbedingungen für FRET 
Experimente die potentielle Photolyse der Co-C-Bindung berücksichtigt werden muss, da sie 
zu einer Abspaltung des Fluorophors führen kann. Zudem wurde beobachtet, dass B12 selbst 
die Fluoreszenz des verknüpften Farbstoffs bis zu einem gewissen Grad auslöschen kann. 
Nichtsdestotrotz bietet diese neue Strategie der Fluoreszenzmarkierung des Metaboliten die 
Möglichkeit Einblicke in dessen Bindungsmechanismus zur RNS zu erhalten, die sonst nicht 
zu erreichen wären. Darüber hinaus haben Untersuchungen der modifizierten B12-Derivate 
mit dem btuB Riboschalter gezeigt, dass negative Ladungen am B12 die Faltung des 
Riboschalters beeinflussen. 
Kapitel 3 behandelt die Fluoreszenzmarkierung der RNS (Abbildung 1 b). 
Positionsspezifische interne Markierungsmethoden für große RNS gibt es zwar, aber sie 
leiden unter unzulänglichen Markierungsausbeuten und einer aufwendigen Synthese. 
Übliche indirekte Methoden wiederum benötigen relativ große Modifikationen der RNS, an 
die DNS-Farbstoff-Konjugate hybridisiert werden können, was eine Fehlfaltung der RNS 
verursachen kann. Basierend auf diesem bekannten Schema haben wir die 
Markierungsstrategie durch die Verwendung von Peptidnukleinsäuren (PNS), anstelle von 
DNS, verbessert. PNS ist ein ungeladenes, künstliches Nukleinsäureanaloga, welches 
bekannt dafür ist stärker an die RNS zu binden als es DNS kann. Folglich können die 
Modifikationen der RNS minimiert werden um den Marker zu binden. 
Neue PNS-Derivate, die sulfonierte Cy3 oder Cy5 FRET Farbstoffe tragen, entweder direkt 
oder über einen zusätzlichen Abstandshalters angebunden, wurden mittels 
Festphasensynthese synthetisiert und dann charakterisiert. Die Farbstoffkonjugate wurden 
an einem genau untersuchten Modellsystem getestet, was einen direkten Vergleich des 
zuvor verwendeten Markierungsschemas mit dem Verbesserten ermöglicht. Hierfür haben 
wir eine verkürzte Version des mitochondrialen Gruppe II Introns Sc.ai5γ aus 
Saccharomyces cerevisiae (D135-L14, Abbildung 1 b) ausgewählt. Es ist ein katalytisch 
aktives großes RNS Molekül (> 600 Nukleotide), das bereits erfolgreich mittels smFRET 
untersucht wurde. Daher würden etwaige Beeinträchtigungen der RNS-Faltung durch die 
PNA-Markierung leicht erkannt werden. 
Die Fluoreszenzeigenschaften der Proben sind unter den Einflüssen, die für eine optimale 
Fluoreszenzmarkierung berücksichtigt werden müssen. Ein wichtiger Aspekt ist ihre 
Abhängigkeit von Umgebungseinflüssen. Fluoreszenzquantenausbeuten und statische 
Anisotropiemessungen haben gezeigt, dass sich die wichtigsten photophysikalischen 
Eigenschaften der Farbstoffe nicht verändern wenn man das Markierungssystem von DNS 
zu PNS ändert. Bei beiden Systemen wird eine Fluoreszenzverstärkung der Cyaninfarbstoffe 
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durch das Anbinden an die Nukleinsäuren im Vergleich zu den freien Farbstoffen 
beobachtet. Schmelzexperimente wurden durchgeführt um die mindestens benötigte Länge 
für eine effiziente Oligonukleotid-RNS Bindung zu untersuchen. Es hat sich gezeigt, dass 
kürzere PNS aus 10 Nukleotiden eine stabilere Duplex mit RNS bilden als die üblicherweise 
verwendeten 18 Nukleotide langen DNS Oligonukleotide. Folglich ermöglicht dies eine 
Verringerung der Modifikation der RNS, die für die Anbringung der Markierung benötigt wird, 
in Richtung einer Struktur, die eher der natürlichen entspricht. Dies wurde mit der 
erfolgreichen Markierung eines neuen Konstrukts, D135-L1shL4 mit einer künstlichen 
Schlaufe L1sh, die im Vergleich zu D135-L14 um 9 Nukleotide gekürzt ist, bewiesen. 
Zusätzlich wurde eine optimierte Anbindungsprozedur für die PNS-Marker entwickelt, welche 
zu reduzierter Farbstoff- und RNS-Degradation sowie RNS-Aggregation führt, indem die 
hohen Temperaturen, die zur Anbindung der DNS-Marker benötigt werden, vermieden 
werden. Desweiteren. wird kein Überschuss von PNS benötig, im Gegensatz zur DNS. Unter 
gemeinsamer Berücksichtigung der stärkeren Bindungsaffinität führt dies zu einer höheren 
Markierungseffizienz von PNS gegenüber DNS, was in nativen Fluoreszenzgelen anhand 
einer größeren Fraktion an markierten Molekülen und weniger ungebunden Markern 
beobachtet wurde. Im Hinblick auf FRET Experimente impliziert dies einen reduzierten 
Fluoreszenzhintergrund und eine höhere Dichte an detektierbaren Molekülen. 
Um eine unveränderte Aktivität der RNS zu bestätigen wurden Spaltungs-Assays 
durchgeführt. Es wurden gleiche Aktivitäten der Ribozymkonstrukte (D135-L14, D135-
L1shL4) bei Markierung mit DNS oder PNS beobachtet. 
Das schlussendliche Interesse an den PNS-Markern ist ihre Verwendung zur Untersuchung 
des Faltungsverhaltens von RNS mittels smFRET. Daher wurden Vergleichsexperimente am 
Ribozymmodell, das mit PNS- oder DNS-Farbstoff-Konjugaten markiert wurde, durchgeführt. 
Es wurde der gleiche Faltungsweg der RNS für beide Markierungsschemata anhand der 
gleichen FRET Zustände 0.1, 0.2, 0.4 und 0.6 und im Großen und Ganzen gleichen Trends 
in den Zustandsverteilungen beobachtet. Eine kompaktere RNS-Struktur ist mit den kurzen 
PNS begünstigt verglichen mit DNS, was sich anhand einer Verschiebung zu einem höheren 
FRET Zustand bemerkbar macht. Nichtsdestotrotz wird das generelle Faltungsverhalten der 
RNS nicht durch die PNS verändert. Kleine Variationen kommen wahrscheinlich von einer 
veränderten Struktur der Schlaufe, die den Marker trägt, und von der Faltungsheterogenität 
des Konstrukts. Die Dynamiken des RNS Systems zeigen zudem gleiche Trends mit allen 
Markierungsschemata. Auffälliger Weise wurde in allen Experimenten, also mit DNS- und mit 
PNS-Markern, eine zweite Familie von Übergängen beobachtet (0.1↔0.2↔0.5), die bisher 
noch nicht beschrieben wurde. Diese Ergebnisse lassen vermuten, dass ein zusätzlicher 
alternativer Faltungsweg existiert. 
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Einen signifikanten Einfluss durch die An-oder Abwesenheit einer Abstandshaltergruppe 
zwischen der PNS und dem Farbstoff, z.B. auf die freie Drehbarkeit des Farbstoffs, die 
Markierungseffizienz oder die Faltung der RNS hat man nicht festgestellt. 
Zusammenfassend konnte in dieser Machbarkeitsstudie gezeigt werden, dass PNS 
Oligonukleotide perfekte spezifische interne Markierungsstoffe für große RNS Systeme 
darstellen zur Untersuchung ihres Faltungsmechanismus ohne letzteren zu beeinflussen. 
Das bemerkenswerte Potential von PNS kommt besonders dort zum Tragen wo 
Modifikationen innerhalb der Struktur einen großen Einfluss ausüben. Zum Beispiel hat sich 
für die Faltung des btuB Riboschalters aus E. coli eine Beeinflussung durch interne 
Sequenzmodifikationen und eine sehr geringe Markierungsausbeute mit DNS-
Oligonukleotiden gezeigt. Die oben beschriebene Markierungsmethode wurde deshalb auf 
den Riboschalter angewendet. Die Markierungseffizienz war bei Markierung mit PNS statt 
mit DNS beträchtlich höher. Dies gibt die Möglichkeit den Riboschalter mit verringerten oder 
sogar ohne Modifizierungen durch Verwendung von PNS-Markern zu untersuchen. 
Somit kann PNS als schnelle und effiziente Markierungstechnik mit bequemer Handhabung 
für verschiedenste Fluoreszenzanwendung verwendet werden, eingeschlossen smFRET zur 
Abbildung von RNS Faltungsprozessen in vitro und in lebenden Zellen. 
Kapitel 4 behandelt zwei gemeinschaftliche Projekte. In einer weiteren erfolgreichen 
Anwendung des PNS Markierungsschemas (siehe oben) wurden neue PNS Derivate 
synthetisiert um die Splicing-Reaktion eines Gruppe II Intron Ribozyms zu untersuchen. 
Zum Abschluss wird eine Studie beschrieben, die mit dem Ziel durchgeführt wurde, die 
Wechselwirkung von organometallischen Rhenium-Verbindungen mit RNS unter 
Verwendung des Gruppe II Intron Ribozymkonstrukts D135-L14 als Modellsystem für große 
RNS zu charakterisieren. Es wird gezeigt, dass die Rhenium-Komplexe, die mit einer photo-
labilen Schutzgruppe und einer Kernlokalisierungssequenz derivatisiert sind, mit RNS 
wechselwirken können und toxisch gegenüber zervikalen Krebszellen sind. 
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A. MALDI-MS Spectra and HPLC Chromatograms 
 
Figure A1: MALDI-MS spectrum and HPLC chromatogram (inset) of PNA1S-Cy5. 
 
 
Figure A2: MALDI-MS spectrum and HPLC chromatogram (inset) of PNA2-Cy5. 
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Figure A3: MALDI-MS spectrum and HPLC chromatogram (inset) of PNA2S-Cy5. 
 
 
Figure A4: MALDI-MS spectrum and HPLC chromatogram (inset) of PNA3-Cy5. 
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Figure A5: MALDI-MS spectrum and HPLC chromatogram (inset) of PNA3S-Cy5. 
 
 
Figure A6: MALDI-MS spectrum and HPLC chromatogram (inset) of PNA4-Cy3. 
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Figure A7: MALDI-MS spectrum and HPLC chromatogram (inset) of PNA-Ex1-Cy3. 
 
 
Figure A8: MALDI-MS spectrum and HPLC chromatogram (inset) of PNA-Ex2-Cy5. 
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B. Melting Curves 
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Figure A9: Melting curves of PNA-Cy and DNA-Cy derivatives with complementary RNA oligonucleotides 
recorded at 260 nm. Three cycles of heating and cooling. The absorbance was normalized (divided by mean). 
For exact conditions see Chapter 5.4.3. 
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Figure A10: Melting curves of PNA1S-Cy3 with complementary RNA4 recorded at 260 nm. Three cycles of 
heating and cooling. The absorbance was normalized (divided by mean). For exact conditions see Chapter 5.4.3. 
 
C. Single-Turnover Cleavage Assays 
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Figure A11: Cleavage of 17/7 substrate by different ribozyme constructs. Plots of product fraction versus 
time with exponential fit (red). For exact conditions see Chapter 5.4.6. 
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Figure A12: Cleavage of 17/7 substrate by different ribozyme constructs. Plots of product fraction versus 
time with exponential fit (red). For exact conditions see Chapter 5.4.6. 
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D. Plasmid Table pSPA7a 
 
Figure A13: Plasmid pSPA7a. The plasmid pSP7a contains the ribozyme construct D135-L14sh. 
1	 TCGCGCGTTT	 CGGTGATGAC	 GGTGAAAACC	 TCTGACACAT	 GCAGCTCCCG	 	
	 GAGACGGTCA	 CAGCTTGTCT	 GTAAGCGGAT	 GCCGGGAGCA	 GACAAGCCCG	 	
101	 TCAGGGCGCG	 TCAGCGGGTG	 TTGGCGGGTG	 TCGGGGCTGG	 CTTAACTATG	 	
	 CGGCATCAGA	 GCAGATTGTA	 CTGAGAGTGC	 ACCATATGCG	 GTGTGAAATA	 	
201	 CCGCACAGAT	 GCGTAAGGAG	 AAAATACCGC	 ATCAGGCGAC	 GCGCCCTGTA	 	
	 GCGGCGCATT	 AAGCGCGGCG	 GGTGTGGTGG	 TTACGCGCAG	 CGTGACCGCT	 	
301	 ACACTTGCCA	 GCGCCCTAGC	 GCCCGCTCCT	 TTCGCTTTCT	 TCCCTTCCTT	 	
	 TCTCGCCACG	 TTCGCCGGCT	 TTCCCCGTCA	 AGCTCTAAAT	 CGGGGGCTCC	 	
401	 CTTTAGGGTT	 CCGATTTAGT	 GCTTTACGGC	 ACCTCGACCC	 CAAAAAACTT	 	
	 GATTAGGGTG	 ATGGTTCACG	 TAGTGGGCCA	 TCGCCCTGAT	 AGACGGTTTT	 	
501	 TCGCCCTTTG	 ACGTTGGAGT	 CCACGTTCTT	 TAATAGTGGA	 CTCTTGTTCC	 	
	 AAACTGGAAC	 AACACTCAAC	 CCTATCTCGG	 TCTATTCTTT	 TGATTTATAA	 	
601	 GGGATTTTGC	 CGATTTCGGC	 CTATTGGTTA	 AAAAATGAGC	 TGATTTAACA	 	
	 AAAATTTAAC	 GCGAATTTTA	 ACAAAATATT	 AACGCTTACA	 ATTTCCATTC	 	
701	 GCCATTCAGG	 CTGCGCAACT	 GTTGGGAAGG	 GCGATCGGTG	 CGGGCCTCTT	 	
	 CGCTATTACG	 CCAGCTGGCG	 AAAGGGGGAT	 GTGCTGCAAG	 GCGATTAAGT	 	
801	 TGGGTAACGC	 CAGGGTTTTC	 CCAGTCACGA	 CGTTGTAAAA	 CGACGGCCAG	 	
	 									EcoRI	 	 	 	 	 											D135‐L14sh	
	 GGCGAATTCG	 TGAATTGTAA	 TACGACTCAC	 TATAGAGCGG	 TCTGAAAGTT	 	
901	 ATCATAAATA	 ATATTTACCA	 TATAATAATG	 GATAAATTAT	 ATTTTTATCA	 	
	 ATATAAGTCT	 AATTACAAGT	 GTATTAAAAT	 GGTAACATAA	 ATATGCTAAG	 	
1001	 CTGTAATGAC	 AAAAGTATCC	 ATATTCTTGA	 CAGTTATTTT	 ATATTATAAA	 	
	 AAAAAGATGA	 AGGAACTTTG	 ACTGATCTAA	 TATGCTCAAC	 GAAAGTGAAT	 	
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1101	 CAAATGTTAT	 AAAATTACTT	 ACACCACTAA	 TTGAAAACCT	 GTCTGATATT	 	
	 CAATTATTAT	 CCCACGCTCT	 TGGTAGGGAT	 AAAATGGTTG	 ATGTTATGTA	 	
1201	 TTGGAAATGA	 GCATACGATA	 AATCATATAA	 CCATTAGTAA	 TATAATTTGA	 	
	 GAGCTAAGTT	 AGATATTTAC	 GTATTTATGA	 TAAAACAGAA	 TAAACCCTCT	 	
1301	 TCGGAGGGTA	 AAAGATTGTA	 TAAAAAGCTA	 ATGCCATATT	 GTAATGATAT	 	
	 GGATAAGAAT	 TATTATTCTA	 AAGATGAAAA	 TCTGCTAACT	 TATACTATAG	 	
1401	 GTGATACCCA	 CGGACTACGT	 AGGGTATTGC	 GTGAGCCGTA	 TGCGATGAAA	 	
	 	 	 	 	 	 	 	 	 	 HindIII	
	 GTCGCACGTA	 CGGTTCCTGG	 ATCCTCTAGA	 GTCGACCTGC	 AGGCATGCAA	 	
1501	 GCTTTTGTTC	 CCTTTAGTGA	 GGGTTAATTC	 CGAGCTTGGC	 GTAATCATGG	 	
	 TCATAGCTGT	 TTCCTGTGTG	 AAATTGTTAT	 CCGCTCACAA	 TTCCACACAA	 	
1601	 CATACGAGCC	 GGAAGCATAA	 AGTGTAAAGC	 CTGGGGTGCC	 TAATGAGTGA	 	
	 GCTAACTCAC	 ATTAATTGCG	 TTGCGCTCAC	 TGCCCGCTTT	 CCAGTCGGGA	 	
1701	 AACCTGTCGT	 GCCAGCTGCA	 TTAATGAATC	 GGCCAACGCG	 CGGGGAGAGG	 	
	 CGGTTTGCGT	 ATTGGGCGCT	 CTTCCGCTTC	 CTCGCTCACT	 GACTCGCTGC	 	
1801	 GCTCGGTCGT	 TCGGCTGCGG	 CGAGCGGTAT	 CAGCTCACTC	 AAAGGCGGTA	 	
	 ATACGGTTAT	 CCACAGAATC	 AGGGGATAAC	 GCAGGAAAGA	 ACATGTGAGC	 	
1901	 AAAAGGCCAG	 CAAAAGGCCA	 GGAACCGTAA	 AAAGGCCGCG	 TTGCTGGCGT	 	
	 TTTTCCATAG	 GCTCCGCCCC	 CCTGACGAGC	 ATCACAAAAA	 TCGACGCTCA	 	
2001	 AGTCAGAGGT	 GGCGAAACCC	 GACAGGACTA	 TAAAGATACC	 AGGCGTTTCC	 	
	 CCCTGGAAGC	 TCCCTCGTGC	 GCTCTCCTGT	 TCCGACCCTG	 CCGCTTACCG	 	
2101	 GATACCTGTC	 CGCCTTTCTC	 CCTTCGGGAA	 GCGTGGCGCT	 TTCTCATAGC	 	
	 TCACGCTGTA	 GGTATCTCAG	 TTCGGTGTAG	 GTCGTTCGCT	 CCAAGCTGGG	 	
2201	 CTGTGTGCAC	 GAACCCCCCG	 TTCAGCCCGA	 CCGCTGCGCC	 TTATCCGGTA	 	
	 ACTATCGTCT	 TGAGTCCAAC	 CCGGTAAGAC	 ACGACTTATC	 GCCACTGGCA	 	
2301	 GCAGCCACTG	 GTAACAGGAT	 TAGCAGAGCG	 AGGTATGTAG	 GCGGTGCTAC	 	
	 AGAGTTCTTG	 AAGTGGTGGC	 CTAACTACGG	 CTACACTAGA	 AGGACAGTAT	 	
2401	 TTGGTATCTG	 CGCTCTGCTG	 AAGCCAGTTA	 CCTTCGGAAA	 AAGAGTTGGT	 	
	 AGCTCTTGAT	 CCGGCAAACA	 AACCACCGCT	 GGTAGCGGTG	 GTTTTTTTGT	 	
2501	 TTGCAAGCAG	 CAGATTACGC	 GCAGAAAAAA	 AGGATCTCAA	 GAAGATCCTT	 	
	 TGATCTTTTC	 TACGGGGTCT	 GACGCTCAGT	 GGAACGAAAA	 CTCACGTTAA	 	
2601	 GGGATTTTGG	 TCATGAGATT	 ATCAAAAAGG	 ATCTTCACCT	 AGATCCTTTT	 	
	 AAATTAAAAA	 TGAAGTTTTA	 AATCAATCTA	 AAGTATATAT	 GAGTAAACTT	 	
2701	 GGTCTGACAG	 TTACCAATGC	 TTAATCAGTG	 AGGCACCTAT	 CTCAGCGATC	 	
	 TGTCTATTTC	 GTTCATCCAT	 AGTTGCCTGA	 CTCCCCGTCG	 TGTAGATAAC	 	
2801	 TACGATACGG	 GAGGGCTTAC	 CATCTGGCCC	 CAGTGCTGCA	 ATGATACCGC	 	
	 GAGACCCACG	 CTCACCGGCT	 CCAGATTTAT	 CAGCAATAAA	 CCAGCCAGCC	 	
2901	 GGAAGGGCCG	 AGCGCAGAAG	 TGGTCCTGCA	 ACTTTATCCG	 CCTCCATCCA	 	
	 GTCTATTAAT	 TGTTGCCGGG	 AAGCTAGAGT	 AAGTAGTTCG	 CCAGTTAATA	 	
3001	 GTTTGCGCAA	 CGTTGTTGCC	 ATTGCTACAG	 GCATCGTGGT	 GTCACGCTCG	 	
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	 TCGTTTGGTA	 TGGCTTCATT	 CAGCTCCGGT	 TCCCAACGAT	 CAAGGCGAGT	 	
3101	 TACATGATCC	 CCCATGTTGT	 GCAAAAAAGC	 GGTTAGCTCC	 TTCGGTCCTC	 	
	 CGATCGTTGT	 CAGAAGTAAG	 TTGGCCGCAG	 TGTTATCACT	 CATGGTTATG	 	
3201	 GCAGCACTGC	 ATAATTCTCT	 TACTGTCATG	 CCATCCGTAA	 GATGCTTTTC	 	
	 TGTGACTGGT	 GAGTACTCAA	 CCAAGTCATT	 CTGAGAATAG	 TGTATGCGGC	 	
3301	 GACCGAGTTG	 CTCTTGCCCG	 GCGTCAATAC	 GGGATAATAC	 CGCGCCACAT	 	
	 AGCAGAACTT	 TAAAAGTGCT	 CATCATTGGA	 AAACGTTCTT	 CGGGGCGAAA	 	
3401	 ACTCTCAAGG	 ATCTTACCGC	 TGTTGAGATC	 CAGTTCGATG	 TAACCCACTC	 	
	 GTGCACCCAA	 CTGATCTTCA	 GCATCTTTTA	 CTTTCACCAG	 CGTTTCTGGG	 	
3501	 TGAGCAAAAA	 CAGGAAGGCA	 AAATGCCGCA	 AAAAAGGGAA	 TAAGGGCGAC	 	
	 ACGGAAATGT	 TGAATACTCA	 TACTCTTCCT	 TTTTCAATAT	 TATTGAAGCA	 	
3601	 TTTATCAGGG	 TTATTGTCTC	 ATGAGCGGAT	 ACATATTTGA	 ATGTATTTAG	 	
	 AAAAATAAAC	 AAATAGGGGT	 TCCGCGCACA	 TTTCCCCGAA	 AAGTGCCACC	 	
3701	 TGACGTCTAA	 GAAACCATTA	 TTATCATGAC	 ATTAACCTAT	 AAAAATAGGC	 	
	 GTATCACGAG	 GCCCTTTCGT	 C	
	
The plasmid pSPA7b is analogous to pSPA7a encoding D135-L1shL4 instead of D135-
L14sh. 
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E. UV/Vis Spectra 
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Figure A14: UV/Vis spectra of B12-Cy3 and B12-Cy5. Normalized absorbance spectra of a) B12-Cy3 and b) B12-
Cy5 in water at r.t. 
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Figure A15: UV/Vis spectra of B12 derivatives. Normalized absorbance spectra of a) AdoCbl (dotted line) and 
B12-linker (solid line), and b) Sulfo-Cy5 (dotted line) and B12-Sulfo-Cy5 (solid line) in water at r.t. 
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F. HR-ESI-MS Spectra 
 
Figure A16: HR-ESI-MS spectrum of B12-Cy5. 
 
 
Figure A17: HR-ESI-MS spectrum of B12-Sulfo-Cy5. 
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Figure A18: HR-ESI-MS spectrum of B12-Sulfo-Cy3. 
 
G. NMR Spectra 
 
Figure A19: 1H-NMR spectrum of B12-Sulfo-Cy3 in MeOD-d4 (500 MHz, 300 K). Protons belonging to Sulfo-
Cy3 are marked with black dots (). 
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Figure A20: 1H-NMR spectrum of B12-Sulfo-Cy5 in MeOD-d4 (500 MHz, 300 K). Protons belonging to Sulfo-
Cy5 are marked with black dots (). 
 
 
Figure A21: 1H-NMR spectrum of B12-Cy5 in MeOD-d4 (500 MHz, 300 K). Protons belonging to Cy5 are 
highlighted with black dots ().
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H. Time Trajectories of smFRET Experiments 
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Figure A22: Characteristic time trajectories of smFRET experiments of D135-L14 labeled with PNA2-Cy5, 
PNA2S-Cy5, or PNA1S-Cy5. The different conformational states at 0.1, 0.2, 0.4 and 0.6 are determined by 
vbFRET software based on HMM (red line). 
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I. btuB Constructs 
pPC1 
The btuB riboswitch (E. coli) construct pPC1 (Figure A23) encoded in the plasmid pPC1 is 
designed by Choudhary et al.[176] To improve the transcription start site for the T7 RNA 
polymerase, the construct contains an insertion of three nucleotides (GGA) between the 
TATA box and the btuB coding sequence. Furthermore, the plasmid contains the btuB 
aptamer, and SacI and EcoR1 restriction sites located downstream of the riboswitch region.  
 
Figure A23: Secondary structure of the btuB riboswitch (E. coli) construct pPC1. The btuB aptamer is 
depicted in black, extensions are in green and characteristic structure elements are in blue. The numbering 
corresponds to the wild-type sequence. 216 nts 
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pPC4 
The btuB riboswitch (E. coli) construct pPC4 (Figure A24) encoded in the plasmid pPC4 is 
designed by Choudhary et al.[176] To improve the transcription start site for the T7 RNA 
polymerase, the construct contains an insertion of three nucleotides (GGA) between the 
TATA box and the btuB coding sequence. Furthermore, an artificial loop for binding of 
oligonucleotides for labeling purpose is inserted. The plasmid contains the modified btuB 
aptamer and expression platform, and an EcoR1 restriction site located downstream of the 
riboswitch region. 
 
Figure A24: Secondary structure of the btuB riboswitch (E. coli) construct pPC4. The wild-type sequence of 
the btuB riboswitch is depicted in black, insertions and extensions are in green, characteristic structure elements 
are in blue and the ribosomal binding site is highlighted in the green box. The numbering corresponds to the wild-
type sequence. 270 nts 
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pSG1 
The btuB riboswitch (E. coli) construct pSG1 (Figure A25) encoded in the plasmid pSG1 is 
designed by Gallo et al.[87] The plasmid contains the btuB aptamer, the self-cleaving 
hammerhead ribozyme sequence at the 5’- and the self-cleaving hepatitis delta virus 
ribozyme sequence at the 3’-site, which lead to uniform RNA ends after transcription and 
cleavage, and additionally an EcoR1 restriction site located downstream of the riboswitch 
region. 
 
Figure A25: Secondary structure of the btuB riboswitch (E. coli) construct pSG1. The btuB aptamer is 
depicted in black and characteristic structure elements are in blue. 202 nts. Figure adapted from Dr. Sofia 
Gallo.[87] 
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If you still wonder WHAT IS FRET … 
… For sure it is more than just noise. 
